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Nontyphoidal Salmonella (NTS) is a globally important bacterial pathogen, typically 
associated with foodborne gastroenteritis. However, NTS can also invade normally sterile 
sites in humans, resulting in an extraintestinal infection known as invasive nontyphoidal 
Salmonella (iNTS) disease. The majority of cases of iNTS disease in humans are caused by a 
small minority of Salmonella pathovariants, which exhibit genomic signatures of adaptation 
to a systemic lifestyle within a restricted host-range. With the increasing availability of whole 
genome sequencing (WGS)-based pathogen surveillance, it has become possible to use 
genomic approaches to investigate the adaptive process that occurred when NTS serovars 
evolved to exploit a new niche. I aimed to determine the temporal, geographical and 
evolutionary trends in nontyphoidal Salmonella serovars, in order to understand the 
genomic signatures acquired on the trajectory towards extraintestinal adaptation. 
My genome-based analysis began with a phylogenetic approach to differentiate a broad 
range of NTS serovars. Specifically, I assembled a unique dataset of 133 reptilian isolates to 
study S. enterica species-level evolution and ecology, with a focus on Salmonella that 
colonised the guts of venomous snakes. The serovars belonged to four of the six S. enterica 
subspecies and included a small number of multidrug resistant isolates of clinical relevance. 
The subspecies enterica isolates were distributed between two distinct phylogenetic 
clusters, clade A and clade B, and exhibited different levels of metabolic flexibility reflecting 
distinctive host-ranges. My species-level analysis provided a context for a more detailed 
study of two epidemiologically important serovars responsible for iNTS disease in humans; 
S. Typhimurium and S. Panama.  
By studying the stepwise evolution of 680 S. Typhimurium isolates that caused bloodstream 
infection in sub-Saharan Africa, I uncovered the timeline of crucial loss-of-function genetic 
events that facilitated the emergence of the invasive ST313 S. Typhimurium pathovariant in 
the immunocompromised human niche. The findings link the acquisition of particular 
nucleotide changes with gene function during the evolution of ST313 lineage 2 (ST313 L2). A 
recently emerged pan-susceptible ST313 lineage (ST313 L3) was discovered in Malawi, with 
evidence of genome degradation in important virulence genes which had not occurred in 
other ST313 lineages. My work describes the evolutionary dynamics of S. Typhimurium 
ST313 and highlights epidemiological shifts in the circulation of ST313 lineages in Malawi.   
To compare and contrast with my work in S. Typhimurium, I explored an understudied 
serovar responsible for extraintestinal infection globally. Specifically, I described the 
population structure, phylodynamics and invasiveness potential of 489 S. Panama isolates 
from 27 countries. The findings revealed 6 geographically associated clades, and regional 
trends in AMR.  Finally, I determined the genetic markers of invasiveness that varied between 
S. Panama clades, highlighting the importance of prophage presence and genome 
degradation, as was the case in S. Typhimurium.  
Taken together, my study provides new insights into the evolution of niche-adaptation in a 
globally important pathogenic genus. My findings highlight the need for an integrated 
approach for pathogen surveillance and scientific research that combines the power of 
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1.1 The emerging field of genomic epidemiology 
1.1.1 Traditional bacterial typing methods 
Bacterial typing methods have been used to inform epidemiological investigations since the 
1920’s, traditionally involving phenotypic classification of pathogens using labour intensive 
methods such as serotyping (Grimont and Weill, 2007) and phage typing (Ibrahim, 1969; 
Rabsch, 2007). Despite their initial success, these phenotypic tools have proven to lack the 
discriminatory power required in outbreak situations. Consequently molecular typing 
methods have been developed which can resolve complex population structures and 
monitor the genetic relatedness between bacterial pathogens (Deng et al., 2016). Early 
molecular typing tools included MultiLocus Variable number of tandem repeats Analysis 
(MLVA) (Best et al., 2007; Lindstedt et al., 2004) and Pulse-Field Gel Electrophoresis (PFGE) 
(Swaminathan et al., 2001). PFGE was pioneered in the mid 1990s by an organisation called 
PulseNet which played an instrumental role in improving the investigation of foodborne-
disease outbreaks that were previously difficult to detect (Swaminathan et al., 2001). For 
example, eight times as many Listeria outbreaks were resolved in the five years following the 
introduction of PulseNet, compared with the twenty years prior (Cartwright et al., 2013). 
This routine use of molecular methods has also benefitted other foodborne bacteria such as 
Salmonella, and Shiga Toxin Producing Escherichia coli (STEC) (Tolar et al., 2019).  
 
1.1.2 A brief history of whole genome sequencing 
Meanwhile, a ground-breaking new technology was being developed called whole-genome 
sequencing (WGS), which would soon revolutionise the fields of public health, clinical care 
and scientific research (Heather and Chain, 2016). In 1977, Frederick Sanger developed a 
technique that involved the selective incorporation of chain-terminating dideoxynucleotides 
by deoxyribonucleic acid (DNA) polymerase during in vitro DNA replication, and was used to 
generate the world’s first whole-genome sequence, that of a bacteriophage called ϕX174 
(Sanger et al., 1977). Sanger’s approach quickly became the most commonly used DNA 
sequencing technology worldwide (Heather and Chain, 2016). In subsequent years, the 
original Sanger method was improved by replacing phospho-radiolabelling of nucleotides 
with fluorometric based detection which facilitated the invention of increasingly automated 
WGS machines (Hunkapiller et al., 1991). The first generation of sequencing technologies 
were able to produce reads up to 1 kilobase (kb) in length, and multiple separate runs were 
required to analyse longer genomes. This shotgun sequencing approach was complemented 
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with computational processing, in which overlapping DNA fragments were assembled into 
longer contiguous sequences (contigs) (Anderson, 1981; Staden, 1979). Shotgun sequencing 
was used to complete the first bacterial genome sequences; Haemophilus influenzae 
(Fleischmann et al., 1995) and Mycoplasma influenzae (Fraser et al., 1995) in 1995, 
Escherichia coli (E. coli) in 1997 (Blattner et al., 1997) and Salmonella enterica in 2001 
(McClelland et al., 2001). Despite being robust and simple, early sequencing technologies 
proved to be very expensive and labour intensive, and so their application on a larger scale 
was limited. 
 
Subsequent advances in DNA sequencing were markedly different from the initial Sanger 
method, however have still utilised the same sequencing by synthesis approach (Heather 
and Chain, 2016). Specifically, researchers have utilised a novel luminescent method for 
measuring pyrophosphate synthesis from nucleotides which can be used in real time 
(Hyman, 1988; Nyrén and Lundin, 1985). Following ongoing development and refinement 
including the invention of the Flow Cell and bridge-amplification, this technology became 
much more high throughput, cost effective and accessible and came to be defined as next 
generation sequencing (NGS) (Shendure and Ji, 2008).  
 
It is now possible to sequence complete microbial genomes at a price comparable to earlier 
subtyping methods, leading to an exponential increase in sequencing data over the past 20 
years (Land et al., 2015). Broadly speaking, there are two types of whole genome sequencing 
technology; short read sequencers and long read sequencers (Quail et al., 2012). In recent 
years, the short-read sequencing industry has been dominated by Illumina (previously known 
as Solexa Ltd), whose high throughput platform can sequence reads up to 300 base pairs (bp) 
in length (Bennett, 2004). Specifically, the Illumina process uses clonal amplification and 
sequencing by synthesis. The process adds DNA bases into a nucleic acid chain and unique 
fluorescent signals emitted from each base are used to determine the order of the DNA 
sequence (Heather and Chain, 2016). Although Illumina sequencing is rapid, cheap and 
accurate; the method does not usually enable complete bacterial genome assembly, because 
reads are too short to reconstruct repetitive regions (Schatz et al., 2010). However, various 
bioinformatic approaches can be used to construct draft genome assemblies, which are 
widely used in research and public health (Ashton et al., 2016). Long read sequencing can be 
used instead-of or as-well-as short read sequencers to resolve complex bacterial genomes, 
 4 
largely pioneered by companies such as Pacific Biosciences (Rhoads and Au, 2015) and 
Oxford Nanopore Technologies (Clarke et al., 2009; Eisenstein, 2012). In particular, Oxford 
Nanopore’s MinION machine, has generated a great deal of excitement in recent years, as 
the first mobile DNA sequencer which is able to be deployed rapidly and in-field, unlocking 
the power to decentralise WGS  (Jain et al., 2016). 
 
1.1.3 Bioinformatic approaches used to process sequencing data 
Alongside the huge availability of WGS data, countless bioinformatic tools have been 
developed to aid genomic analysis (Deng et al., 2016). A fundamental requirement for 
analysing WGS data, is the ability to assemble short reads into more complete genomes. 
Most short read de novo assembly pipelines are based on de Bruijn graph strategies, 
involving breaking reads into shorter DNA fragments of variable length k (kmers), after which 
a graph of perfectly overlapping kmers is constructed (Compeau et al., 2011; Miller et al., 
2010). A major challenge for short read assembly pipelines is reconstruction of repetitive 
DNA regions called tandem repeats, which are sequences composed of several DNA 
fragments lying one after another (Fan and Chu, 2007). Common genome assemblers such 
as SPAdes (Bankevich et al., 2012), Velvet (Zerbino, 2010), and ABySS (Jackman et al., 2017), 
used paired end information to overcome issues with tandem repeats. Short read data will 
typically result in draft genome assemblies, composed of multiple contigs (Parkhill, 2013). 
Hybrid assembly pipelines which combine short and long read data such as Unicycler can be 
used to produce a complete genome (Wick et al., 2017). 
 
Alternatively, reference-based assembly can be used which involves mapping short read data 
against a complete, genetically similar and preferably high-quality reference genome (Deng 
et al., 2016). The mapping process involves building an index for the reference genome, 
which is used to identify the genomic positions of each read. There are various techniques 
which may be used to build the index such as hash-tables and an algorithm known as Burrows 
Wheeler Transform (Hatem et al., 2013). In particular, Burrows Wheeler Transform is a very 
efficient indexing technique which was extended to a newer data structure called FM-index 
to support instances where a single read matches multiple locations across the genome 
(Ferragina and Manzini, 2000). Tools which use the Burrows Wheeler Transform include 
Bowtie (Langmead and Salzberg, 2012), BWA (Li and Durbin, 2009) and SOAP2 (R. Li et al., 
2009). Although reference-based mapping techniques do not take into consideration regions 
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which may be missing from the reference genomes, the approach is relatively rapid, 
computationally inexpensive and widely used in the scientific community.  
 
Short read mapping is an ideal tool for identifying genomic regions which differ between a 
query sequence and a reference and may be used to detect single nucleotide polymorphisms 
(SNPs) used for phylogenetic inference through variant calling.  Typical tools used for the 
mapping and variant-calling process have been implemented through programs such as 
SAMtools (H. Li et al., 2009; Li, 2011), GATK (McKenna et al., 2010), Freebayes (Garrison and 
Marth, 2012), VarScan (Koboldt et al., 2009) and Cortex (Iqbal et al., 2012). Cortex is unique 
in that it is a de Bruijn graph-based tool that detects SNPs by directly loading reads from 
multiple samples into the same graph (Iqbal et al., 2012). As WGS has become more 
accessible, some dedicated SNP-calling pipelines have begun to emerge for bacterial isolates 
such as Snippy (https://github.com/tseemann/snippy), CFSAN (Davis et al., 2015), NASP (Sahl 
et al., 2016) and PHEnix (https://github.com/phe-bioinformatics/PHEnix). Generally, these 
SNP-calling pipelines involve an external mapping tool and variant caller, followed by a series 
of filtering steps to remove low-quality SNPs. A limitation of the SNP-calling process is that 
there may be an accumulation of false positive SNPs amongst closely related bacterial 
isolates, with new pipelines such as BactSNP aiming to overcome this issue (Yoshimura et al., 
2019).  
 
1.1.4 An overview of phylogenetic methods 
Phylogenetics are used to infer the evolutionary history and structure of bacterial 
populations (e.g. Nightingale, Windham and Wiedmann, 2005; Holt et al., 2012; Mather et 
al., 2013; Wong et al., 2016). A phylogenetic reconstruction usually involves applying an 
evolutionary model to an alignment of core genome SNPs which vary against a reference 
genome. Highly recombinant regions are excluded from the alignment as they may impair 
accurate phylogenetic reconstruction (Croucher et al., 2014). The main reason for these 
inaccuracies is because recombination results in a large number of SNPs compared to the 
reference genome; because phylogenetic methods have an underlying assumption of 
vertical evolution, recombination tends to inflate branch lengths, although generally 
topology is not affected (Hedge and Wilson, 2014). The extent of recombination varies 
greatly among bacterial species, for example Escherichia coli has a very low recombination 
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rate and Neisseria gonorrhoeae has a very high recombination rate (Pérez-Losada et al., 
2006).  
 
There are multiple approaches used for phylogenetic inference, including distance-based, 
maximum parsimony, maximum likelihood and Bayesian (Svennblad et al., 2006). Maximum-
likelihood methods use a hill climbing algorithm to identify the tree that is most likely to have 
produced the observed data, given a model of evolution (Felsenstein, 1981). Specifically, the 
evolutionary model is used to estimate base frequencies and substitution rates and ranges 
from simple (e.g. Jukes Cantor 69) to more complex (e.g. General Time Reversible (GTR) plus 
gamma distribution). Maximum likelihood approaches are commonly executed through 
programs such as RAxML (Randomised Accelerated Maximum Likelihood) (Stamatakis, 2014) 
or IQ-tree (Nguyen et al., 2015). Note that maximum parsimony approaches also use a hill 
climbing algorithm to search through tree topologies, but using a much simpler model of 
evolution (Giribet, 2007).  In contrast, Bayesian algorithms use Markov Chain Monte Carlo 
(MCMC) to average over tree space and achieve the highest posterior probability given the 
observed data and a set of prior assumptions. The most widely-used Bayesian phylogenetic 
software is BEAST (Bayesian Evolutionary Analysis by Sampling Trees) (Drummond and 
Rambaut, 2007), although other programs such as MrBayes are also available (Ronquist et 
al., 2012). Although Bayesian methods are generally considered to be less user friendly and 
more computationally intense than maximum likelihood methods, the approach has 
incredible power and facilitates the study of the spatio-temporal process (Lau et al., 2015). 
Thus, Bayesian approaches allow key epidemiological quantities such as contact tracing 
latent periods, population expansion and migration rates to be estimated, which are critical 
to risk assessments and disease control.   
 
1.1.5 Deriving phenotypic information from bacterial genomes 
Bacterial genomes can also be used to monitor trends in antimicrobial resistance (AMR), a 
global health problem which results in hundreds of thousands of deaths every year (O’Neill, 
2019). Traditionally AMR has been detected by measuring the inhibitory effects of a specific 
antimicrobial agent on bacterial growth using phenotypic methods (Brown et al., 2015). 
However, AMR can also be predicted by identifying resistance conferring genes and 
mutations in bacterial genomes (Hendriksen et al., 2019). By 2019, there were at least 47 
freely accessible bioinformatic resources for detection of AMR determinants in genome 
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sequence data including databases such ResFinder (including PointFinder), AMRFinder and 
CARD (Alcock et al., 2019; Feldgarden et al., 2019; Zankari et al., 2017, 2012). AMR detection 
tools may be contig-based such ABRicate and staramr or may use short reads such as SRST2 
and ARIBA, (Hunt et al., 2017; Inouye et al., 2014). Previously, whole genome-based analysis 
accurately predicted the AMR phenotypes of 89.8 % (1007/1122) of Salmonella enterica 
serovar Typhimurium isolates, with 83% sensitivity and 96% specificity (Mensah et al., 2019). 
By studying the diversity, temporal and phenotypic relatedness of resistance profiles, studies 
have been able to infer probable sources of AMR in bacterial pathogens, which can then be 
used to inform policy choices (Mather et al., 2012).  
 
A powerful tool that can be used to investigate associations between genotype and 
phenotype is a genome wide association study (GWAS) (Lees and Bentley, 2016). GWAS 
approaches have successfully identified resistance-conferring variants in Mycobacterium 
tuberculosis (Desjardins et al., 2016). In addition to studying AMR, GWAS’ have also been 
used to study host resistance in Salmonella Pullorum (Li et al., 2019) and the genetic basis of 
increased virulence in Listeria monocytogenes (Maury et al., 2016) and Staphylococcus 
aureus (Young et al., 2019). However, the clonality of bacterial populations represents a 
major hurdle for GWAS methods. Specifically, when comparing lineages with different 
phenotypes, all variants that separate the lineages appear to be associated with a phenotype 
even though there is no causal link (Lees and Bentley, 2016). Thus, various models have been 
developed to incorporate a correction for population structure (Lees et al., 2019, 2018).  
 
1.1.6 Defining genomic epidemiology 
WGS allied with an expanding repertoire of bioinformatic tools has been a cornerstone in 
modern science. The term genomic epidemiology has increasingly been used to describe the 
process of using DNA sequence data to determine temporal, geographical and evolutionary 
trends in microbial pathogens (Kan et al., 2018; Mather et al., 2015). Genomic epidemiology 
has proven to be instrumental in pathogen surveillance and has been particularly used for 
monitoring enteric bacteria (Hawken and Snitkin, 2019). 
 
In recent years, routine WGS of Salmonella isolates from foodborne disease outbreaks has 
being adopted by public health authorities in high income countries, including the United 
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Kingdom and the United States of America (Ashton et al., 2016; Ribot et al., 2019). These 
data have been complemented by global efforts to increase sequencing in low-middle 
income countries, for example that driven by the 10,000 Salmonella genomes project (Perez-
Sepulveda et al., 2020). Sharing of WGS data has been facilitated by publicly available 
repositories such as those hosted by the NCBI (Leinonen et al., 2011). Organism specific 
databases also exist such as EnteroBase, which consists of a combination of data sourced 
from the National Center for Biotechnology Information (NCBI) sequence read archives (SRA) 
and user uploads (Zhou et al., 2020). Indeed, there are 258,817 Salmonella genomes alone 
on EnteroBase at the time of writing (https://enterobase.warwick.ac.uk/, accessed 1 August 
2020), a figure which has doubled since 2018 (Figure 1.1)(Alikhan et al., 2018). At the 
moment, there are more than twice as many Salmonella genomes in the SRA as any other 
bacterial pathogen (Moustafa et al., 2020). 
 
As the cost of WGS continues to decrease, and more user-friendly bioinformatic approaches 
begin to emerge, genomics has become a viable and advanced solution for epidemiological 
investigation and intensive scientific research for many bacterial species, including the 





Figure 1.1 The increasing number of Salmonella genomes available on EnteroBase 2005-2018  
EnteroBase is a user-friendly online resource for analysing and visualising genomic variation within 
enteric bacteria. The platform has been automatically assembling Salmonella genomes from 
sequencing reads that have been submitted to the SRA (yellow) or directly uploaded to EnteroBase by 
users (green). EnteroBase also contains a small number of complete genomes (pink) and a number of 
entries with legacy MLST genotypes (blue). (Figure from Alikhan et al., 2018). 
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1.2 Subtyping schemes for Salmonella 
1.2.1 The complexity of Salmonella nomenclature 
The genus Salmonella consists of rod-shaped bacteria belonging to the Enterobacteriaceae 
family, and more broadly the class Gammaproteobacteria (Tindall et al., 2005). Salmonella 
taxonomy is complex, and current usage often combines many classification systems that 
inconsistently discriminate between species, subspecies, serovars and sequence types 




Figure 1.2 A summary of Salmonella nomenclature 
The complexity of Salmonella nomenclature can be broken down into genus (green), species (blue), 
subspecies (yellow) clinical manifestation (grey), serovars and sequence types (orange). Note that a 
comprehensive list of all Salmonella serovars and sequence types is not provided for extraintestinal 
serovars, rather common serovars are shown. (Figure adapted from Langridge et al., 2013). 
 
1.2.2 History of Salmonella subtyping 
Historically, Salmonella species were defined on the basis of serological identification of O 
(somatic) and H (flagella) antigens (Kauffmann, 1966). If this one species-one serotype 
concept was still in use today, there would be over 2,600 different species of Salmonella 
(Issenhuth-Jeanjean et al., 2014). However, in 1973 a method known as DNA-DNA 
hybridisation was developed which demonstrated that multiple serovars could be linked at 
the species level, in a defining moment for Salmonella taxonomy (Crosa et al., 1973). 
Subsequently, two Salmonella species were identified, and initially named S. bongori (which 
still stands today) and S. choleraesuis. The name S. choleraesuis was originally chosen 











































confusion owing to the fact it was used to classify both the species and the serovar (Brenner 
et al., 2000). Thus, in 1986 the International Sub-Committee in Systemic Bacteriology for 
Enterobacteriaceae unanimously recommended the species designation for S. choleraesuis 
be changed to S. enterica (Penner, 1988) a name coined by Kauffman and Edwards in 1952 
(Kauffmann and Edwards, 1952).  
 
1.2.3 Species-level classification 
There are currently two recognised Salmonella species; S. enterica and S. bongori (Brenner 
et al., 2000), which are thought to have diverged from a recent common ancestor with 
Escherichia coli (E. coli) over 100 million years ago (Battistuzzi et al., 2004; Desai et al., 2013). 
The genomes of Salmonella and E. coli still display extensive regions of synteny; whilst 
differing in the presence of large genomic regions known as the Salmonella Pathogenicity 
Islands (SPIs) which are crucial for the intracellular lifestyle of Salmonella. The species S. 
bongori is primarily found in cold-blooded animals and lacks SPI-2 which is required for 
optimal replication within mammalian macrophages. S. bongori is therefore considered to 
be an evolutionary intermediate between E. coli and S. enterica (Fookes et al., 2011).  
 
S. enterica is further divided into six subspecies, which reflect previously defined subgenera 
and differ both biochemically and by genomic content (Ryan et al., 2017). Specifically, the 
Salmonella subspecies are; S. enterica subsp. enterica (I), S. enterica subsp. salamae (II), S. 
enterica subsp. arizonae (IIIa), S. enterica subsp. diarizonae (IIIb), S. enterica subsp. houtenae 
(IV) and S. enterica subsp. indica (VI). Henceforth, the term Salmonella will be used to refer 
to the S. enterica species and the S. enterica designation will be used to refer to the S. 
enterica subspecies enterica alone, unless stated otherwise. 
 
1.2.4 Salmonella serovar designations 
The Salmonella subspecies can be further classified into serovars which are ecologically, 
phenotypically and genetically diverse (Winfield and Groisman, 2004). The serotyping 
scheme relies on agglutination of a bacterial strain with specific antisera that has been raised 
against well-characterised Salmonella strains. An antigenic formula is then assigned to the 
strain based on the identification of O and H antigenic variants (Grimont and Weill, 2007). 
There are at least 46 O-antigens and 14-H antigens that have been identified, which in 
combination characterise over 2,600 different serovars (Issenhuth-Jeanjean et al., 2014). 
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Serotyping was designed as an epidemiological typing tool to aid differentiation among 
Salmonella variants in diagnostic and public health settings. However, significant limitations 
are associated with this traditional method including low throughput methodology, high 
expense, the requirement for expert personnel and the over 150 specific antisera required 
to be generated through immunising rabbits (McQuiston et al., 2004). In the current 
genomic-era of pathogen surveillance, several in silico platforms utilising WGS data to predict 
serotype have now been developed (Ashton et al., 2015; Yoshida et al., 2016; Zhang et al., 
2015). This computational serotyping approach involves detecting SNPs within flagella 
antigens (Yoshida et al., 2016). An underlying assumption of serotyping is that serovar 
designations reflect genetic relatedness, which holds true in most instances within the 
Salmonella genus. Notable exceptions are in the serovars; Java, Paratyphi C and 
Choleraesuis. (Achtman et al., 2012). 
 
Approximately 60% of all of the recognised Salmonella serovars belong to S. enterica (I) 
(Grimont and Weill, 2007). Phylogenetic analysis of S. enterica serovars has shown evidence 
of at least two sub-populations (clade A and clade B) with distinct genome characteristics 
including host-specific virulence gene repertoires, suggesting differences in transmission 
characteristics and ecological niches occupied by the groups (den Bakker et al., 2011; Falush 
et al., 2006; Parsons et al., 2015). Although S. enterica clade B serovars have been associated 
with an increased ability to cause clinically systemic infections, the majority of serovars 
which are able to cause human disease belong to S. enterica clade A (Worley et al., 2018). 
Interestingly, the distribution of disease caused by the ~1,500 S. enterica serovars is highly 
skewed. Over the past decade for example, just six nontyphoidal Salmonella serovars have 
been responsible for ~70% of cases of human disease in Europe and the USA, namely 
Enteritidis, Typhimurium, monophasic Typhimurium 1,4,[5],12:i:-, Infantis, Newport and 
Javiana (Centers for Disease Control and Prevention, 2018; European Food Safety Authority 
and European Centre for Disease Prevention and Control (EFSA and ECDC), 2019).  
 
1.2.5 Phage typing 
To complement and enhance serological classifications, phage typing was introduced as a 
rapid, accurate and cheap tool for epidemiological use (Ibrahim, 1969). This classification 
system involves differentiating Salmonella into a number of phage types based on their 
pattern of susceptibility to killing by a specific set of bacteriophages (viruses that can infect 
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bacteria) (Rabsch, 2007). Like antibodies in sera, phages recognise receptors on the bacterial 
cell surface, and consequently phage typing correlates well with serology (Ibrahim, 1969). 
Since the 1990s, phage typing proved to be an important tool for grouping strains at the sub-
serovar level and has successfully been used for source attribution and outbreak 
investigations within the public health setting (Baggesen et al., 2010). 
 
1.2.6 Multi Locus Sequence Typing 
Though traditional typing methods have played an important role in Salmonella disease 
epidemiology, molecular methods have provided a new level of discriminatory resolution 
and allowed evolutionary relatedness to be incorporated into the classification process 
(Alikhan et al., 2018). Multi Locus Sequence Typing (MLST) is a system that has been 
introduced to support (and possibly replace) previous Salmonella nomenclature (Achtman 
et al., 2012). The scheme was initially developed to discriminate S. Typhi clusters (Kidgell et 
al., 2002), and has subsequently been used throughout the S. enterica subspecies. 
Specifically, MLST involves assessment of the conservation of seven housekeeping gene 
fragments, specifically thrA, purE, sucA, hisD, aroC, dnaN and hemD (Maiden et al., 2013). 
The seven genes were selected based on the fact they are scattered around the 
chromosome, are flanked by genes of known function and that neither the gene nor the 
flanking genes are likely to be under diversifying selection (Kidgell et al., 2002). For a given 
isolate, the sequence for each of these genes is determined and each known allelic variant is 
assigned a number based on the chronology of the discovery of that variant. The 
combination of the seven alleles is then assigned a Sequence Type (ST) (Maiden et al., 2013). 
STs which share 6/7 alleles can be clustered into 139 genetic populations known as eBurst 
Groups (eBGs), which correlate to a certain extent with serovar designations (Figure 1.3). For 
example, the serovar S. Typhimurium corresponds to eBG 1 and contains multiple sequence 
types including ST19 which is responsible for foodborne gastrointestinal infection globally 
(Achtman et al., 2012) 
 
Traditionally, the allelic sequences of the seven housekeeping genes were obtained using 
Polymerase Chain Reaction (PCR) amplification followed by Sanger Sequencing, but more 
recently WGS data has been used to derive MLST status (Alikhan et al., 2018). As a result, 
MLST schemes with an even greater power of resolution have been introduced, largely 
pioneered through the online platform EnteroBase. Salmonella schemes include; ribosomal 
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MLST (51 loci), core genome MLST (3,002 loci) and whole genome MLST (21,065 loci) (Alikhan 
et al., 2018). In particular core genome MLST has been used for phylogenetic inference, 
providing an alternative and reference-free methodology to SNP-based approaches.  
 
 
Figure 1.3 Genetic population structure of Salmonella based on MLST data  
Minimal spanning tree of 4,257 isolates of S. enterica available on EnteroBase. Each circle corresponds 
to a sequence type. Grey shading is used to indicate eBGs and cluster labels refer to eBG. Serovars 
associated with the most isolates in each eBG is indicated with a colour and a number.  An example 
of the MLST scheme is also provided showing the MLST genes, allele number, sequence type, serovar 
























1.3.1 Differences between host-restricted, adapted and generalist Salmonella 
Salmonella has a very broad host-range at the genus level, being able to survive in a wide 
range of niches, however individual subspecies and serovars lie on a spectrum of host-
adaptation (Bäumler and Fang, 2013). A small number of Salmonella serovars are considered 
to be host-restricted, having evolved to colonise only a very limited range of hosts. For 
example, S. Typhi, S. Sendai and S. Paratyphi A, B and C are highly adapted to humans (Uzzau 
et al., 2000). Reservoirs for these specialised serovars include water, vegetables, seafood and 
raw eggs (Gal-Mor et al., 2014). Host-restricted serovars are also apparent in other animal 
species including S. Gallinarum in chickens, S. Typhisuis in swine, S. Abortusovis in sheep and 
S. Abortusequi in horses (Shivaprasad, 2000; Uzzau et al., 2000). Other serovars of 
Salmonella are regarded as host-adapted, and are usually associated with a particular animal 
host (Kingsley and Bäumler, 2000). Examples include S. Dublin in cattle and S. Choleraesuis 
in pigs, both of which can also cause disease in humans (Uzzau et al., 2000).  
 
However, the majority of Salmonella serovars can infect a wide variety of hosts including 
humans, wild and domestic animals and the environment, they are therefore described as 
host-generalists (Langmead and Salzberg, 2012; Li and Durbin, 2009). These serovars are 
mainly transmitted to humans through the food-chain including beef, pork, poultry and 
contaminated raw eggs (Ferrari et al., 2019). Although host-generalist Salmonella can infect 
a wide range of hosts, serovars are often linked with certain reservoirs. For example, poultry 
and contaminated chicken eggs have played a central role in the dissemination of S. 
Enteritidis into humans, causing multiple outbreaks over the past several decades (Betancor 
et al., 2010; Braden, 2006; Dallman et al., 2016; Pijnacker et al., 2019). A recent metadata 
analysis of Salmonella serovars in animal-based foods additionally highlighted links between 
S. Anantum in beef, S. Weltevreden in seafood, and S. Typhimurium in swine (Ferrari et al., 
2019). Indeed, pigs have been regarded as the most likely reservoir for a pandemic of 
monophasic ST34 S. Typhimurium variant, S. I:4,[5],12:i:− (Antunes et al., 2011; Hopkins et 
al., 2010). In addition to livestock, wild animals may also play a role in dissemination of 




1.3.2 Salmonella in reptiles  
Both wild and domestic reptiles are natural asymptomatic reservoirs for host-generalist 
Salmonella (Hoelzer et al., 2011; Warwick et al., 2001). The reported prevalence of 
Salmonella carriage in reptiles is highly variable amongst the literature, ranging from 14% to 
100% with inconsistent results reflecting intermittent faecal shedding patterns (Goupil et al., 
2012; Lukac et al., 2015). Historically, non-enterica Salmonella subspecies have been 
associated with carriage in cold-blooded animals such as reptiles and amphibians, but rarely 
in humans (Bäumler and Fang, 2013; Clancy et al., 2016; Nair et al., 2014; Schroter et al., 
2004). However, reptiles are also capable of carrying serovars belonging to S. enterica, a 
species that is responsible for causing the majority (99%) of human cases of salmonellosis 
(Anon, 2013; Eng et al., 2015; Kanagarajah et al., 2018; Murphy and Oshin, 2015; Whiley et 
al., 2017).  
 
Salmonella can be transmitted from reptiles to humans in several ways resulting in reptile 
associated salmonellosis (RAS). RAS occurs worldwide and is recognised as an emerging 
disease of global public health significance (Whiley et al., 2017). In the USA, it is estimated 
that around 6% of human Salmonella cases are attributed to reptiles each year (Mermin et 
al., 2004) and in South West England, 27.4% of Salmonella cases in children under age five 
were linked to reptile exposure (Murphy and Oshin, 2015). The latter study also 
demonstrated that RAS was more likely to lead to systemic disease resulting in 




1.4 The relationship between host-specificity and clinical syndrome  
Generally, there is an inverse relationship between the breadth of host range and clinical 
disease severity, with host-restricted Salmonella tending to cause systemic disease and host-
generalist Salmonella tending to cause gastrointestinal disease (Figure 1.4) (Kingsley and 
Bäumler, 2000). The association between the various clinical outcomes caused by different 
serovars was described by Jones et al. who studied a large dataset of Salmonella collected 
over ten years from the USA. The study made the conclusion that disease outcome is a 
function of serovar and that understanding this may be the key to a more general 
understanding of invasiveness (Jones et al., 2008). Within humans, Salmonella causes a huge 
range of clinical disease syndromes, including enteric fever, gastroenteritis, sepsis, 
meningitis and focal infections (Stanaway et al., 2019a, 2019b). Because of the huge number 
of serovars and the various clinical disease outcomes, clinicians have found it useful to 
broadly classify Salmonella as typhoidal or nontyphoidal. 
 
1.4.1 Typhoidal Salmonella 
Typhoidal Salmonella is restricted to human hosts and presents as a systemic infection. The 
most recent estimate for disease burden is 14.3 million cases and 135,900 fatalities according 
to the “global burden of diseases, injury and risk factors” study in 2017 (Stanaway et al., 
2019b). However, earlier estimates in 2010 had predicted 26.9 million cases and 
approximately 200,000 typhoid related deaths (Buckle et al., 2012). Only a handful of 
serovars are known to cause the febrile bacteraemia syndrome associated with Typhoid 
fever including S. Typhi and S. Paratyphi A, B and C. These Typhoid and Paratyphoid infections 
most commonly affect countries which have a poor water quality and modest sanitation, 
especially south Asia, south East Asia and sub-Saharan Africa (Crump et al., 2004; Mogasale 
et al., 2014).  
 
1.4.2 Nontyphoidal Salmonella 
The remaining serovars are considered to be nontyphoidal Salmonella (NTS). NTS infections 
most commonly result in a self-limiting gastrointestinal disease with low fatality and occur 
worldwide, with links to industrialised food production (Ricke et al., 2015). In 2010, NTS 
disease was estimated to be responsible for 93.8 million gastroenteric illnesses and 155,000 
deaths worldwide (Majowicz et al., 2010). However, in 2017 the “global burden of diseases, 
injuries and risk factors study” updated these original approximations, estimating that the 
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worldwide disease burden of NTS was 95.1 million cases of enterocolitis and 50,771 deaths 
worldwide (Stanaway et al., 2019a).  
 
1.4.3 Invasive nontyphoidal Salmonella 
A recent systematic review established that nontyphoidal Salmonella was also the most 
frequently-isolated pathogen found in a large cohort of patients suffering from community-
onset bloodstream infections in both Africa and Asia between 2008 and 2018 (Marchello et 
al., 2019). The associated disease, invasive nontyphoidal Salmonella (iNTS), poses a 
significant burden to public health globally, resulting in 535,000 cases and 77,500 deaths in 
2017 (Stanaway et al., 2019a). Incidence is particularly high in sub-Saharan Africa, resulting 
in 34.5 cases per 100,000 person years (Stanaway et al., 2019a). Although iNTS is 
comparatively uncommon in other parts of the world, the disease has also been described 
in Southeast Asia, albeit in a relatively smaller patient cohort (103 iNTS patients in an 
infectious disease hospital in Southern Vietnam between 2008 and 2013) (Phu Huong Lan et 
al., 2016). Specific host-factors are considered to increase susceptibility of humans to iNTS 
infection; including Malaria and malnutrition in infants and Human Immunodeficiency Virus 
(HIV) in adults (Feasey et al., 2012; Gordon, 2008). Indeed, recurrent iNTS disease was added 
to the United States Centres for Disease Control and Prevention case definition for HIV in 
1987 and by 1990 NTS had been confirmed as a common Acquired Immune Deficiency 
Syndrome (AIDS)-related pathogen in sub-Saharan Africa (Feasey et al., 2012; Gilks et al., 
1990). 
 
1.4.4 Human-human transmission of NTS and iNTS 
Although the majority of NTS infections are foodborne and are ultimately animal-derived, 
there is mounting evidence that several key pathovariants spread via human-human 
transmission. For example, a recent study focused on novel biphasic S. Typhimurium ST34 
variants causing iNTS disease in Vietnam, found little evidence of zoonotic transfer between 
co-locating animals and humans (Mather et al., 2018). Similarly, an analysis in Kenya showed 
that there was no significant relationship between NTS isolated from humans and those 
isolated from animals, food or environmental samples within or near iNTS patient homes 
(Kariuki et al., 2002). Further investigations in Kenya have revealed that NTS isolated from 
the bloodstream of cases was more comparable to that found in asymptomatic human 
carriers than that found in environmental sources including food, sewers, soil and animals 
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(Kariuki et al., 2006). Comparably, in Malawi different serovars of NTS were isolated from 
patients with iNTS disease and livestock within the same households (Post et al., 2019). In an 
industrialised setting, WGS was used to show that the major source of human NTS infection 
and the AMR associated with those infections was unlikely to be local animal populations 
(Mather et al., 2013). 
 
1.4.5 Gene degradation 
Pathovariants of iNTS display genetic signatures which suggest adaptation to an invasive and 
host-adapted lifestyle. It was initially believed that Salmonella evolution was driven primarily 
by the acquisition of virulence genes that conferred some sort of selective advantage to the 
bacteria (Bäumler et al., 1998). However, WGS-based data has revealed a much more 
complex evolutionary perspective, specifically that host-adapted, extraintestinal Salmonella 
variants have evolved independently multiple times from gastrointestinal ancestors and 
show a greater degree of genomic degradation in comparison with host-generalist 
Salmonella (Bäumler and Fang, 2013; Key et al., 2020; Zhou et al., 2018). Genomic 
degradation is a term used to describe an accumulation of loss-of-function mutations and 
deletions across a genome. For instance, functions required for promoting colonisation of 
the inflamed mammalian gut are often lost in invasive, host-adapted serovars in a series of 
gene pseudogenisation events (Nuccio and Bäumler, 2014; Okoro et al., 2015).  
 
Examples of gene pseudogenisation are apparent across the S. enterica species, with host-
generalist serovars containing far fewer pseudogenes than host-restricted serovars. A 
deeper insight into the evolutionary progression towards host-adaptation can be seen by 
looking at genomic comparisons between ancient and contemporary S. enterica isolates (Key 
et al., 2020). A recent study has shown how ancient S. enterica were host-generalist and 
experienced convergent evolution of pseudogenisation that accompanied downstream host 
adaptation (Key et al., 2020). Indeed, the number of pseudogenes in the host-generalist S. 
Typhimurium strain LT2 (n = 25) is significantly less than in systemically adapted host-
restricted serovars such as S. Gallinarum (n = 309),  S. Typhi (n = 204), S. Dublin (n = 177), S. 
Paratyphi A (n = 173 pseudogenes), S. Paratyphi C (n = 152 pseudogenes) or S. Choleraesuis 
(n = 151 pseudogenes) (Betancor et al., 2012; Chiu et al., 2005; Liu et al., 2009; McClelland 
et al., 2004; Parkhill et al., 2001; Thomson et al., 2008). However, there are notable 
exceptions where important iNTS pathovariants display little evidence of genome 
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degradation including a multidrug resistant (MDR) sub-group of S. Typhimurium ST34 in 
Vietnam (Mather et al., 2018).  
 
The invasiveness of some Salmonella serovars can be assessed experimentally with animal 
infection models (Tsolis et al., 2011). However, given that systemic pathovariants are often 
linked with host-adaptation, there have been concerns regarding the use of animal models. 
Several previous analysis have demonstrated that cellular and animal models fail to 
distinguish between levels of invasiveness in extraintestinal and gastrointestinal Salmonella 
variants (Lacharme-Lora et al., 2019; Van Puyvelde et al., 2019). In theory, the extent of 
genome degradation in S. enterica pathovariants can indicate the extraintestinal potential of 
the pathogen. Initial attempts to measure pseudogenisation between bacterial genomes 
have been labour intensive, relying on the manual annotation of truncations, deletions and 
frameshifts in genes (Langridge et al., 2015; Nuccio and Bäumler, 2014).  
 
A more recent approach involved the calculation of an invasiveness index, a value that 
represents the extent of genome degradation and diversifying selection specific to invasive 
serovars using a set of top extraintestinal predictor genes (Wheeler et al., 2018). The 
approach specifically uses a random forest classifier and delta bitscore functional variant 
calling to place Salmonella strains on spectrum from invasive to gastrointestinal. The 
invasiveness index has been validated using multiple Salmonella serovars and the approach 
has also been used to discriminate between S. Enteritidis and S. Typhimurium lineages 
associated with extraintestinal infections in sub-Saharan Africa (Van Puyvelde et al., 2019; 




Figure 1.4 The host adaptation and disease syndrome paradigm  
Infographic overview of the relationship between host-specificity and clinical disease syndrome for S. 




1.5 An introduction to S. Typhimurium 
1.5.1 S. Typhimurium in sub-Saharan Africa 
The most common iNTS serovars in sub-Saharan Africa have been S. Typhimurium and S. 
Enteritidis (Uche et al., 2017). This is exemplified by a recent cross-sectional study focused 
on iNTS samples collected from children in the Democratic Republic of Congo, which showed 
that 68.6% of isolates were S. Typhimurium, 30.4% were S. Enteritidis and only 1% were 
classified as other serovars (Phoba et al., 2020). A high proportion of S. Typhimurium 
infections has been seen in several countries across sub-Saharan Africa, with meta-analysis 
predicting that the serovar was responsible for 48% of all iNTS infections between 1966 and 
2014 (Uche et al., 2017). Furthermore, between 2002 and 2008, MDR S. Typhimurium was 
responsible for an epidemic of bloodstream infections in Malawi. However, since 2008 the 
proportion of bloodstream infections caused by S. Typhimurium has significantly decreased 
(Feasey et al., 2015) potentially indicating that this serovar is becoming less important in 
modern day.  
 
1.5.2 S. Typhimurium ST313 
WGS showed that the majority of S. Typhimurium isolated from bloodstream infections in 
Africa belong to the sequence type (ST)313 (Kingsley et al., 2009). Subsequent phylogenetic 
analysis has identified two closely-related but genetically distinct lineages of ST313, differing 
from each other by 455 SNPs (Okoro et al., 2012). According to early spatial-temporal 
reconstructions of the ST313 phylogeny, the emergence of ST313 lineage 1 (L1) occurred in 
approximately 1960 in south west Africa, whereas ST313 lineage 2 (L2) occurred in 
approximately 1977 in Malawi, in close temporal correlation with the HIV epidemic (Okoro 
et al., 2012). The finished genome of ST313 L2 strain D23580, is widely used as the reference 
strain for ST313. 
 
1.5.3 Antimicrobial resistance patterns in ST313 lineages 
Both ST313 lineages are associated with resistance to multiple antibiotic agents, mostly 
encoded by various Tn21-like integrons inserted on the pSLT Salmonella virulence plasmid 
(Kingsley et al., 2009). The spread of these combined virulence-resistance-plasmids has 
increased rapidly in the past few decades and are believed to be important drivers of iNTS 
epidemics (Emond-Rheault et al., 2020). The characteristic AMR profile associated with 
ST313 lineages includes resistance to ampicillin, trimethoprim/sulfamethoxazole 
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(henceforth cotrimoxazole) and chloramphenicol (Feasey et al., 2014). Of these 
antimicrobials, chloramphenicol resistance is specifically found in ST313 L2, which is thought 
to have offered an evolutionary advantage, resulting in the clonal replacement of ST313 L1 
by L2 in the early 2000s (Okoro et al., 2012). High levels of chloramphenicol resistance 
necessitated the use of alternative antimicrobials be used for the empirical management of 
iNTS in many countries in sub-Saharan Africa (Feasey et al., 2014). Consequently, ceftriaxone 
and fluoroquinolones are some of the few antimicrobial classes currently recommended for 
treatment of iNTS disease (Crump et al., 2015; Cuypers et al., 2018; Shane et al., 2017). Of 
concern, extensively drug resistant (XDR) isolates of ST313 have begun to emerge in Kenya 
(Kariuki et al., 2015; Oneko et al., 2015), Malawi (Feasey et al., 2014) and the Democratic 
Republic of Congo (DRC) (Van Puyvelde et al., 2019). The XDR profile is mediated by the 
presence of incompatibility group (Inc)HI2 plasmids which encode resistance to ciprofloxacin 
and extended spectrum beta-lactams (ESBLs) including ceftriaxone (Piccini and Montomoli, 
2020). 
 
1.5.4 Prophage repertoire 
In addition to accessory genome elements relating to antimicrobial resistance, the majority 
of ST313 additionally carry two novel prophages named Blantyre Prophage 1 (BTP1) and 
Blantyre Prophage 5 (BTP5) (Kingsley et al., 2009; Okoro et al., 2012; Owen et al., 2017). 
Prophages encode many key Salmonella virulence factors (Brussow et al., 2004; Figueroa-
Bossi et al., 2001; Ho and Slauch, 2001; Wagner and Waldor, 2002). For example, the 
common prophage Gifsy-2 carries the gene sodC and the SopEɸ prophage carries the 
guaninine nucleotide exchange factor (Figueroa-Bossi et al., 2001; Pelludat et al., 2003). A 
comprehensive investigation which characterised the prophage repertoire of ST313 revealed 
fascinating insights about BTP1 and posed interesting questions about the potential fitness 
costs and benefits of the prophage (Owen et al., 2017). For instance, BTP1 carries the bstA 
(st313-td) gene (STMMW_03531), which is associated with increased bacterial survival 
within murine macrophages (Herrero-Fresno et al., 2014). Additionally, the BstA protein of 
BTP1 is a novel abortive phage immunity system which mediates defence against attack by 
P22-like phages, and could improve fitness of ST313 in certain environmental niches (Owen 
et al., 2020).  
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It had originally been thought that the ST313 sequence type was geographically restricted to 
Africa. However, ST313 has also been isolated from Latin America, Asia and Europe (Almeida 
et al., 2017; Ashton et al., 2017; Jacob et al., 2019). For example, in 2017 it was discovered 
that 2.7% of S. Typhimurium isolated in England and Wales belong to ST313 and were 
associated with gastrointestinal infection (Ashton et al., 2017). Subsequent phylogenetic 
analysis identified a high level of genetic diversity amongst the UK-related ST313 (Figure 1.5). 
The two complete prophages (BTP1 and BTP5) characteristic of African ST313 were absent 
from the UK isolates, but were carried by the African L1 and L2 lineages of ST313 (Ashton et 




Figure 1.5 Phylogenetic relationship between ST313 lineages in the context of ST19 isolates 
An unrooted maximum likelihood phylogeny is displayed, showing the clonality of ST313 L1 and ST313 
L2 (red) compared with UK-isolated ST313 and ST19 representatives. (Figure from Ashton et al., 
2017). 
 
1.5.5 Functional analysis of ST313 
ST313 is closely related to ST19, the typical S. Typhimurium sequence type which causes self-
limiting gastrointestinal infection globally. Pairwise comparisons between the ST19 
reference strain, LT2 (McClelland et al., 2001) and the ST313 reference strain, D23580 has 
demonstrated 95% similarity in core genome composition (Canals et al., 2019). Genetic 
differences include 788 SNPs, three multi-nucleotide polymorphisms (MNPs), 65 indels, and 
an accumulation of ST313-specific pseudogenes (Canals et al., 2019). The majority of these 
pseudogene-forming SNPs affect metabolic, structural and virulence genes or are of 
unknown function (Okoro et al., 2015). 
 
As previously discussed, genome degradation is a hallmark feature of systemic Salmonella 
which cause bloodstream infections and are adapting to occupy a restricted host range. 
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Accordingly, significant focus has been invested into understanding the functional relevance 
of pseudogene formation in ST313 (Aulicino et al., 2018; Bogomolnaya et al., 2013; Canals et 
al., 2019; Carden et al., 2017; Kingsley et al., 2009; Okoro et al., 2015; Singletary et al., 2016). 
As a pathogen adapts to a more restricted host range, degradation may occur in genes which 
are superfluous in the new environmental conditions. For example, a study in 2016 identified 
a loss of multicellular behaviour in ST313 L2 strain D23580 (Singletary et al., 2016). 
Specifically, two pseudogenes were investigated and shown to impair multicellular stress 
resistance, a phenotype associated with survival outside of the host. One of these mutations 
results in the inactivation of the katE gene which encodes a stationary phase catalase 
required to resist peroxide-mediated killing (Singletary et al., 2016). The second mutation 
affects the bcsG gene which encodes a cellulose biosynthetic enzyme required for the RDAR 
(red, dry and rough) colonial phenotype (Singletary et al., 2016). The loss of traits required 
for environmental stress-resistance supports mounting evidence for a human-human 
transmission of ST313 (Post et al., 2019). 
 
Additional evidence of genome degradation, consistent with niche adaptation can be seen 
in genes associated with gut persistence in murine models (ratB), genes involved in the 
utilisation of certain carbon sources (ttdA and melR) and genes which encode effector 
proteins that are implicated in gastrointestinal pathogenesis (sseI and pipD). The SseI protein 
is particularly interesting as it inhibits the migration of dendritic cells into systemic sites by 
altering chemotaxis (Brink et al., 2018). However, studies within a streptomycin-treated 
murine infection model showed that pseudogenisation of sseI in ST313 L2 caused an 
increased ability of the bacteria to disseminate rapidly from the gut to the draining lymph 
nodes (Carden et al., 2017). Furthermore, the sseI gene was degraded or absent in multiple 
highly-adapted systemic Salmonella serovars, emphasising the importance of gene 
inactivation in promoting systemic spread (Feng et al., 2013; Klemm et al., 2016; Porwollik 
et al., 2005; Thomson et al., 2008). 
 
The high incidence of iNTS disease in adults with HIV has led researchers to believe that 
ST313 is specifically adapting to a systemic lifestyle within the immunocompromised host 
(Feasey et al., 2012; Gordon, 2008). However, it wasn’t until recently that phenotypic data 
was generated to support this hypothesis. The gene macB is a pseudogene in ST313 and 
forms part of the macAB-TolC tripartite efflux pump which is implicated in Salmonella 
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pathogenesis. Variants in macAB have lately been shown to affect replication in 
macrophages and influence fitness during colonisation of the murine gastrointestinal tract 
(Honeycutt et al., 2020). Importantly the infection outcome of S. Typhimurium strains 
carrying macAB variants were affected by a combination of the Salmonella genetic 
background and the host gene Nramp1, an important determinant of innate resistance to 
intracellular bacterial infection (Mastroeni, 2002). A summary of the pseudogenes identified 
in ST313 reference strains is shown in Figure 1.6. 
 
Figure 1.6 Pseudogenes identified in ST313 reference strains 
A list of pseudogenes identified in ST313 L2 reference strain D23580, with their putative functions. 
The conservation of these pseudogenes in the UK-isolated ST313 reference strain U2 is also shown, 
indicating differences in genome degradation. Specifically, grey indicates pseudogenes which are 
conserved in both strains and red indicates genes which are not degraded in the strain U2 and are 
likely to be functional (Figure from Ashton et al., 2017). 
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1.6 An introduction to S. Panama 
1.6.1 Clinical picture of S. Panama in humans 
The high levels of iNTS disease caused by S. Typhimurium in sub-Saharan Africa has 
generated a significant research focus (Ao et al., 2015; Stanaway et al., 2019a). However, 
other Salmonella serovars associated with iNTS infections have received little attention. One 
of these neglected serovars is S. Panama, which has consistently been reported as one of the 
Salmonella serovars most frequently isolated over the past 70 years (Pulford et al., 2019). 
Although S. Panama can cause gastrointestinal infection in humans (Hendriksen et al., 2011), 
the serovar is more widely known for its ability to cause invasive disease and to colonise 
extraintestinal sites. For most salmonellae, extraintestinal colonisation refers to 
bloodstream infection (Ao et al., 2015). However, S. Panama can also invade specific body 
sites, causing atypical presentations, including throat infection, brain abscess, and 
Bartholin’s abscess (Cummins and Atia, 1994; Kostiala et al., 1992; Varela and Ochoa, Aguilar, 
1953) (summarized in Figure 1.7). These unexpected symptoms of S. Panama infection can 
impede diagnosis and delay treatment. 
 
Figure 1.7 Overview of the clinical presentation caused by S. Panama in adults and children 
S. Panama can cause a range of clinical syndromes (Barczi and Foldes, 1990; Borderon et al., 1981; 
Carneiro et al., 2018; Cordano and Virgilio, 1996; Cummins and Atia, 1994; Edel et al., 1978; Elenga et 
al., 2017; Gericke and Luchtrath, 1951; Heysell et al., 2008; Kostiala et al., 1992; Kostiala and Ranta, 
1989; Lazarescu et al., 1971; Leeder, 1956; Modai et al., 1974; Opree, 1975; Salamon and Prag, 2001; 




1.6.2 Global disease burden and epidemiology 
The proportion of clinical cases caused by S. Panama is particularly high in French territories 
in America located in the Caribbean and South America (Guyomard-Rabenirina et al., 2018; 
Olive et al., 1996; Papa, 1976). Historically, S. Panama infections have accounted for 35% of 
Salmonella infections in Martinique, which were 11 times more likely to cause invasive 
disease than other serovars (Olive et al., 1996; Papa, 1976). Similarly, in French Guiana, S. 
Panama was the most frequent Salmonella serovar acquired by humans, accounting for 
12.9% of all cases of Salmonella infection in 2011 (Gay et al., 2014). More recently, S. Panama 
was listed as the Salmonella serovar most frequently isolated from paediatric blood samples 
in Guadeloupe, contributing to one-third of all cases of Salmonella infection between 2010 
and 2014; and univariate analysis showed S. Panama was associated with causing disease in 
children older than 6 months of age (P = 0.002) (Guyomard-Rabenirina et al., 2018). 
 
S. Panama was also introduced into Europe, where the serovar spread through the pork 
industry and caused hospital outbreaks in the 1960s and 1970s. Over this period, there was 
a 3-fold increase in S. Panama cases in the United Kingdom, which caused a doubling of the 
number of salmonellosis cases (Lee, 1974). Subsequently, between 1969 and 1984, S. 
Panama was one of the top five serovars responsible for invasive disease in the United 
Kingdom (Wilkins and Roberts, 1988). Elsewhere in the European Union, S. Panama was 
reported among the top 10 most frequently isolated serovars during 2012, following 706 
confirmed cases of S. Panama salmonellosis associated with outbreaks in Germany and Italy 
(European Food Safety Authority and European Centre for Disease Prevention and Control, 
2012). Sporadic outbreaks of S. Panama salmonellosis also occurred in Switzerland (1972), 
Hungary (1979), Spain (1998), and the Netherlands (2008) (Ernst and Gurdan, 1973; Lantos 
et al., 1981; Noël et al., 2010; Soto et al., 2001). S. Panama maintained its ranking in the top 
20 serovars associated with salmonellosis in the European Union until 2017 (European Food 
Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC), 
2019). 
 
In Asia, S. Panama was the 11th most frequently isolated Salmonella serovar in humans 
between 2001 and 2007 (Hendriksen et al., 2011), with up to 70% of S. Panama isolates 
reported to be invasive compared to 12% of S. Enteritidis isolates (Huang et al., 2013). In 
Tokyo, Japan, S. Panama was the third most common Salmonella serovar between 1974 and 
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1979, accounting for 5% of cases of Salmonella infection, and was commonly isolated from 
asymptomatic people (Horiuchi et al., 1989). In Taiwan, where S. Panama causes 7% of the 
clinical cases of salmonellosis, S. Panama causes a higher rate of bacteraemia in children 
under 5 years of age than other serovars, such as S. Enteritidis (Tsai et al., 2007). 
 
1.6.3 Antimicrobial resistance in S. Panama 
There are conflicting reports in the literature relating to the AMR status of the S. Panama 
serovar. Studies in Italy and Brazil reported low levels of antibiotic resistance (Carneiro et al., 
2018; Lamanna et al., 1977) and 91% of S. Panama isolates from Martinique were susceptible 
to beta-lactams (Olive et al., 1996). In Guadeloupe all Salmonella serovars demonstrated 
high overall susceptibility to antibiotics (Guyomard-Rabenirina et al., 2018). In contrast, 
other studies reported higher levels of resistance in S. Panama, particularly against 
tetracycline (e.g., 67%) and chloramphenicol (e.g., 67%) since the 1980s (Kempf and Pietzsch, 
1977; Lee et al., 2008; Matsushita et al., 2001). In Asia, for example, S. Panama has been 
associated with high levels of AMR since 1980, when 58% of the S. Panama isolates from 
Tokyo were resistant to at least one antibiotic agent (Matsushita et al., 2001). The level of 
AMR in S. Panama appears to be on the rise. By the turn of the millennium, 83% of domestic 
and imported S. Panama isolates from cases in Tokyo were multidrug resistant. Similarly, in 
Taiwan, the serovar also exhibited resistance to multiple antibiotics, including cotrimoxazole 
(67%), ampicillin (56%), streptomycin (56%), kanamycin (56%), and gentamicin (45%) (Lee et 
al., 2008).  
 
1.6.4 Accessory genome and virulence 
A large proportion of S. Panama AMR has been associated with plasmid carriage (P = 0.012), 
class 1 integron presence, and transmissible drug resistance (R) factors (Huang et al., 2013; 
Lee et al., 2008; Rodríguez et al., 2006). Generally, plasmids play a key role in systemic 
Salmonella infection (Silva et al., 2017), but little is known about the plasmid complement of 
the S. Panama serovar. In the small number of available studies, it was reported that S. 
Panama does not commonly carry the large plasmids that have previously been associated 
with virulence in other Salmonella serovars (Carneiro et al., 2018). Rather, S. Panama strains 
carry a heterogeneous population of plasmids (Stanley et al., 1995). Prophages can also make 
significant contributions to Salmonella virulence (Graham et al., 2018; Wahl et al., 2019), but 
only one study has identified the presence of prophages in S. Panama (Yao et al., 2016). The 
Salmonella RE-2010 prophage was identified in the genome of S. Panama ATCC 7378. The 
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prophage (also known as ElPhiS) has also been found in S. Enteritidis, where it has been 
associated with specific phylogenetic clusters (Feasey et al., 2016; Graham et al., 2018; 
Hanna et al., 2012). The paucity of authoritative literature describing collections of S. Panama 
isolates, coupled with the importance of S. Panama for global public health made it 
imperative that a concerted comparative genomic analysis was conducted. 
 
1.6.5 Evolutionary history and virulence 
The study of evolutionary history could explain why S. Panama is associated with invasive 
disease. Phylogenetically, S. Panama belongs to S. enterica clade B, which is associated with 
increased levels of clinically invasive disease (den Bakker et al., 2011). The evolutionary 
history of S. Panama was initially studied by Selander and colleagues who used multilocus 
enzyme electrophoresis to assess the relationships among Salmonella serovars that cause 
invasive disease (Selander et al., 1990). It was proposed that S. Panama evolved from the 
same ancestors that gave rise to S. Paratyphi, S. Sendai (which causes enteric fever), and S. 
Miami (Selander et al., 1990). However, no large-scale phylogenetic study had yet been 
conducted on S. Panama, and only one complete S. Panama genome sequence is available 
(Yao et al., 2016).  
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1.7 Aims of thesis 
1.7.1 Background summary 
NTS is a globally important pathogen, typically associated with foodborne gastrointestinal 
infection (Kirk et al., 2015). However, NTS can also invade normally sterile sites in humans 
resulting in invasive disease such as bacteraemia or meningitis, often in immunosuppressed 
individuals (Feasey et al., 2012; Gordon, 2008; Stanaway et al., 2019a). This systemic 
infection, known as iNTS disease is typically associated with certain Salmonella serovars 
(Jones et al., 2008). Thus, the clinical presentation of NTS disease depends on a combination 
host immune factors and bacterial features that are specific to individual Salmonella 
pathovariants (de Jong et al., 2012; Gilchrist and MacLennan, 2019; Lokken et al., 2016). It 
was initially believed that the evolutionary trajectory from NTS to iNTS would be driven 
primarily by the acquisition of beneficial virulence factors, prophages and plasmids. 
However, with the increasing availability of WGS and subsequent genomic exploration, a 
much more complex picture has emerged (Loman and Pallen, 2015; Pallen and Wren, 2007). 
Specifically, there is a paradigm of bacterial entrance into a more restricted host range 
coupled with a reduced metabolic flexibility and the loss of factors that have become 
unnecessary within the pathogen’s new niche (Kingsley and Bäumler, 2000; Okoro et al., 
2015). A similar pattern is observed in the emergence of other important human pathogens 
from non-pathogenic bacterial species such as Yersinia and Shigella (McNally et al., 2016; 
Merhej et al., 2013; Reuter et al., 2014; The et al., 2016).  
 
1.7.2 Thesis aim 
In the WGS-informed era of pathogen surveillance and scientific research, unravelling the 
genomic epidemiology and evolutionary history of iNTS serovars will significantly advance 
knowledge on key invasive Salmonella pathovariants whilst simultaneously providing vital 
understanding for the prevention of future outbreaks and endemics. In this thesis I aimed 
to determine the temporal, geographical and evolutionary trends in nontyphoidal 
Salmonella serovars, in order to understand the genomic signatures acquired on the 
trajectory towards extraintestinal adaptation.  
 
1.7.3 Overview of work 
In Chapter 2, I investigated the diversity of 133 NTS isolates sampled from venomous snakes 
and non-venomous reptiles. By studying a unique dataset, I have revealed substantial 
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diversity among the serovars carried by reptiles. This broad scope of Salmonella serovars 
provided a good sample population for studying the divergence and radiation of almost the 
entire Salmonella genus into subspecies, clades, serovars and lineages. which facilitated the 
study of S. enterica species level evolution and ecology. I also conducted a genotypic and 
phenotypic investigation into metabolic differences between phylogenetic clades, 
highlighting signatures of niche adaptation in a broad scope of NTS serovars. This broad 
snapshot of Salmonella provided the context to then look in more detail at two 
epidemiologically important serovars associated with invasive infection in humans. 
 
In Chapter 3, I characterised the stepwise evolution of S. Typhimurium ST313 associated with 
bloodstream infection of humans in Africa. Using WGS data from 680 human S. Typhimurium 
bloodstream isolates collected across sub-Saharan Africa, I have identified the trajectory of 
crucial loss-of-function events along the evolutionary pathway of iNTS. Furthermore, I have 
uncovered a pan-susceptible ST313 lineage (ST313) which emerged in Malawi in 2016 and 
has an elevated invasiveness index compared to previously described ST313 lineages. My 
work here provides an expanded insight into the evolutionary dynamics of S. Typhimurium 
ST313 and highlights epidemiological shifts in the circulation of ST313 lineages in Malawi.  In 
order to contrast this work, I looked at a less-well studied serovar responsible for 
extraintestinal infection globally.  
 
In Chapter 4, I determined the genomic epidemiology of 489 S. Panama from 27 countries 
collected over 26 years during routine public health surveillance. I identified six 
geographically-localised S. Panama clades and revealed regional trends in AMR. Further 
phylodynamic investigation revealed spatial-temporal evolution of the serovar, providing a 
vital baseline of understanding for S. Panama infection in the future. 
 
Collectively, this thesis has utilised WGS-approaches to characterise a broad range of NTS 
serovars and complemented this investigation by more detailed studies of two serovars; one 
well-characterised and one understudied, both of which have caused outbreaks, endemics 
and epidemics of extraintestinal infections. By exploring the genomic epidemiology of key 
Salmonella pathovariants associated with invasive disease globally, I have resolved gaps in 
the literature by describing a succession of events and linking them with functional genomic 
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The Salmonella genus contains two species; S. bongori and S. enterica. S. enterica is further 
divided into six subspecies; enterica (I), salamae (II), arizonae (IIIa), diarizonae (IIIb), 
houtanae (IV) and indica (VI) (Brenner et al., 2000). The subspecies are classified into 
approximately 2,600 serovars which are ecologically, phenotypically and genetically diverse 
(Winfield and Groisman, 2004). Serovars which belong to S. enterica subspecies enterica 
cluster phylogenetically into two predominant clades (A and B) (den Bakker et al., 2011; 
Falush et al., 2006; Parsons et al., 2011). Metabolic properties such as carbon utilisation are 
often serovar-specific. The ability of Salmonella to grow in a wide range of conditions reflects 
the adaptation of the bacteria to survival in the environment or in different hosts, as 
demonstrated by a recent study focused on genome-scale metabolic models for 410 
Salmonella isolates spanning 64 serovars in 530 different growth conditions (Seif et al., 
2018).  
 
At the genus level, Salmonella has a broad host-range whilst individual serovars differ in host-
specificity (Bäumler and Fang, 2013). The majority of Salmonella infections in humans (99%) 
are caused by a small number of serovars belonging to the S. enterica subspecies (Eng et al., 
2015). Serovars which belong to non-enterica subspecies are associated with carriage in 
ectothermic animals such as reptiles and amphibians, but are rarely found in humans 
(Bäumler and Fang, 2013; Clancy et al., 2016; Nair et al., 2014; Schroter et al., 2004). Carriage 
rates of non-enterica serovars in reptiles can be high. A study focused on snakes in a pet shop 
found that 81% of animals carried S. diarizonae (Schroter et al., 2004). Previous studies 
demonstrating the diverse range of Salmonella serovars that colonise various reptilian 
species in different countries are summarised in Table 2.1. 
 
Reptiles represent a significant reservoir for serovars of Salmonella that are associated with 
human disease (Guyomard-Rabenirina et al., 2019). Thus, Salmonella isolated from reptiles 
represents an ideal sample population to study serovar-specific adaptation and overall 
population structure. Over 60% of captive-bred reptiles between 1995 and 2006 in Denmark 
were reported to carry S. enterica subspecies enterica serovars (Pedersen et al., 2009). About 
6% of human salmonellosis cases were contracted from reptiles in the USA (Mermin et al., 
2004), and in South West England, 27.4% of Salmonella cases in children under five years old 
were linked to reptile exposure (Murphy and Oshin, 2015). The latter study demonstrated 
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that reptile-derived salmonellosis was more likely to cause bloodstream infection in humans 
than non-reptile-derived Salmonella (Murphy and Oshin, 2015). Reptile-associated 
Salmonella is therefore considered to be a global threat to public health (Whiley et al., 2017). 
 
The majority of reptile-associated salmonellosis cases reported in humans are caused by 
Salmonella from non-venomous reptiles (Whiley et al., 2017), probably because these 
animals are frequently kept as pets. Therefore, non-venomous reptiles have been the focus 
of numerous studies whilst the prevalence and diversity of Salmonella in venomous snakes 
has not been investigated. The recent inclusion of snakebite as a neglected tropical disease 
(Chippaux, 2017) demonstrates that these reptiles frequently interact with humans in 
tropical and sub-tropical countries. The proximity of venomous snakes to humans may lead 
to contaminated faecal matter being shed on the surfaces and in water sources used for 
human homes and to irrigate salad crops (Harrison et al., 2009; Ogunfowokan, 2012; Warrell 
et al., 1976). Research to improve snakebite treatment at the Liverpool School of Tropical 
Medicine (LSTM) led to the creation of the most extensive collection of venomous snakes in 
the UK, containing 195 venomous snakes. The LSTM herpetarium houses venomous snakes 
from a diverse range of species and geographical origins, representing an ideal source of 
samples to assess Salmonella in this under-studied group of reptiles.  
 
The aims of this study were three-fold. Firstly, to determine the period prevalence of 
Salmonella in a collection of captive venomous snakes and investigate whether this group of 
reptiles had the potential to act as reservoirs for human salmonellosis. Secondly, to assess 
the serological and phylogenetic diversity of Salmonella amongst reptiles. Thirdly, to use the 
diversity of reptile-associated Salmonella to determine clade-specific differences that could 
reflect adaptation to survival in different niches. Here, I present the first whole genome-
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Germany Captive reptiles 
13 of 16 
(81.3%) 
100% diarizonae (Schroter et al., 2004) 
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2.3 Methods 
2.3.1 Source of Salmonella isolates 
The Salmonella isolates were derived from faecal samples from two collections of reptiles. 
One hundred and six faecal samples were collected from venomous snakes at LSTM, with an 
emphasis on snakes originating from Africa (Table S2.1), and investigated for the presence 
of Salmonella. All venomous snakes were housed in individual enclosures and fed with frozen 
mice provided by a single supplier. Sixty-nine of the samples (71%) were sourced from wild-
caught snakes originating from: Togo, Nigeria, Cameroon, Egypt, Tanzania, Kenya, South 
Africa, and Uganda. A further 28 Salmonella isolates (29%) came from venomous snakes bred 
in captivity. The LSTM herpetarium is a UK Home Office licensed and inspected animal 
holding facility. A second collection of 27 Salmonella isolates from non-venomous reptiles 
and 1 Salmonella isolate from a venomous reptile were sourced from the veterinary 
diagnostics laboratory based at the University of Liverpool’s Leahurst campus (reptilian 
species described in Table S2.1). These isolates were collected from specimens submitted as 
part of Salmonella surveillance for import/export, in addition to veterinary faecal samples 
and tissues from post-mortem investigations. The provenance of the isolates is described in 
Table S2.1. The majority of the non-venomous reptiles were sourced from a zoological 
collection, however two animals were privately owned and three were sourced from the 
Royal Society for the Prevention of Cruelty to Animals (RSPCA). The LSTM isolates are 
henceforth referred to as venomous snake isolates and the Leahurst isolates are referred to 
as non-venomous reptile isolates unless otherwise stated. 
 
2.3.2 Isolation of Salmonella 
All media were prepared and used in accordance with the manufacturer’s guidelines unless 
otherwise stated. Salmonella bacteria were isolated using a modified version of the protocol 
described in the national Standard Operating Procedure for detection of Salmonella issued 
by Public Health England (PHE)(Public Health England, 2014).  
 
Faecal droppings were collected from reptiles and stored in 15 mL plastic centrifuge tubes at 
4˚C. Two different methods were used for the enrichment of Salmonella from faecal samples 
due to reagent availability at the time of isolation. Table S2.1 provides information on isolate 
specific methods. In enrichment method 1, faecal samples were added to 10 mL of buffered 
peptone water (Fluka Analytical, UK, 08105-500G-F) and incubated overnight at 37˚C with 
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shaking at 220 rpm. Following overnight incubation, 100 μL of the faeces mixture was added 
to 10 mL of Selenite Broth (19 g/L selenite broth base, Merck, UK, 70153-500G and 4 g/L 
sodium hydrogen selenite, Merck, UK, 1.06340-50G) and incubated overnight at 37°C with 
shaking at 220 rpm. In enrichment method 2, faecal samples were added to 10 mL of 
Buffered Peptone Water (Fluka Analytical, 08105-500G-F) supplemented with 10 μg/mL 
Novobiocin (Merck, N1628), and incubated overnight at 37˚C with shaking at 220 rpm. 
Following overnight incubation, 100 μL of the faeces mixture was added to 10 mL Rappaport-
Vassilliadis Medium (Lab M, UK, LAB086) and incubated for 24 hours at 42˚C with shaking at 
220 rpm. 
 
Following enrichment by method 1 or 2, 10 μL of overnight broth was spread onto Xylose 
Lysine Deoxycholate (XLD) (Oxoid, UK, CM0469) agar plates which were incubated overnight 
at 37˚C. Putative Salmonella colonies were selected by black appearance on XLD plates and 
confirmed by pink and white colony formation on Brilliant Green Agar (Merck, 70134-500G) 
supplemented with 0.35 g/L mandelic acid (Merck, M2101) and 1 g/L sodium sulfacetamide 
(Merck, S8647). 
 
To identify S. enterica species, colony PCR of the Salmonella-specific ttr locus, which is 
required for tetrathionate respiration (Malorny et al., 2004), was performed. PCR reagents 
included MyTaq Red Mix 1x (Bioline, UK, BIO-25043), ttr-4 reverse primer (5'-
AGCTCAGACCAAAAGTGACCATC-3') and ttr-6 forward primer (5'-
CTCACCAGGAGATTACAACATGG-3') on colonies suspected to be Salmonella. PCR reaction 
conditions were as follows: 95˚C 2 min, 35 x (95˚C 15 s, 60˚C 30 s, 72˚C 10 s), 72˚C 5 min. PCR 
products were visualised using agarose gel (3.5%) (Bioline, BIO-41025) electrophoresis in tris-
acetate-EDTA (TAE) buffer. Midori Green DNA stain (3 μL/100 mL) (Nippon Genetics, 
Germany, MG 04) was used to visualise DNA bands under Ultra Violet light. Throughout the 
isolation procedure, S. Typhimurium strain LT2 (Beltran et al., 1988) was used as a positive 
control, and E. coli MG1655 (Blattner et al., 1997) was used as a negative control (Table S2.1).  
 
2.3.3 Whole-genome sequencing of Salmonella from venomous and non-
venomous reptiles 
All non-venomous reptile isolates (n = 27), one venomous reptile isolate, and the majority of 
venomous snake isolates (n = 87/97) were sent for WGS. Isolates were sent for WGS during 
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or before December 2016 to accommodate project timescales. Because ten venomous snake 
isolates were collected in January 2017, they were unable to be sent for sequencing. Isolates 
were sent to either MicrobesNG, UK (n = 55) or the Earlham Institute, UK (n =60) for WGS on 
the Illumina HiSeq platform (Illumina, California, USA). Isolates which were sequenced by 
MicrobesNG were prepared for sequencing in accordance with the company’s preparation 
protocol for single colony-derived bacterial cultures 
(https://microbesng.com/documents/3/MicrobesNG_preparing_your_bead_tubes.pdf). 
  
 Isolates which were sequenced by the Earlham Institute were prepared by inoculating a 
single colony of Salmonella into a FluidX® 2D Sequencing Tube (FluidX Ltd, UK) containing 
100 μL of Lysogeny Broth (LB, Lennox) and incubating overnight at 37˚C, with shaking at 220 
rpm. LB was made using 10 g/L Bacto tryptone (BD Biosciences, UK, 211705), 5 g/L bacto 
yeast extract (BD, 212750) and 5 g/L sodium chloride (Merck, S3014-1kg). Following 
overnight growth, the FluidX® 2D Tubes were placed in a 95˚C oven for 20 minutes to heat-
kill the isolates.  
 
DNA extractions and Illumina library preparations were conducted using automated robots 
at MicrobesNG and the Earlham Institute. At the Earlham Institute, the Illumina Nextera XT 
DNA Library Prep Kit (Illumina, FC-131-1096) was used for library preparation. High 
throughput sequencing was performed using an Illumina HiSeq 4000 sequencing machine to 
generate 150 bp paired-end reads. Sequencing was multiplexed with 768 unique barcode 
combinations per sequencing lane. The insert size was approximately 180 bp, and the 
median depth of coverage was 30x.  
 
At MicrobesNG, genomic DNA libraries were prepared using the Nextera XT Library Prep Kit 
(Illumina, FC-131-1096) with two nanograms of DNA used as input and double the elongation 
time described by the manufacturer. Libraries were sequenced on the Illumina HiSeq 2500 
using a 250 bp protocol. 
 
2.3.4 Obtaining contextual reference sequences 
The Salmonella in silico typing resource (SISTR) v1.0.2 was used for serovar prediction 
(Yoshida et al., 2016). Enterobase (Alikhan et al., 2018) was used to assign an MLST to each 
isolate, based on sequence conservation of seven housekeeping genes (Alikhan et al., 2018). 
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Where available, reference isolates representing previously sequenced Salmonella isolates 
for all subspecies and serovars identified were included in the analysis. Reference sequence 
assemblies were downloaded from the NCBI. Accession numbers are available in Table S2.2. 
 
2.3.5 Quality control checks 
FastQC v0.11.5 (www.bioinformatics.babraham.ac.uk/projects/fastqc/) and MultiQC v1.0 
(http://multiqc.info) were used to assess sequence read quality against the following criteria; 
passed basic quality statistics, per base sequence quality, per base N content, adapter 
content and an average GC content of between 47 % and 57 %. Only high-quality reads were 
used in downstream analysis. Kraken v0.10.5-beta (Wood and Salzberg, 2014) was run to 
ensure reads were free from contamination using the MiniKraken 8gb database and a 
Salmonella abundance cut-off of 70%. Trimmomatic v0.36 (Bolger et al., 2014) was then used 
on the paired-end reads to trim low-quality regions using a sliding widow of 4:200. 
ILLUMINACLIP was used to remove adapter sequences. 
 
2.3.6 Phylogenetics- core gene alignment tree 
Genomes were assembled using SPADES v3.90 (Bankevich et al., 2012). The Quality 
Assessment Tool for genome Assemblies (QUAST) v4.6.3 (Gurevich et al., 2013) was used to 
assess the quality of assemblies, the results of which can be found in Table S2.3. Assemblies 
which comprised of greater than 500 contigs failed quality control (QC) as they were deemed 
too fragmented for downstream analysis. Additional criteria to evaluate assembly quality to 
standards consistent with EnteroBase (Alikhan et al., 2018) was also assessed. Specifically, 
samples were excluded if they had an N50 less than 20 kb or if they had a total number of 
bases below 4Million base pairs (Mbp) or above 5.8Mbp. All assemblies which passed QC 
were annotated using Prokka v1.12 (Seemann, 2014). Roary v3.11.0 (Page et al., 2015) was 
used to generate a core gene alignment. SNP-sites v2.3.3 (Page et al., 2016) was used to 
extract SNPs. A maximum likelihood tree was built from the core gene SNP alignment of all 
isolates using RAxML-NG v0.4.1 BETA (Stamatakis, 2014) with the GTR model and gamma 
distribution for site-specific variation and 100 bootstrap replicates to assess support. The 
tree was rooted using the Salmonella species S. bongori. Interactive Tree Of Life v4.2 (Letunic 
and Bork, 2016) was used for tree visualisation.  
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Confirmation that there was no bias in phylogenetic signal between the two different 
sequencing platforms was achieved by mapping metadata onto the phylogenetic tree using 
iTOL (Letunic and Bork, 2016) and visually assessing clustering. Table S2.1 contains details of 
the sequencing facility used for each genome. Monophyletic clustering of isolates was used 
to assign subspecies to newly sequenced Salmonella isolates from venomous and non-
venomous reptilian hosts. The level of association between venom status and phylogenetic 
clade was determined using odds ratios and χ2 statistics using the OpenEpi website 
(http://www.openepi.com). 
 
2.3.7 Identification of clade-specific genomic regions 
Genes involved in the utilisation of individual carbon sources were identified using KEGG 
(Kanehisa et al., 2014) and relevant literature (Table 2.2). Genes that encoded proteins 
involved in the uptake of carbon sources were prioritised. Sequences were downloaded 
using the online tool SalComMac (Srikumar et al., 2015), which allows the download of fasta 
sequences of the genes from S. Typhimurium ST19 strain 4/74. In the case of lac genes, the 
sequences were taken from the E. coli reference sequence MG1655. The sequences can be 
found in Data S2.1.  
 
The software tool MEGABLAST v2.2.17 (Morgulis et al., 2008) was used to perform a BLAST 
(Basic Local Alignment Search Tool) search of genes in the reptile-derived genomes against 
a custom-made database of genes diagnostic for Salmonella Pathogenicity Islands and genes 
involved in carbon utilisation. To confirm all MEGABLAST results, the short reads were 
mapped against each gene using BWA v0.7.10 (Li and Durbin, 2009) and SAMtools v0.1.19 
(H. Li et al., 2009). The resulting bam files were manually assessed for gene presence and 
absence using the Integrative Genomics Viewer v2.4.15 (Robinson et al., 2011). The results 
were plotted against the maximum likelihood phylogeny using Interactive Tree Of Life (iTOL) 
v4.2 (Letunic and Bork, 2016). 
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Table 2.2 Carbon source utilisation gene information 
Carbon Source Gene Gene product LT2 Locus ID SL1344 Locus ID KEGG Pathway Citation demonstrating gene activity in Salmonella 
Glucose crr PTS system, glucose-specific IIA component STM2433 SL1344_2396 sey00010  (Steeb et al., 2013) 
ptsG PTS system, glucose-specific IIBC component STM1203 SL1344_1140 sey00010  (Steeb et al., 2013) 
Tricarballylic Acid 
tcuA FAD-Dependent tricarballylate dehydrogenase STM0691 SL1344_0673 NA (Lewis et al., 2004; Lewis and Escalante-Semerena, 2006) 
tcuB Citrate/tricarballylate utilization protein TcuB STM0690 SL1344_0672 NA (Lewis et al., 2004) 
tcuC Citrate-proton symporter TcuC STM0689 SL1344_0671 NA (Lewis et al., 2004) 
tcuR LysR-family transcriptional regulator TcuR STM0692 SL1344_0674 NA (Lewis et al., 2004) 
Maltose 
malE Periplasmic maltose-binding protein STM4229 SL1344_4166 sey02010 (Daus et al., 2007) 
malF Maltose transport inner membrane protein STM4228 SL1344_4164 sey02010 (Daus et al., 2007) 
malG Maltose transport inner membrane protein STM4227 SL1344_4163 sey02010 (Daus et al., 2007) 
malK Maltose transport ATP-binding protein STM4230 SL1344_4167 sey02010 (Daus et al., 2007) 
Acetate 
ackA Acetate kinase STM2337 SL1344_2306 sey00620  (Fox and Roseman, 1986) 
pta Phosphate acetyltransferase STM2338 SL1344_2307 sey00620  (Starai et al., 2005) 
Fructose 
fruA PTS system, fructose-specific IIBC component STM2204 SL1344_2181 sey00051 (Feldheim et al., 1990) 
fruB PTS system, fructose-specific IIA/FPR component STM2206 SL1344_2183 sey00051 (Feldheim et al., 1990) 
Melibiose 
melA Alpha-galactosidase STM4298 SL1344_4235 sey00052 (Canals et al., 2019) 
melB Melibiose carrier protein STM4299 SL1344_4236 NA (Canals et al., 2019) 
melR Melibiose operon regulatory protein STM4297 SL1344_4234 NA (Canals et al., 2019) 
Glucosamine 
nagA N-acetylglucosamine-6-phosphate deacetylase STM0683 SL1344_0665 sey00520  (Steeb et al., 2013) 
nagB Glucosamine-6-phosphate deaminase STM0684 SL1344_0666 sey00520  (Steeb et al., 2013) 
nagE N-acetylglucosamine-specific IIABC component STM0685 SL1344_0667 sey00520  (Steeb et al., 2013) 
ycfX N-acetyl-D-glucosamine kinase STM1220 SL1344_1157 stm00520 (Steeb et al., 2013) 
Glycerol gldA Glycerol dehydrogenase STM4108 SL1344_4058 sey00561 (Steeb et al., 2013) 
glpK Glycerol kinase STM4086 SL1344_4035 sey00561 (Steeb et al., 2013) 
Lactose 
lacY MFS transporter, OHS family, lactose permease NA NA NA (Leonard et al., 2015) 
lacZ Beta-galactosidase NA NA eco00052 (Leonard et al., 2015) 
Tartaric acid 
ttdA Tartrate dehydratase STM3355 SL1344_3327 sey00630 (Malorny et al., 2004) 
ttdB Tartrate dehydratase STM3354 SL1344_3326 sey00630 (Malorny et al., 2004) 
Dulcitol 
gatA PTS system, galactitol-specific IIA component STM3258 SL1344_3231 sey00052 (Nolle et al., 2017) 
gatB PTS system, galactitol-specific IIB component STM3259 SL1344_3232 sey00052 (Nolle et al., 2017) 
gatC PTS system, galactitol-specific IIC component STM3260 SL1344_3233 sey00052 (Nolle et al., 2017) 
gatD Galactitol-1-phosphate dehydrogenase STM3261 SL1344_3234 sey00052 (Nolle et al., 2017) 
gatR Galactitol utilization operon repressor STM3262 SL1344_3235 NA (Nolle et al., 2017) 
gatY Tagatose-bisphosphate aldolase STM3253 SL1344_3226 sey00052 (Nolle et al., 2017) 
Myo-inositol 
iolA Myo-inositol metabolism protein STM4421 SL1344_4354 NA (Kröger and Fuchs, 2009) 
iolB Myo-inositol metabolism protein STM4420 SL1344_4353 NA (Kröger and Fuchs, 2009) 
iolR Repressor of myo-inositol metabolism STM4417 SL1344_4350 NA (Kröger and Fuchs, 2009) 
iolT1 Myo-inositol transport protein IolT1 STM4418 SL1344_4351 NA (Kröger and Fuchs, 2009) 
iolT2 Myo-inositol transport protein IolT2 STM4419 SL1344_4352 NA (Kröger and Fuchs, 2009) 
Allantoin 
allB Allantoinase STM0523 SL1344_0516 sey00230  (den Bakker et al., 2011; Okoro et al., 2015) 
allP Hypothetical allantoin permease STM0522 SL1344_0515 NA (den Bakker et al., 2011; Okoro et al., 2015) 
gcl Glyoxylate carboligase STM0517 SL1344_0510 NA (den Bakker et al., 2011; Okoro et al., 2015) 
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2.3.8 Carbon source utilisation 
Differential carbon source utilisation of 39 reptile-derived Salmonella isolates from S. 
diarizonae, S. enterica clade A and S. enterica clade B was assessed experimentally. Sub-
sampling was necessary to accommodate experimental restrictions on the number of 
isolates that could be tested. The sub-sampling encompassed a range of serovars, location 
origins and reptile species. Filter-sterilised carbon sugar solutions were added into M9 
(Merck, M6030-1kg) agar at concentrations detailed in Table 2.3. Isolated colonies were 
transferred from LB agar plates onto M9 carbon source plates using a sterile 48-pronged 
replica plate stamp and incubated at 37°C under aerobic conditions. An LB control plate was 
used to validate successful bacterial transfer and all experiments were performed in 
duplicate. If no growth was seen under aerobic conditions for a particular carbon source, the 
procedure was repeated under anaerobic conditions (approx. 0.35% oxygen) with 20 mM 
Trimethylamine N-oxide dihydrate (TMAO) (Merck, 92277) as a terminal electron acceptor. 
Anaerobic conditions were achieved by incubating plates in an anaerobic jar with 3x 
AnaeroGen 2.5 L sachets (Thermo Scientific, UK, AN0025A) to generate anaerobic gas. 
Oxygen levels were measured using SP-PSt7-NAU Sensor Spots and the Microx 4 oxygen 
detection system (PreSens, Regensburg, Germany). Salmonella growth was determined at 
18, 90 and 162 hours in aerobic growth conditions and at 162 hours in anaerobic growth 
conditions. A subset of growth positive isolates were assessed for single colony formation to 
validate the results of the replica plating.  
 




in solid media 
Aerobic/Anaerobic 
incubation Product Details References 
Sodium acetate 0.60% Aerobic Merck, S2889-1KG (Nichols et al., 2011) 
Allantoin 0.10% Anaerobic Merck, 5670 (Feasey et al., 2016) 
D-fructose 0.40% Aerobic Merck, F0127-100G (Feasey et al., 2016) 
D-glucosamine 0.40% Aerobic Merck, A15532 (Feasey et al., 2016) 
D-melibose 0.40% Aerobic Merck, M5500-5G (Feasey et al., 2016) 
Dulcitol 0.40% Aerobic Merck, D0256-100G (Feasey et al., 2016) 
Glucose 0.40% Aerobic Merck, G7021 (Nichols et al., 2011) 
Glycerol 0.40% Aerobic F, G/0650/17 (Nichols et al., 2011) 
Maltose 0.40% Aerobic Merck, 1.0591 (Nichols et al., 2011) 
Myo-inositol 0.40% Aerobic Merck, I7508-100G (Gutnick et al., 1969) 
L-tartaric acid 0.40% Anaerobic Merck, T109-500G-A (Gutnick et al., 1969) 
Tricarballylic acid 0.40% Aerobic Merck, T53503 (Gutnick et al., 1969) 
Lactose 0.40% Aerobic BDH, 10139 (Gutnick et al., 1969) 
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2.3.9 Antimicrobial susceptibility testing of Salmonella isolated from venomous 
and non-venomous reptiles 
Antimicrobial susceptibility was determined using a modified version of the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion method 
(Matuschek et al., 2014) using Mueller Hinton (Lab M, LAB039) agar plates and a 
DISKMASTER ™ dispenser (Mast Group, UK, MDD64). Inhibition zone diameters were 
measured and compared to EUCAST zone diameter breakpoints for Enterobacteriaceae 
(Andrews and Howe, 2011). Isolates were first tested with six commonly used antibiotics 
(ampicillin 10 μg, chloramphenicol 30 μg, nalidixic acid 30 μg, tetracycline 30 μg, ceftriaxone 
30 μg, and trimethoprim/sulfamethoxazole 25 μg) and were then tested with five additional 
antibiotics (meropenem 10 μg, gentamicin 10 μg, amoxicillin/clavulanic Acid 30 μg, 
azithromycin 15 μg, and ciprofloxacin 5 μg) if any resistance was seen to the primary 
antibiotics (all disks from Mast Group). If resistance was observed phenotypically, then the 
presence of antimicrobial resistance genes were investigated using the ResFinder software 
tool (Zankari et al., 2012). Antimicrobial resistance was defined as resistance to one 




2.4 Results and Discussion 
2.4.1 Similarities in Salmonella prevalence between captive venomous snakes 
and non-venomous reptiles 
Salmonella carriage is well documented amongst reptiles (Table 2.1), however, no published 
study reports the incidence of Salmonella in venomous snakes. The period prevalence of 
Salmonella was assessed in a collection of 106 venomous snakes housed at the LSTM venom 
unit between May 2015 and January 2017. Please note that the sampling of faecal isolates 
was largely completed prior to the start of this project and does not form part of the thesis 
work. All subsequent work forms part of this thesis. A remarkably high proportion (91%; 
97/106) of the faecal samples contained Salmonella (Table S2.1), which should be seen in 
the context of the significant carriage rate of Salmonella by other non-venomous reptiles 
described in the literature (Whiley et al., 2017). Variable rates of Salmonella carriage have 
been observed in collections of reptiles (Table 2.1), and the large proportion of venomous 
snakes carrying Salmonella in this study sits at the higher end of the reported spectrum. The 
findings pose important public health considerations for individuals who work with 
venomous snakes housed in captivity, which may previously have been overlooked.  
 
2.4.2 The diversity of Salmonella highlights the possibility of local transmission 
events and the role of long-term shedding 
To assess diversity, 87 venomous snake-derived Salmonella isolates, 27 non-venomous 
reptile-derived Salmonella isolates and one venomous reptile-derived Salmonella isolate 
were whole genome sequenced. In silico serotyping revealed 58 different Salmonella 
serovars (Figure 2.1). A wide range of serovars was found in each of the venomous and non-
venomous snake collections. Given that many of the serovars identified have a very broad 
host specificity, there was no suggestion that the presence of particular serovars was linked 
to the venom status of the reptile.
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Figure 2.1 The distribution of the 58 Salmonella enterica serovars isolated from venomous and non-venomous reptiles.  
Each bar represents the total number of isolates which belonged to each serovar. Serovars containing isolates that had multiple serovar designations from SISTR (Section 
2.3.4) are indicated with asterisks. Human pictographs are displayed on serovars which are amongst the top 20 isolated from humans in Africa. Data is based on the global 


























Similar levels of Salmonella carriage were seen in wild-caught and captive-bred reptiles. It is 
likely that the difference in serovar distribution reflects the sourcing of the reptiles from two 
independent housing facilities, and represents a limitation of this study. Nevertheless, a high 
level of Salmonella diversity was identified amongst both venomous and non-venomous 
reptiles. Following whole genome sequencing, multi-locus sequence typing was used for sub-
serovar genetic characterisation of Salmonella (Alikhan et al., 2018; Maiden et al., 2013). In 
all cases, isolates falling within the same serovar had identical sequence types (Table S2.1), 
reflecting the intra-serovar homogeneity of the Salmonella isolated in this study. 
 
The most common serovar to be identified amongst the venomous snake isolates was S. 
Souhanina (n = 12). All S. Souhanina isolates clustered locally on the phylogeny (Figure 2.2) 
falling within a 5 SNP cluster characteristic of a clonal expansion event (Dallman et al., 2018). 
Four of these isolates were found in captive-bred reptiles, whilst 11 isolates came from 
venomous snakes which originated in Cameroon, Uganda, Tanzania, Nigeria, Togo and Egypt. 
The close phylogenetic relationship between the S. Souhanina isolates that belong to the 
same MLST type (ST488) from imported animals with a range of origins and from captive 
animals suggests that local Salmonella transmission may be occurring. Local transmission of 
near-identical salmonellae could occur between snakes or as a result of a single 





Figure 2.2 Diversity of S. enterica isolated from venomous snakes and non-venomous reptiles.  
Core genome maximum likelihood phylogenetic tree (Section 2.3.6). The 25 contextual reference 
genomes representing previously sequenced isolates are indicated. Bootstrap values are indicated on 
key branches. Colour strips showing metadata are as follows; Subspecies – Subspecies of isolate, 
Origin – Country of origin of the snake, V or NV – Depicts whether the reptile host was venomous (V) 
or non-venomous (NV), AMR phenotype – Isolates shown in red were resistant to one or more 
antimicrobial agent (Section 2.3.9). M.L. Redway assisted with phenotypic AMR characterisation. 
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Although the data suggested that S. Souhanina was locally transmitted within the 
herpetarium, a single source of Salmonella would not explain the wide variety of serovars 
and MLST types carried by the venomous snakes. Significant Salmonella diversity was 
reported in a study that involved 166 faecal samples from wild-caught reptiles in Spain, 
identifying 27 unique serovars (Briones et al., 2004). Another study looking at Salmonella 
diversity in wildlife in New South Wales, Australia identified 20 unique serovars amongst 60 
wild-reptiles (Simpson et al., 2018). I speculate that the majority of the diversity of 
Salmonella identified originated from wild-caught reptiles and reflect their varied habitats in 
Africa. 
 
Underpinning the strategy for sampling Salmonella was the assumption that venomous 
snakes can carry and shed Salmonella for long periods of time. The longitudinal shedding of 
Salmonella has been reported in 12 captive non-venomous snakes from 7 different species. 
Over 10 consecutive weeks, 58% of the snakes shed Salmonella intermittently (Goupil et al., 
2012). Chronic Salmonella carriage has been reported in many other animals, including laying 
hens which shed the bacteria continually for up to 10 weeks (Gast et al., 2017). To assess the 
continuity of Salmonella shedding from venomous snakes in this study, faecal samples were 
collected from a Western Green Mamba from Togo over a three-month period between 31st 
October 2016 and 31st January 2017. All three faecal samples contained Salmonella which 
belonged to sequence type ST488, showing that individual snakes have the capacity to shed 
the same sequence type of Salmonella over a 90-day period in this study.  
 
I conclude that the majority of the reptile-derived Salmonella described in this study were 
likely acquired by reptiles prior to captivity, whilst some isolates were transmitted locally 
within the herpetarium.
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2.4.3 Venomous reptiles carry multidrug resistant Salmonella serovars of clinical 
relevance 
Because the majority of venomous snakes examined in this study were of African origin or 
belonged to a species of snake native to the African continent (Figure 2.2), the Salmonella 
serovars isolated from all reptiles in this study were compared with those most frequently 
associated with human disease in Africa. The Salmonella serovar distribution was reported 
by the WHO global foodborne infections network data bank based on data from quality 
assured laboratories in Cameroon, Senegal and Tunisia (Hendriksen et al., 2011) (Figure 2.1). 
Eleven snake-derived isolates belonged to serovars commonly pathogenic in humans. This 
finding prompted me to determine the proportion of all venomous snakes and non-
venomous reptiles that carried antimicrobial resistant Salmonella (Table 2.4). In Salmonella 
collected from venomous snakes, 4.1% of isolates (4/97) were resistant to at least one 
antimicrobial and two isolates were multidrug resistant (Table 2.4). Three resistant isolates 
from venomous snakes belonged to the serovar Enteritidis and were closely related to the 
global S. Enteritidis epidemic clade which causes human disease in Africa (Feasey et al., 
2016). These findings demonstrate that venomous snakes are capable of carrying and 
shedding Salmonella that have the potential to cause disease in humans.
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Table 2.4 Relating antimicrobial resistance to phenotype and genotype 
# Serovar predicted from genome sequence with SISTR(Yoshida et al., 2016)
 
* Determined experimentally, as described in Materials and Methods (Section 2.3.9) 
** Resistance genes and mutations were identified using ResFinder as described in Material and Methods (Section 2.3.9) 
*** Less than 100% sequence identity on ResFinder 
NB: Multidrug resistance is defined as resistance to greater than three antibiotics
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2.4.4 Phylogenetic diversity and molecular epidemiology of Salmonella in 
venomous snakes and non-venomous reptiles demonstrated for the first 
time 
Venomous snakes can shed Salmonella. The vast diversity of Salmonella has long been 
acknowledged in the literature (Alikhan et al., 2018). To study the diversity of reptile-
associated Salmonella from an evolutionary perspective, 87 high quality whole genome 
sequences were obtained for a phylogenetic comparison that involved 24 contextual 
Salmonella genomes (Section 2.3.6). The 87 genomes represented 60 isolates from 
venomous snakes, 26 Salmonella isolates from non-venomous reptiles and 1 Salmonella 
isolate from a venomous reptile. Following a comprehensive comparative genomic analysis, 
a total of 405,231 core genome SNPs were identified that differentiated the 87 isolates, and 
were used to infer a maximum likelihood phylogeny (Figure 2.2). SNPs are a valuable marker 
of genetic diversity (Dallman et al., 2018), and the identification of hundreds of thousands of 
core-genome SNPs reflects a high level of genetic diversity among the reptile associated 
Salmonella isolates. The collection of reptile-derived Salmonella represented most of the 
known diversity of the Salmonella genus (Brenner et al., 2000), spanning four of the six 
Salmonella enterica subspecies: diarizonae, enterica, houtanae and salamae. Reptile-derived 
S. enterica subspecies enterica isolates were approximately equally distributed into two 
distinct phylogenetic clusters, known as clade A (58%) and clade B (48%) (den Bakker et al., 
2011; Falush et al., 2006; Parsons et al., 2011) (Figure 2.2). No significant association was 
found between venom status and phylogenetic group (Odds Ratio = 1.1, Confidence Interval 
= 0.3-3.0, χ2 = 0.02, p-value = 0.4).  
 
2.4.5 Genotypic and phenotypic conservation of infection-relevant carbon source 
utilisation and virulence-associated genomic regions sheds new light on 
Salmonella ecology 
The unique collection of diverse Salmonella isolates was used to determine the phenotypic 
and genotypic conservation of infection-relevant properties and genomic elements. Whilst 
the reptile-associated Salmonella belonged to five evolutionary groups, the majority of 
isolates were classified as S. diarizonae or S. enterica. The clustering of S. enterica into two 
clades (A and B) has previously been inferred phylogenetically based on the alignment of 92 
core loci (den Bakker et al., 2011; Falush et al., 2006). The biological significance of S. enterica 
clade A and clade B has been established as the two clades differ in host specificity, virulence-
associated genes and metabolic properties such as carbon utilisation (Parsons et al., 2011). 
The genome sequences were used to expand upon pre-existing knowledge and determine 
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phenotypic and genotypic conservation of metabolic and virulence factors across S. 
diarizonae and S. enterica (clades A and B). 
 
Although the majority of Salmonella serovars of public health significance belong to clade A, 
certain clade B serovars such as S. Panama have been associated with invasive disease 
(Chaudhuri et al., 2013; Kostiala et al., 1992). The clade B S. enterica generally carry a 
combination of two Salmonella genomic islands. The Salmonella Pathogenicity Island-18 
encodes an intracellularly expressed pore forming hemolysin hlyE and the cytolethal 
distending toxin islet which includes the gene cdtB (Crump et al., 2004; den Bakker et al., 
2011). An association with invasive disease has been suggested because the two islands have 
previously only been identified in S. enterica serovar Typhi and Paratyphi A, which cause 
bloodstream infections (Crump et al., 2004; den Bakker et al., 2011). The combination of hlyE 
and cdtB genes were present in all S. diarizonae and S. enterica clade B isolates in this study, 
but absent from all but one S. enterica clade A isolate (14L-2174). The significant proportion 
of reptiles which carried S. enterica clade B could partially explain the increased likelihood of 
reptile-associated salmonellosis involving invasive disease, compared to non-reptile-
acquired salmonellosis (Murphy and Oshin, 2015). 
 
To assess metabolic differences that distinguish S. enterica clade A, S. enterica clade B and S. 
diarizonae, 39 reptile isolates were phenotypically screened for the ability to catabolise a 
number of infection-relevant carbon sources (Feasey et al., 2016; Gutnick et al., 1969; Kröger 
and Fuchs, 2009; Nichols et al., 2011) (Section 2.3.8, Table 2.2 and Table 2.3). The sampling 
encompassed isolates from a range of snakes, origins and serovars (Section 2.3.8). A 
summary of the results for phenotypic carbon utilisation and the presence of genes 
associated with the cognate metabolic pathway is shown in Figure 2.3. 
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Figure 2.3 Phylogenetic context of carbon-source utilisation by reptile-derived-Salmonella isolates. 
Carbon source utilisation data were mapped against the core genome phylogenetic tree. The maximum likelihood tree includes all reptile-derived Salmonella isolates which 
were assessed for carbon utilisation and had high quality genome sequences (see Table 2.2, Table 2.3 and Data S1). Reference sequences for the majority of carbon utilisation 
and acquisition genes were taken from S. Typhimurium strain 4/74, and the lac gene sequences were from E. coli MG1655. Carbon sources which required anaerobic 
conditions are indicated with asterisk. E. V. Rodwell and H. J. Webster assisted in phenotypic characterisation of carbon sources. See Section 2.3.8 for experimental details.
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In general, the genotype accurately reflected phenotype in terms of carbon source 
utilisation; however, this was not always the case (Figure 2.3). Discrepancies between 
phenotypic growth and genotype suggests that mechanisms of Salmonella metabolism 
remain to be elucidated. For example, S. diarizonae isolate LSS-18 grew well on myo-inositol 
as a sole carbon source (Figure 2.3) but showed zero percent homology with any of the iol 
genes from the well-characterised Salmonella strain 4/74. 
  
The ability to utilise lactose was a property of most S. diarizonae isolates, consistent with 
previous reports that 85% of S. diarizonae are Lac+ (Lamas et al., 2018). It is estimated that 
less than 1% of all Salmonella ferment lactose due to the absence of the lac operon from the 
S. enterica subspecies (McDonough et al., 2000). It was interesting to discover that one non-
venomous snake isolate (13L-2837) which belongs to S. enterica clade B was capable of 
utilising lactose as a sole carbon source. Isolate 13L-2337 belongs to the serovar S. 
Johannesburg and this is the first published occurrence of a Lac+ S. Johannesburg isolate. The 
13L-2837 pan-genome had zero percent homology to the lac genes from reference strain E. 
coli MG1655 (sequence in S1 Text) (results in Figure 2.3), suggesting an alternative method 
for lactose utilisation. The 13L-2837 S. Johannesburg isolate also lacked the ability to grow 
on dulcitol, despite possessing all of the relevant gat genes, raising the possibility of an 
inverse relationship between the ability of Salmonella to utilise dulcitol and lactose as a sole 
carbon source. These findings require further investigation which is beyond the scope of the 
current study. 
 
The majority of S. enterica clade A and clade B isolates utilised dulcitol, whereas dulcitol was 
rarely used as a sole carbon source by S. diarizonae. These findings are consistent with a 
study of Salmonella derived from Australian sleepy lizards, which demonstrated that dulcitol 
utilisation was observed in almost all S. enterica and S. salamae isolates but only 10% of S. 
diarizonae isolates (Parsons et al., 2015). Over 50% of the S. enterica clade A isolates lacked 
the gatY gene but grew well on dulcitol as a sole carbon source, suggesting that GatY is not 
required for dulcitol catabolism. A variety of repertoires of dulcitol catabolic genes have been 
described across Salmonella, with individual serovars carrying one of two gat gene clusters 
(Nolle et al., 2017). Both of these clusters carry the gatY gene. The findings may indicate that 
a third gat gene cluster is carried by some Salmonella serovars. 
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In the majority of cases, allantoin was only utilised as a sole carbon source by S. enterica 
clade A isolates, consistent with a previous report that described an association of clade A 
with the allantoin catabolism island (den Bakker et al., 2011). The majority of clade B isolates 
lacked the allantoin catabolism island and thus were unable to utilise allantoin as a sole 
carbon source. However, one clade B isolate was identified as an exception, isolate 11L-2351 
which was sampled from a non-venomous reptile. This isolate belongs to the serovar 
Montevideo, which is frequently associated with outbreaks of human salmonellosis (Gaffga 
et al., 2012; Gieraltowski et al., 2013; Stocker et al., 2011). In reptiles, the end product of the 
purine catabolic pathway is not allantoin, but uric acid (den Bakker et al., 2011). The 
consequent absence of allantoin from the snake gastrointestinal tract could explain why a 
substantial number of S. enterica clade B were found in snakes. 
 
It is possible that the gain and loss of allantoin catabolic genes is relevant to host-specificity. 
Allantoin is a metabolic intermediate derived from uric acid that is found at high levels in 
some animal hosts (chickens and rats) but not in humans (Matiasovicova et al., 2011). A 
relationship between the pseudogenisation of the allantoin metabolic genes and niche 
adaptation has also been proposed for the iNTS reference isolate for S. Typhimurium: 
D23580 (Kingsley et al., 2009; Okoro et al., 2015). Compared with S. Typhimurium isolate 
4/74, which shows a broad host range, D23580 is unable to utilise allantoin as a sole carbon 
source, consistent with the adaptation of invasive Salmonella in Africa towards non-allantoin 
producing hosts (Kingsley et al., 2009; Okoro et al., 2015). Furthermore, accumulation of 
pseudogenes in the allantoin degradation pathway has been reported in host-restricted 
Salmonella serovars which cause invasive disease, suggesting that the ability to grow on 
allantoin is a marker of a switch from enteric to invasive disease (Langridge et al., 2015). 
These findings may reflect the clinical observation that snake-acquired salmonellosis is 
frequently an invasive disease that commonly results in hospitalisation, compared to disease 





Although reptiles are known to harbour a diverse range of Salmonella bacteria, until now 
Salmonella carriage has not been examined in many key reptilian species. Here, I have shown 
that venomous snakes harbour and shed a wide variety of Salmonella serovars that represent 
much of the spectrum of the Salmonella genus and are phylogenetically distributed in a 
similar way to Salmonella found in non-venomous reptiles. I demonstrated that venomous 
snakes can carry and excrete Salmonella serovars which cause human disease. My findings 
raise the possibility that venomous snakes represent a previously uncharacterised reservoir 
for Salmonella both in captive settings and in the wider environment. Further study is 
required to investigate the relationship between clinical cases and reptile-derived 
Salmonella in tropical regions inhabited by venomous reptiles such as Africa. This study 
provides a good baseline for this future work.  
 
Reptiles are an ideal population of animals for the study of genus-level evolution of 
Salmonella because they carry phylogenetically-diverse isolates that belong to the majority 
of Salmonella subspecies. By demonstrating the phenotypic and genotypic conservation of 
metabolic properties across three phylogenetic groups of Salmonella I have shed new light 
on the evolution of Salmonella serotypes. 
 
All the reptile-derived genome-sequenced Salmonella isolates described in this chapter, are 
now in long-term cryogenic storage in the Hinton laboratory at the University of Liverpool, 





The stepwise evolution of Salmonella 
Typhimurium ST313 responsible for 
bloodstream infection in Africa 
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Bloodstream infections caused by NTS have emerged as a major public health concern, 
resulting in an estimated 49,600 deaths every year in Africa (Stanaway et al., 2019a). iNTS 
disease disproportionally affects immunocompromised individuals such as adults with HIV 
and children under five years of age with malaria, malnutrition or severe anaemia living in 
lower-to-middle income countries (Feasey et al., 2012). Recently, a systematic review 
established that Salmonella was the most frequently isolated pathogen in hospitalised 
patients diagnosed with community-onset bloodstream infections in Africa and Asia (2008 
to 2018) (Marchello et al., 2019). S. Typhimurium is responsible for approximately two thirds 
of iNTS disease cases in Africa (Reddy et al., 2010), and consequently is a focal point for 
research. 
 
The majority of S. Typhimurium isolated from bloodstream infections in Africa belong to 
sequence type ST313, a single locus variant of S. Typhimurium ST19 (Kingsley et al., 2009; 
Okoro et al., 2015, 2012). ST19 is a common cause of gastrointestinal infection globally and 
can cause bloodstream infections in immunocompromised individuals (Majowicz et al., 
2010). Phylogenetic reconstruction has revealed that two distinct and tightly clustered 
lineages of ST313 exist in Africa, differing from each other at a whole genome sequence level 
by 455 single nucleotide polymorphisms (SNPs) (Kingsley et al., 2009). ST313 L1 and ST313 
L2 have been estimated to have emerged ~52 and ~35 years ago respectively, and differ from 
ST19 by over 700 SNPs (Okoro et al., 2012). These African ST313 L1 and L2 are genetically 
distinct from ST313 found in the United Kingdom and Latin America (Almeida et al., 2017; 
Ashton et al., 2017).  
 
It is proposed that antimicrobial resistance has contributed to the success of ST313 lineages 
in Africa, with a large proportion of strains being multidrug resistant, specifically against 
ampicillin, chloramphenicol and trimethoprim/sulfamethoxazole (henceforth 
cotrimoxazole) (Feasey et al., 2015). Amongst S. Typhimurium ST313, chloramphenicol 
resistance is specifically found in ST313 L2, and is thought to have contributed to the clonal 
replacement of ST313 L1 by ST313 L2 prior to 2001, when chloramphenicol was the empirical 
treatment choice for suspected sepsis in Malawi (Okoro et al., 2012). Subsequently, 
chloramphenicol was replaced by the oral fluoroquinolone, ciprofloxacin, for treatment of 
iNTS infections from approximately 2002 onwards in several parts of Africa including Malawi 
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(Feasey et al., 2015). The third-generation cephalosporin, ceftriaxone became the empirical 
therapeutic for suspected sepsis from 2005 (Feasey et al., 2015). In 2014, an XDR isolate of 
ST313 L2 was identified in Malawi with ESBL-mediated resistance to third-generation 
cephalosporins and resistance to fluoroquinolones including ciprofloxacin (Feasey et al., 
2014). More recently, an XDR sub-lineage of ST313 L2 (ST313 L2.1) was identified in the DRC 
with additional resistance to azithromycin (Van Puyvelde et al., 2019). ST313 L2.1 also 
displays chromosomal evidence of further evolution within ST313, highlighting the 
importance of continued surveillance of S. Typhimurium strains causing bloodstream 
infection. The MDR phenotypes limit the available therapeutic options, prompting the need 
for an effective vaccine to prevent iNTS disease (Tack et al., 2020). 
 
In addition to AMR, loss-of-function mutations (genome degradation) have also featured in 
the ST313 lineages (Piccini and Montomoli, 2020). Evidence of host adaptation in S. 
Typhimurium ST313 involved specific pseudogenes that inactivated gene function and 
modified metabolic, structural and virulence phenotypes (Bogomolnaya et al., 2013; Canals 
et al., 2019; Carden et al., 2017; Kingsley et al., 2009; Okoro et al., 2015; Singletary et al., 
2016). A similar pattern of genome degradation is found in other invasive bacteria with 
restricted host ranges such as Yersinia pestis (Chain et al., 2004), Mycobacterium leprae (Cole 
et al., 2001) and S. Typhi (Holt et al., 2009). Notably however, S. Typhimurium ST313 retains 
the ability to cause diarrhoea in humans (Lokken et al., 2016), and so has not undergone the 
same level of niche-specialisation as S. Typhi. 
 
The functional relevance of genome degradation in ST313 has been investigated at the 
transcriptomic, proteomic and phenotypic levels for several key isolates (Aulicino et al., 
2018; Bogomolnaya et al., 2013; Canals et al., 2019; Carden et al., 2017; Kingsley et al., 2009; 
Okoro et al., 2015; Singletary et al., 2016). To understand the evolutionary trajectory and 
epidemiological relevance of functional degradative events, a population-level study of 
Salmonella genomes from a wide range of contemporary and historical isolates is required. 
Here, I studied a large and up-to date collection of ST313 to analyse the stepwise evolution 
of S. Typhimurium causing bloodstream infection in Africa. I uncovered a pan-susceptible 
ST313 lineage (ST313 lineage 3 (L3)) which emerged in Malawi in 2016, with a distinct 
genome degradation pattern. Despite only appearing recently in clinical surveillance, my 
core and accessory genome analyses revealed ST313 L3 to be a phylogenetic intermediate 
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between ST313 L1 and ST313 L2. This facilitated my genotypic characterisation of the crucial 
functional degradative events that occurred along the evolutionary pathway of invasive S. 
Typhimurium across Africa.   
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3.3 Methods  
3.3.1 Dataset 
Salmonella samples were derived from two archived blood culture collections. The main 
dataset was sourced from the Malawi-Liverpool Wellcome Clinical Research Programme 
(MLW) in Blantyre, Malawi which contains over 14,000 Salmonella bloodstream isolates from 
patients with iNTS disease at the Queen Elizabeth Central Hospital between 1996 and 2018. 
Isolates listed as S. Typhimurium were extracted from the metadata file for the entire 
collection and stratified by AMR profile into the following four categories: susceptible, 
resistant to one first line agent, resistant to two first line agents or MDR. First line agents 
were considered to be ampicillin, cotrimoxazole and chloramphenicol. Random sub-
sampling was then performed using random number generator (RAND function in Excel, 
Microsoft) and selected samples were collected and resuscitated from the freezer archives 
at MLW. It was possible to recover 647 isolates for whole-genome sequencing.  
 
To complement the MLW data, a contextual dataset was sourced from the Institut Pasteur 
(IP), Paris. The dataset consisted of 96 S. Typhimurium isolates collected from human 
extraintestinal sites from patients contaminated in Algeria, Burkina Faso, Cameroon, Central 
African Republic, Congo, France, Côte d’Ivoire, Madagascar, Mali, Niger, Senegal, Sudan, 
Togo and Vietnam between 1966 and 2012. All 96 S. Typhimurium samples were selected, 
resuscitated and sent for whole genome sequencing.  
 
3.3.2 Whole genome sequencing of short reads 
Isolates were prepared by inoculating a single bead of frozen Salmonella stock into a FluidX 
2D Sequencing Tube (FluidX Ltd, UK) containing 100 μL of buffered peptone water (Oxoid, 
CM0509) and incubating overnight at 37°C. Cultures were heat killed in a 95°C water bath 
for 20 minutes to produce thermolysates, prior to DNA extraction (MagAttract kit, Qiagen) 
and whole-genome sequencing, as part of the 10,000 Salmonella Genomes Project 
(https://10k-salmonella-genomes.com/) (Perez-Sepulveda et al., 2020). Illumina Nextera XT 
DNA Libraries were prepared (Illumina, FC-131-1096) and sequenced (Illumina HiSeq 4000) 
in multiplex (768) as 150 bp paired-end reads.  
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3.3.3 Assembly and annotation of short reads 
Trimmomatic (Bolger et al., 2014) v0.36 was used to trim adapters and Seqtk v1.2-r94 
(https://github.com/lh3/seqtk) was used to trim low-quality regions using the trimfq flag. 
FastQC v0.11.5 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and MultiQC 
v1.0 (http://multiqc.info) were used for quality control of sequence reads according to the 
following criteria: passed basic quality statistics, per base sequence quality, per base N 
content, adapter content and an average GC content of between 47 % and 57 %. Only high-
quality reads were used in downstream analysis. Unicycler (Wick et al., 2017) v0.3.0 was used 
to assemble genomes and QUAST (Gurevich et al., 2013) v4.6.3 was used to evaluate 
assembly quality to standards consistent with EnteroBase (Alikhan et al., 2018). Specifically, 
N50 > 20 kb, 600 or fewer contiguous sequences, total number of bases between 4Million 
base pairs (Mbp) and 5.8Mbp. Prokka (Seemann, 2014) v1.12 was used to annotate the 
genomes.  
 
3.3.4 Sequence typing 
Serotyping was confirmed using SISTR (Yoshida et al., 2016) v1.0.2 and compared with the 
original metadata table (Table S3.1). The strains were assigned a Multi Locus Sequence Type 
using MLST (Larsen et al., 2012) v2.10 based on the conservation of seven housekeeping 
genes.   
 
3.3.5 Reference mapping to D23580 
Trimmed sequencing data were mapped against the S. Typhimurium ST313 L2 reference 
genome D23580, using BWA mem (Li and Durbin, 2009) v0.7.10-r789. The reference 
genome consists of the D23550 chromosome (GenBank accession: LS997973.1), and four 
plasmids including pSLT-BT (GenBank accession: LS997974.1), pBT1 (GenBank accession: 
LS997975.1), pBT2 (GenBank accession: LS997976.1) and pBT3 (GenBank accession: 
LS997977.1). Mapped reads were then cleaned and sorted using the SAMtools suite (H. Li 
et al., 2009) v1.7. Reads were realigned against the reference using GATK (McKenna et al., 
2010) v3.7 by creating targets for realignment (RealignerTargetCreator) and performing 
realignment (IndelRealigner). Removal of optical duplicates was completed using Picard 
v2.10.1-SNAPSHOT (https://broadinstitute.github.io/picard/). Sequence variants were 
called using Bcftools v1.9-80 (http://samtools.github.io/bcftools) to generate a reference-
based pseudogenome for each sample with greater than 10x depth.  QualiMap (García-
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Alcalde et al., 2012) v2.0 was used to identify a mean sample depth of 35.17x across all 
isolates.  
 
3.3.6 Phylogenetic reconstruction of dataset 
High quality pseudogenomes (MLW n = 608, contextual n = 72) were concatenated, plasmids 
were excluded and Gubbins (Croucher et al., 2014) v2.2 was used to remove recombinant 
regions and invariable sites. The resultant multiple sequence alignment of reference-based 
pseudogenomes (12,013 variant sites) was used to infer a maximum likelihood phylogeny 
using RAxML-ng (Stamatakis, 2014) v0.6.0 with 100 bootstrap replicates to assess support. 
To assign clusters, rhierBAPs (Tonkin-Hill et al., 2018) was used specifying two cluster levels, 
20 initial clusters and infinite extra rounds. Visualisations were performed using iTOL (Letunic 
and Bork, 2016) v4.2.  
 
3.3.7 Phylogenetic reconstruction of dataset and publicly available dataset 
For contextual interpretation, sequencing data from 286 previously published S. 
Typhimurium ST313 were retrieved from public repositories (Table S3.1) and constructed in 
a core gene phylogeny. Roary (Page et al., 2015) v3.11.0 was used to generate a core gene 
alignment and SNP-sites (Page et al., 2016) v2.3.3 was used to extract SNPs. The resultant 
multiple sequence alignment (15,240 variant sites) was used to construct a maximum 
likelihood phylogeny using RAxML-ng (Stamatakis, 2014) v0.6.0 with 100 bootstrap replicates 
to assess branch support. Visualisations were made using iTOL (Letunic and Bork, 2016) v4.2. 
 
3.3.8 Temporal phylogenetic reconstruction 
To determine the evolutionary history of ST313, a chronogram was produced using Bayesian 
phylogenetic inference. Because the MLW collection is substantially larger than the 
contextual collection and to reduce computation time, 150/680 samples were chosen for 
inclusion in the analysis. Sampling reflected original sample selection for this study and 
included all contextual isolates which passed quality control (n=72) and a subset of MLW 
isolates randomly selected using a random number generator (n=78, Microsoft Excel). A 
reference-mapped multiple sequence alignment (7,231 variant sites) was created as 
described above. The alignment was loaded into BEAUti (Bayesian Evolutionary Analysis 
Utility)(Bouckaert et al., 2019) v2.6.1 and tip dates were extracted from the metadata file. 
The BEAST model test (Bouckaert and Drummond, 2017) was used to integrate over all 
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possible site models. The clock model was specified as “relaxed clock log normal” in line with 
previously published Bayesian analysis for S. Typhimurium (Ashton et al., 2017; Okoro et al., 
2012; Van Puyvelde et al., 2019).  
 
BEAST2 (Bouckaert et al., 2019) v2.6.1 was used to execute three independent chains of 
length 250,000,000, logging every 1,000 with 10% burn-in and accounting for invariant sites 
(Data S3.1). Tracer (Rambaut et al., 2018) v1.7.1 was used to assess convergence, with all 
parameter effective sampling sizes being > 200. LogCombiner (Bouckaert et al., 2019) v2.6.1 
was used to combine tree files, resampled at a lower frequency of 10,000 and DensiTree 
(Bouckaert, 2010) v2.2.7 was used for visualisation. Finally, a maximum clade credibility tree 
was created using TreeAnnotator (Bouckaert et al., 2019) v2.6.0. 
 
3.3.9 Determination of invasiveness index 
The invasiveness index of each isolate was calculated using previously defined methods 
(Wheeler et al., 2018). Specifically, samples were analysed with the model described in 
Wheeler et al. (2018) using 196 top predictor genes for measuring invasiveness in S. enterica. 
The distribution of invasiveness index values for each lineage were compared using the 
Wilcoxon Mann Whitney test implemented through R (R Core Team, 2017) v3.4.0. A custom-
made database of the top 196 invasiveness predictor genes was then created from the multi-
fasta file provided in Wheeler et al. (2018). SRST2 (Inouye et al., 2014) v0.2.0 was used to 
flag any genes with mutations in ST313 L3 compared with ST313 L2. Details of specific 
mutations were investigated manually using MegaX (Kumar et al., 2018) v0.1. 
 
3.3.10 Antimicrobial resistance testing and statistical analysis 
Genetic determinants for AMR were identified using staramr v0.5.1 
(https://github.com/phac-nml/staramr) against the ResFinder (Zankari et al., 2012) and 
PointFinder (Zankari et al., 2017) databases. Phenotypic antimicrobial susceptibility testing 
was performed using the EUCAST disk diffusion method (Matuschek et al., 2014) assisted by 
J. Bevington (University of Liverpool, UK). Antibiotic disks were ampicillin 10 μg, 
chloramphenicol 30 μg and trimethoprim/sulfamethoxazole 25 μg (Mast Group). To 
compare the results of genotypic against phenotypic testing, sensitivity and specificity were 
calculated for first line agents used over the study period using MedCalc’s test evaluation 
calculator with Clopper-Pearson confidence intervals (https://www.medcalc.org/calc/diagnostic_test.php).  
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3.3.11 Genomic conservation of plasmids, prophages and pseudogenes  
A literature search was used to identify genomic regions known to vary between ST19 and 
ST313, including plasmids (Kingsley et al., 2009), prophages (Owen et al., 2017) and 
pseudogenes (Ashton et al., 2017; Bogomolnaya et al., 2013; Canals et al., 2019; Carden et 
al., 2017; Lawley et al., 2006; Nishino et al., 2006; Okoro et al., 2015; Singletary et al., 2016; 
Yang et al., 2015). A custom-made database of the identified regions was created, along with 
known variants. Sequences downloaded using the online tool SalComD23580 
(http://bioinf.gen.tcd.ie/cgi-bin/salcom_v2.pl?_HL) (Canals et al., 2019). SRST2 (Inouye et 
al., 2014) v0.2.0 were then used to identify alleles present and the non-exact matches were 
investigated manually using MegaX (Kumar et al., 2018) v0.1. Results were manually mapped 
onto the phylogeny and chronogram using iTOL (Letunic and Bork, 2016) v4.2 which allowed 
inference of branches in which functional gene loss and plasmid and prophage acquisition 
occurred. Phenotypic testing was conducted to determine the relevance of plasmid and 
functional gene loss by B. Perez-Sepulveda, R. Canals, N. Wenner, X. Zhu, H. Webster 
(University of Liverpool, UK), J. Bengoechea and A. Dumigan (Queens University Belfast, UK).  
 
3.3.12 Phylogenetic reconstruction of pSLT plasmid 
Plasmid sequences were extracted from high quality pseudogenomes and snp-sites (Page et 
al., 2016) was used to extract SNPs. The resultant multiple sequence alignment of length 
1,034 sites was used to infer a maximum likelihood phylogeny using RAxML-ng (Stamatakis, 
2014) v0.6.0 with 100 bootstrap replicates to assess support. The resultant phylogeny was 
visualised in iTOL (Letunic and Bork, 2016) and convenience rooted to display lineages. 
 
3.3.13 Long read sequencing of ST313 L3 reference strain BKQZM9 
ST313 L3 strain BKQZM9 was selected for long read sequencing, based on having good 
overall quality statistics based on short read sequencing in terms of number of contigs and 
coverage. An Oxford Nanopore MinION (Jain et al., 2016) 9.4.1 flowcell and SQK-RAD004 
rapid sequencing kit was used with base calling by Guppy v3.1.5 
(https://nanoporetech.com/nanopore-sequencing-data-analysis#). Long read sequencing 
was performed by A. Beliavskaia, A. Predeus and A. Darby (University of Liverpool, UK). 
Approximately 120x coverage (600 Mb, 60,164 reads, read N50 33 kb) was generated. Hybrid 
genome assembly with the Illumina reads was done using Unicycler (Wick et al., 2017) v0.4.4 
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which generated a 4.9 Mb circular chromosome (GenBank Accession: CP060169), a 94 kb 
circular plasmid (pSLT) (Accession: CP060170) and a 1,975 bp circular plasmid (pBT3) 
(Accession: CP060171). Prokka (Seemann, 2014) v1.12 was used for annotation.  
 
3.3.14 Genomic comparison of ST313 lineages 
To determine the basic architecture of the ST313 L3 BKQZM9 genome, the identity of the 
chromosomal and plasmid regions were compared with existing sequences from ST313 L1 
(A130), ST313 L2 (D23580) and ST313 UK (U2) using BLAST (Altschul et al., 1990) and 
visualised using the Artemis Comparison Tool (ACT) (Carver et al., 2005) v13.0.0. Putative 
prophage and plasmid sequences were extracted and identified using a BLAST (Altschul et 
al., 1990) search against known ST313 prophages and plasmids and the non-redundant NCBI 
nucleotide database. Prophage and plasmid presence/absence were also determined 




3.4 Results and Discussion 
3.4.1 Assembling an informative collection of S. Typhimurium isolates 
A combination of historical and contemporary S. Typhimurium bloodstream isolates were 
sampled from two sources (Figure 3.1). The main dataset consisted of 608 human 
bloodstream isolates from the Malawi-Liverpool Wellcome Trust Clinical Research 
Programme (hereafter referred to as MLW isolates) and their associated epidemiological 
metadata (Table S3.1). These were sampled from the MLW collection which contains 
approximately 8,000 S. Typhimurium isolates from patients presenting to the Queen 
Elizabeth Central Hospital in Blantyre (Malawi) between 1996 and 2018, and represents one 
of the most comprehensive blood culture archives available in sub-Saharan Africa. To 
improve sampling precision and ensure a range of AMR phenotypes were collected, the 
entire MLW dataset was stratified by AMR phenotype (Section 3.3.1) and 1,000 strains were 
randomly selected for inclusion in the study. The majority (647) of these isolates were 
resuscitated and whole-genome sequenced as part of the 10,000 Salmonella genomes 
project (Perez-Sepulveda et al., 2020). After assessing sequence quality (Table S3.2), 608 
samples were included in the final dataset.  
 
For context, 72 human bloodstream isolates collected between 1966 and 2012 by the Unité 
des Bactéries Pathogènes Entériques, Institut Pasteur, Paris, France (hereafter called the 
contextual collection) were also included. These were derived from 13 African, 1 European 
and 1 Asian country. The study periods were selected based on availability of isolates, and 
encompassed an epidemic of bloodstream infections caused by S. Typhimurium ST313 in 
Africa between 2002 and 2008 (Feasey et al., 2015). In total, 96 contextual isolates were 
whole-genome sequenced, 72 of which passed quality control (Table S3.2) and were 
included in the final dataset. 
 
A description of the isolates is summarised in Figure 3.1 and is available with all metadata 




Figure 3.1 Bloodstream isolates of S. Typhimurium used in this study  
Isolates were collected from either the Unité des Bactéries pathogènes entériques (UBPE) of the 
Institut Pasteur Centres (light blue) or the Malawi-Liverpool Wellcome Trust Clinical Research Center 
(dark blue) (Section 3.3.1). Bar graphs show the number of isolates of different sequence types 
collected by centre per year. Donut charts indicate the proportion of sequence types collected per 
country and show the total number of isolates from each location in the centre. Note that Madagascar 
is written as M’gascar. Letters appearing in superscript relate to location on map. The colour code is 
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3.4.2 Population structure of S. Typhimurium 
To define the population structure of S. Typhimurium that is currently causing bloodstream 
infection in Africa, the relationship of the 680 S. Typhimurium genomes from the MLW and 
contextual collections were explored. In silico prediction methods revealed that the two 
predominant sequence types causing bloodstream infection in Malawi were ST313 (n=549) 
and ST19 (n=34). Additionally, a small number of isolates (n=25) were typed as one of five 
single locus variants of ST313 (ST3257 [n=17], ST2080 [n=3], ST302 [n=3], ST4200 [n=1], 
ST4274 [n=1]). The contextual dataset contained two different sequence types: ST313 (n=43) 
and ST19 (n=29). Taken together, the ST313 isolates originated from ten African countries 
(Figure 3.1). It should be noted that there were less than five isolates that originated from 
six of these countries. Previous genome-based analyses of the ST313 epidemic in Africa have 
included isolates from Eastern and Central Africa including Malawi, Kenya, Uganda, DRC and 
Mozambique (Okoro et al., 2012; Van Puyvelde et al., 2019). Here, by including a range of 
countries, in particular from Western Africa, the known geographic range of ST313 has been 
expanded to Cameroon, Central African Republic, Niger, Senegal, Sudan and Togo (Almeida 
et al., 2017; Ashton et al., 2015; Jacob et al., 2019; Kagambega et al., 2018; Okoro et al., 
2012; Tran-Dien et al., 2018; Van Puyvelde et al., 2019). 
 
To investigate population structure, a whole-genome SNP-based maximum likelihood 
phylogenetic tree was constructed and cluster designation was performed using rHierBAPs 
(Tonkin-Hill et al., 2018). This analysis revealed three major ST313 clusters, four major ST19 
clusters, and a small number of miscellaneous strains (Figure 3.2). Multi-locus sequence type 
variants formed discrete sub-lineages. The three ST313 clusters identified were highly clonal, 
with Cluster 1 and Cluster 2 corresponding to previously defined lineages (ST313 L1 and 
ST313 L2) (Kingsley et al., 2009). L1 was almost entirely clonally-replaced by L2 in the early 
2000s, consistent with previous studies (Kingsley et al., 2009). 
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Figure 3.2 Phylogenetic relationship between all S. Typhimurium isolates in this study in the context of antimicrobial resistance and accessory genome 
Maximum likelihood phylogeny based on the core genome SNP alignment of strains from Malawi-Liverpool Wellcome Clinical Research Center (MLW) and Institut Pasteur 
Unité des Bactéries pathogènes entériques Contextual Collection (IP) (Section 3.3.6). Background shading represents cluster designation (rHierBAPs), additional metadata is 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































Resistance demonstrated phenotypically 
Susceptible/Absence of gene or mutation





















The genomes of contemporary isolates revealed that a third lineage has been circulating in 
Malawi since 2016 (hereafter called L3). To fully contextualise ST313 L3, a maximum 
likelihood phylogenetic tree was constructed that included all previously published ST313 
genomes (Table S3.3) alongside the current dataset (Figure 3.3). This global 
contextualisation revealed that ST313 L3 is a novel lineage that forms a monophyletic cluster 
within a group of ST313 strains isolated in the United Kingdom and Brazil (Almeida et al., 
2017; Ashton et al., 2017), raising the possibility of an international transmission event.  
 
Figure 3.3 Phylogeny of S. Typhimurium ST313 isolates dating from 1966 to 2018 
Maximum likelihood phylogeny based on the core gene SNP alignment of strains in this study in the 
context of published ST313 genomes (methods described in Section 3.3.7). Background shading on 
phylogeny represents cluster designation (rHierBAPs). Outer ring provides details of the relevant 
publication. Grey represents genomes reported in this thesis. Figure visualised using iTOL (Letunic and 
Bork, 2016) and rooted on ST19. 
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3.4.3 Accessory genome of S. Typhimurium ST313 lineages 
Characterisation based on long-read sequencing showed that ST313 L3 strain BKQZM9 had 
a circular chromosome (4.8 Mb) with 99.98 % sequence identity to the ST313 L2 reference 
strain D23580 (Kingsley et al., 2009). The number of genes shared between D23580 and 
BKQZM9 was 4,529. An additional 167 genes were BKQZM9-specific, whereas 309 genes 
were exclusive to D23580, largely explained by differences in the prophage and plasmid 
repertoire of the two strains.  
 
To understand the relationship between ST313 L3 and other ST313 lineages, the accessory 
genome was examined in the context of population structure (Figure 3.4). The plasmid 
profiles of the ST313 lineages were established. All lineages carried the virulence plasmid 
pSLT (Rotger and Casadesus, 1999), and ST313 L2 additionally contained plasmids pBT1, pBT2 
and pBT3, consistent with previous studies (Kingsley et al., 2009). ST313 L1 was also found 
to carry a previously unreported 8,274 bp plasmid in the current study which shared 99.27 % 
sequence identity with pAnkS (Sahin et al., 2008) (GenBank NC_010896.1) and encoded the 
LsoA/ LsoB toxin-antitoxin proteins. This pAnkS-like plasmid was experimentally confirmed 
to carry a bacteriophage exclusion system by N. Wenner (University of Liverpool, UK) (Otsuka 
and Yonesaki, 2012). The ST313 L3 strain BKQZM9 contained the large 95 kb plasmid (pSLT) 
and the 1,975 bp pBT3 plasmid. A fourth plasmid corresponding to the 2,556 bp pBT2 was 
also identified using short read data. Thus, the plasmid profile of ST313 L3 shared more 





Figure 3.4 The four major ST313 clusters have different prophage and plasmid repertoires  
Population structure of ST313 L1, L2 and L3 showing presence/absence of prophages and plasmids 
using data from Figure 3.2. Approximate location of UK-isolated ST313 lineages is indicated 
schematically due to the diversity of isolates (see Figure 3.3). Prophage and plasmid repertoire of 
lineage reference strains are shown (dark grey indicates presence; light grey represents absence). 
Reference isolates used; A130 (ST313 L1), D23580 (ST313 L2), BKQZM9 (ST313 L3) and U2 (UK strains). 
Red blocks represent the extent of conservation between lineage reference genomes, with white gaps 
indicating missing regions. Coloured squares on the pSLT plasmid represents different AMR cassettes. 
Note that phylogeny was rooted on ST19, as shown in Figure 3.3. 
 
Prophages encode many key S. Typhimurium virulence factors (Brussow et al., 2004; 
Figueroa-Bossi et al., 2001; Ho and Slauch, 2001; Owen et al., 2017; Wagner and Waldor, 
2002), and it is clear that different Salmonella pathovariants carry distinct prophage 
repertoires (Wahl et al., 2019). A pairwise comparison of reference strains BKQZM9 (ST313 
L3), D23580 (ST313 L2) and U2 (the representative UK-isolated ST313 strain) (Figure 3.5) 
revealed chromosomal differences involving the prophage repertoires, which were generally 
conserved within lineages (Figures 2, S1). The common S. Typhimurium prophages Gifsy-1, 
Gifsy-2 (Figueroa-Bossi et al., 2001) and ST64B (Tucker and Heuzenroeder, 2004) were 
identified in all three ST313 African lineage reference strains. We found that ST313 L3 carries 
a Fels-2-like prophage which shares 99.99 % sequence identity to the RE-2010 prophage 
(Hanna et al., 2012), also found in other extraintestinal Salmonella serovars including the 
global outlier cluster of S. Enteritidis (Feasey et al., 2016) and S. Panama (Section 4.3.7), but 






Figure 3.5 Chromosomal comparison of ST313 lineages 
Comparison of the complete genome sequences of ST313 lineage representatives generated using ACT (Carver et al., 2005) (see Section 3.3.14). Reference isolates used; 
D23580 (ST313 L2), BKQZM9 (ST313 L3) and U2 (UK-isolated strains). Red represents sequence similarity and white represents regions absent. Prophage positions are 












Prophage BTP5 was absent from the ST313 L3 reference strain. BTP5 is associated with ST313 
L1 and L2 (Owen et al., 2017), and generally absent from ST313 isolated in the UK (Ashton et 
al., 2015). Although prophage BTP1 was not found in ST313 L3, a related P22-like prophage 
that had 74 % fragmented sequence identity to BTP1 occupied the same attachment site 
(Figure 3.6a). The P22-like prophage had almost identical replication, lysis and capsid genes 
to BTP1, differing only in the Ea, immunity, tail and gtr regions.  
 
The ST313 L3 P22-like prophage contained the sieB gene, which encodes a superinfection 
exclusion phage immunity protein (Susskind et al., 1974). The SieB proteins of ST313 L3 and 
P22 were 92% identical, with the two proteins sharing 177/192 amino acids. It is possible 
that the carriage of a gene that mediates abortive phage infection confers a selective 
advantage to ST313 L3, reflecting similar findings in ST313 L2 (Owen et al., 2020). Specifically, 
the novel BstA family of prophage defence proteins has recently been identified in the BTP1 
prophage of ST313 L2. BstA defends bacterial cells that carry BTP1 against exogenous attack 
by a variety of lytic phage, without sacrificing lytic autonomy, thus conferring a beneficial 
trait to ST313 L2 (Owen et al., 2020). Although BTP1 is missing from the UK reference strain 
U2, two UK-isolated ST313 strains (U15 and U8 (Ashton et al., 2017)) carried a P22-like phage 
with 99.96 % sequence identity to that found in ST313 L3 (Figure 3.6b). In summary, the 
prophage repertoire of ST313 L3 is more similar to that of the UK-isolated ST313 strains than 
to African ST313 L1 and L2.
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Figure 3.6 Conservation of BTP1 and P22-like prophages in S. Typhimurium ST313 L3 
Comparison of P22-like prophage regions identified in ST313 lineages generated using ACT (Carver et al., 2005) (see Section 3.3.14). Red represents sequence similarity and 
white represents regions absent. (a) shows the comparison between P22-like prophage in ST313 L3 (strain BKQZM9) and ST313 L2 (strain D23580). Prophage annotation is 
adapted from that shown in Owen et al., 2017 (Owen et al., 2017), with different colours highlighting different prophage regions. (b) shows the comparison between P22-
like prophage in ST313 L3 (strain BKQZM9) and a P22-like prophage in ST313 sampled in the UK. 
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3.4.4 Genomic epidemiology of antimicrobial resistance 
To obtain epidemiological insights into the emergence of S. Typhimurium lineages which 
cause systemic disease in Africa, the dynamics of AMR were investigated. The draft genome 
sequences of all 680 isolates were examined for genes and mutations that confer reduced 
susceptibility to antimicrobials. In total, 65 % (n = 440) of isolates had an MDR genotype 
(Magiorakos et al., 2012). To confirm genome-based predictions, AMR profiles were 
confirmed phenotypically. The sensitivity and specificity of genome predictions was 
calculated for 528 available isolates (measured by EUCAST breakpoint). For chloramphenicol; 
sensitivity was 96.71 % (95 % Confidence Interval [CI] = 94.53 % to 98.19 %) and specificity 
was 83.60 % (95 % CI = 78.42 % to 87.97 %). For ampicillin; sensitivity was 98.04 % (95 % CI 
= 96.52 % to 99.02 %) and specificity was 95.61 % (95 % CI = 90.06 % to 98.56 %). For 
cotrimoxazole; sensitivity was 97.38 % (95 % CI = 95.56 % to 98.60 %) and specificity was 
77.09 % (95 % CI = 70.24 % to 83.03 %). Taken together, the data reiterates previous findings 
in S. Typhimurium that show genome-based analysis accurately predicted the AMR 
phenotypes of 89.8 % isolates with 83% sensitivity and 96% specificity (Mensah et al., 2019).  
 
To determine whether signature AMR profiles accompanied switches in the circulation of 
ST313 lineages, the genetic determinants of resistance were correlated with lineages (Figure 
3.7). Amongst isolates belonging to ST19, only 11 % (7/63) were resistant to ≥ 1 
antimicrobial. However, of the ST313 lineage isolates, 94 % were resistant to ≥ 1 
antimicrobial. There has been a reduction in the proportion of chloramphenicol-resistant 
isolates of ST313 L2, with 89.19 % (n=66/74) prior to 2005, decreasing to 84.11 % 
(n=307/365) between 2006-2015 and 65.28 % (n=47/72) between 2016-2018 (Figure 3.7 and 
Table S3.1). Interestingly, antimicrobial usage policy changes have occurred at the local level 
in Malawi during this timeframe including the phased withdrawal of chloramphenicol from 





Figure 3.7 Temporal AMR Trends in S. Typhimurium lineages (1996 – 2018) 
Combination matrix (lower) depicts predicted AMR patterns of S. Typhimurium (methods in Section 
3.3.10). Isolates collected before 1996 were only sampled sporadically, and thus were excluded from 
analysis. Within the combination matrix, dark grey circles indicate genome-predicted resistance and 
vertical combination of grey circles represents resistance profile. Total number of isolates with each 
resistance profile is indicated below matrix. The combination matrix was created using the UpSetR 
package (Conway et al., 2017). Bubble plot (above) depicts the relative number of isolates (bubble 
size) with each resistance profile (combination matrix) per year (y axis). Lineage assignments are 
shown using bubble colour to identify lineage-specific AMR trends. Local Malawi antimicrobial usage 
policy (Feasey et al., 2015) is highlighted in background colours overlying the timeline in the bubble 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Each column represents a unique AMR signature
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Total number =
 83 
Overall, the ST313 isolates in this study carried numerous genetic determinants of antibiotic 
resistance, with 29 different predicted AMR genotype patterns involving 11 antimicrobial 
agents (Figure 3.7). The AMR phenotype of ST313 L1 and L2 was encoded by resistance 
cassettes carried on a composite Tn21-like transposable element, inserted in the S. 
Typhimurium virulence plasmid pSLT (Ashton et al., 2017; Kingsley et al., 2009; Okoro et al., 
2015, 2012). The plasmid backbone of pSLT was present in all ST313 strains and lineage-
specific variation was observed in the location of the Tn21 insertion site, consistent with 
previous reports (Kingsley et al., 2009). The Tn21-like region varied between isolates, and 
reflected the AMR profile (Figure 3.8). The plasmid pAnkSST313-L1 was also implicated in 




Figure 3.8 Examples of variation within the Tn21-like element 
Annotation of the resistance cassette carried on the Tn21-like element integrated into the Salmonella 
virulence plasmid pSLT-BT. Examples of variation in the Tn21-like element is shown for three different 
resistance profiles in ST313 L2. MDR L2 refers to isolates with the typical L2 resistance profile of 
streptomycin, kanamycin, ampicillin, chloramphenicol, trimethoprim and sulfisoxazole. Two 
additional resistance profiles are shown for L2 as indicated in the figure. Grey boxes between 
annotations represents gene presence. Annotation is adapted from Kingsley et al., 2009 (Kingsley et 
al., 2009), and shows antibiotic resistance genes (red), integrase or transposase (blue), pseudogenes 
(green) and other genes (grey).   
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ST313 L3 was pan-susceptible to all antimicrobials tested, both genotypically and 
phenotypically (Figure 3.3), as were the UK-isolated ST313 (Ashton et al., 2017). In contrast 
to L1 and L2, ST313 L3 did not carry an MDR cassette on the pSLT-BT plasmid (Figure 3.9).  
 
Figure 3.9 pSLT comparison of D23580 vs BKQZM9 
Comparison of the Salmonella virulence plasmid pSLT identified in ST313 L3 (BKQZM9) and ST313 L2 
(D23580) generated using ACT (Carver et al., 2005) (see Section 3.3.14). Red represents sequence 
similarity and white represents regions absent. The location of the Tn21-like element is indicated.  
 
Phylogenetic reconstruction of the pSLT plasmid (Figure 3.10) reflected the core genome 
SNP-based phylogeny, demonstrating four individual clades (ST313 L1, L2, L3 and ST19). No 
evidence of scars associated with plasmid excision at the usual insertion site of the Tn21-like 
transposable element on the pSLT plasmid were found in ST313 L3. Taken together, these 









Figure 3.10 Phylogenetic reconstruction of pSLT plasmid 
Maximum likelihood phylogenetic tree showing the population structure of the pSLT plasmid in ST19 
and ST313 lineages (Section 3.3.12). Colour strip from right to left; cluster assignment (lineage) of 
each isolate and number of antimicrobials each isolate is resistant to. The likely point of insertion of 
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Fluoroquinolone-resistant S. Typhi are causing significant clinical challenges, particularly in 
Asia (Parry et al., 2019). Resistance to fluoroquinolones in high clinical use, such as 
ciprofloxacin result from a combination of mutations which affect the gene gyrA, among 
others (Hooper and Jacoby, 2015). In total, < 1 % (n=5/180) of African S. Typhimurium carried 
mutations associated with reduced susceptibility to fluoroquinolones. Those strains 
belonged to the phylogenetic lineage ST313 L2 and were isolated in either Malawi (n=3), Mali 
(n=1) or Cameroon (n=1). The oldest isolate originated from Cameroon in 1998 and carried 
a single gyrA mutation (S83F). Interestingly, this isolate was sequence-typed as ST19 despite 
belonging to ST313 L2. The Mali isolate, dated from 2008, also carried the same gyrA 
mutation. The three Malawi isolates carried either gyrA (D87N) or gyrA (D87Y) and were 
isolated in 2008, 2013 and 2018, after ciprofloxacin was introduced to treat iNTS disease. All 
five strains were phenotypically susceptible to ciprofloxacin according to results measured 
by EUCAST breakpoints, consistent with having only a single gyrA mutations (Weigel et al., 
1998). Ongoing surveillance will be important to detecting any rises in ciprofloxacin 
resistance, particularly to identify strains with triple mutations which would confer full 
resistance to this clinically important antibiotic.  
 
3.4.5 The evolutionary trajectory of S. Typhimurium ST313 
To obtain dates for lineage divergence, Bayesian phylogenetic inference was used (Figure 
3.11, Figure 3.12). To account for variations in sampling depth in Malawi compared with 
countries sampled in the contextual collection, and to reduce computation time, I selected 
150/680 isolated for BEAST analysis (Section 3.8.8). To validate the results from this BEAST 
analysis, multiple BEAST runs including different random subsets of data could be compared 
to ensure that the study has not been biased by the sub-sampling only a small number of 
isolates. I included the prior assumptions of a coalescent Bayesian skyline model for 
population growth, and a relaxed log normal clock rate to account for rate heterogeneity 
amongst branches (described in Data S3.1 and Methods 3.3.8).  
 
Based on these prior assumptions, the most recent common ancestor (MRCA) of the ST19 
and ST313 sampled in this study date back to the year 918 AD (95 % Highest Posterior 
Distribution (HPD) = 570-1080) and the MRCA of all ST313 sampled in this study (Figure 3.12 
event 0) was 1566 (95 % HPD = 1271-1953). The dataset used here spanned 50 years and 
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included many isolates which predate those used in previous phylodynamic analysis (Ashton 
et al., 2017; Okoro et al., 2012). The incorporation of these historical, more diverse isolates 
generates a mean value for the MRCA of ST313 lineages that is older than previously 
described (~1787) (Ashton et al., 2017). However, it should be noted that the branch linked 
to the MRCA is deeply rooted in the phylogeny and the 95% HPD values reported here have 
a substantial breadth.  A limitation of Bayesian analysis is that it relies upon a series of user-
defined prior probability distributions which influence the estimation of tip dates. 
 
 
Figure 3.11 Distribution of sampled trees from Bayesian phylogenetic inference  
Chronograph of 150 S. Typhimurium strains isolated from bloodstream of human iNTS disease 
patients. Methods are described in Section 3.3.8. The figure displays the distribution of possible 


































































































































































The MRCA of ST313 L1 dated to 1794 (95 % HPD = 1738 - 1965), with Malawian ST313 L1 
forming a discrete sub-lineage with an MRCA (Figure 3.12 event 1) dated to 1950 (95 % HPD 
= 1921-1986). My estimation for the MRCA of ST313 L1 in Malawi confirms previously 
reported  estimates of ~1960 (95 % HPD = 1920-1979) (Okoro et al., 2012), with overlapping 
95 % HPD values. The ST313 L2 MRCA (Figure 3.12 event 2) dated to 1948 (95 % HPD = 1929-
1959). One 1966 sample predates the original prediction for the emergence of ST313 L2 of 
~1977 (95 % HPD = 1957-1968) (Okoro et al., 2012) which may account for my slightly earlier 
average estimation of MRCA. The 1966 sample represents the first ST313 L2 isolate to have 
been reported from Africa. The isolate (STM 252 66) originated from a patient in Senegal, 
and was predicted to be MDR. Although my average estimation for ST313 L2 is slightly earlier 
than that previously reported, the 95 % HPD values do overlap. I therefore conclude that my 
findings support previous estimations. The MRCA of ST313 L3 (Figure 3.12, event 3) was 2007 
(95 % HPD 1998-2012), showing that the clonal expansion of ST313 L3 occurred in recent 
evolutionary history. Overall, this analysis has advanced the current understanding of 
landmark dates in the evolutionary history of ST313 lineages by including a mixture of 




Figure 3.12 Stepwise evolution of S. Typhimurium responsible for bloodstream infections in Africa  
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Figure 3.12 Stepwise evolution of S. Typhimurium responsible for bloodstream infections in Africa 
Chronograph of 150/680 S. Typhimurium strains isolated from bloodstream of human iNTS disease 
patients (Section 3.3.8). The figure displays a maximum clade credibility tree. Posterior support is 
shown for key branches, all of which had the maximum posterior probability of 1.0. Adjacent colour 
strips are as follows (from left to right); ST, lineage assignment (rHierBAPs) with the three major ST313 
lineages highlighted in colour. Predicted functionality (see methods) is depicted as a colour strip for 
each gene and is based on whole genome-based predictions of SNPs likely to play a functional role. 
Genome degradation events that generate functionally relevant pseudogenes are displayed in red 
boxes overlying the chronograph. An asterisk (*) represents a premature stop codon. Numbers 
indicate four key evolutionary events. Figure visualised using iTOL (Letunic and Bork, 2016). 
 
3.4.6 The phylodynamics of pseudogene formation in of S. Typhimurium ST313 
To explore the known association of pseudogenisation and invasive salmonellosis in my 
dataset, I put pseudogene formation into a phylogenetic-temporal context. The 
accumulation of pseudogenes is a feature of invasive, host-adapted bacterial pathogens such 
as S. Typhi and S. Paratyphi (Holt et al., 2009) and has been recognised as a signature of 
adaptation in ST313, termed genome degradation (Kingsley et al., 2009; Okoro et al., 2015). 
For example, a common theme of the loss-of-function of certain metabolic pathways has 
been discovered in invasive pathogens (Wheeler et al., 2018). A list of previously identified 
pseudogenes associated with the emergence of ST313 lineages in Africa was compiled (Table 
S3.4) (Okoro et al., 2015). The collection included metabolic genes (melR and ttdA), 
environmental response genes (katE, macB and bcsG), structurally relevant genes (ratB, flhA 
and lpxO) and virulence genes (sseI, pipD), and excluded genes of unknown function 
(Bogomolnaya et al., 2013; Canals et al., 2019; Carden et al., 2017; Gibbons et al., 2000; 
Lawley et al., 2006; Okoro et al., 2015; Singletary et al., 2016). The SNPs responsible for 
pseudogene formation were detected, as well as other novel non-synonymous mutations. 
The conservation of pseudogene-associated mutations was identified at the population level 
and integrated into the temporal phylogenetic reconstruction. By measuring the 
evolutionary model of ST313 lineages, the stepwise accumulation of pseudogenes was 
characterised and hence the progression of functional gene loss associated with host 
adaptation that likely facilitated the ST313 epidemic in Africa. This phenomenon is 
exemplified by the timeline of pseudogene accumulation in ST313 L2 shown in Figure 3.12.  
 
Recently, the functional significance of the pseudogenisation of macB for ST313 L2 was 
reported (Honeycutt et al., 2020). Here, I report the frameshift event that made the macB 
gene non-functional occurred between 1948 and 1953 (95% HPD = 1931-1963) and 
represents the final stage in the evolution of ST313 L2 (Figure 3.12).  
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ST313 L3 can be considered as a phylogenetic intermediate between ST313 L1 and ST313 L2. 
Here, the term “phylogenetic intermediate” is used to reflect the divergence pattern 
observed in my Bayesian chronogram (Figure 3.12). Specifically, ST313 and ST19 diverged 
first, followed by ST313 L1 and ST313 L3/L2, and finally ST313 L3 and L2. Furthermore, 
isolates belonging to ST313 L3 contain several pseudogenes which are not present in L1, but 
are present in L2. The discovery of ST313 L3 therefore allowed further scrutiny of the 
timeline of gene degradation events. For example, the mutations in melR (F311L), flhA 
(A166T) and pipD (283 bp deletion) occurred prior to the divergence of ST313 L3 and ST313 
L2. The mutations in bscG (W247*), sseI (IS26 insertion) and lpxO (E198*) preceded the clonal 
expansion of ST313 L2, but were not found in ST313 L3. A small number of gene degradation 
events were ST313 L3-associated, specifically an extra non-synonymous mutation in ratB 
(G820S) and an additional 109bp deletion in pipD. Both mutations occurred in genes which 
had been pseudogenised earlier in evolutionary history and so were unlikely to cause specific 
phenotypic changes. The fact that ratB contained four different mutations predicted to 
impair gene function, and pipD carried two independent mutations, is consistent with both 
genes being negatively selected during the evolution of ST313 L3. The macB, sseI and lpxO 
genes that were non-functional in ST313 L2 were functional in ST313 L3, as previously 
reported for the UK-isolated ST313 representative (strain U2) (Ashton et al., 2017). I 
conclude that the pseudogenisation of the macB, sseI and lpxO genes was a landmark 
evolutionary event for the development of ST313 L2. 
  
3.4.7 Function of evolutionarily significant S. Typhimurium ST313 genes 
My genome-derived evolutionary insights were combined with phenotypic experiments that 
were performed with clinical S. Typhimurium isolates with particular genetic differences in 
specific genes. These experiments allowed the number of lineage-specific phenotypes to be 
linked to individual SNPs (detailed fully in Table S3.4). For example, the KatE catalase 
protects bacteria from oxidative stress in the environment, and has a high level of activity in 
stationary phase cultures of S. Typhimurium ST19 (Singletary et al., 2016). It was reported 
previously that the E117G KatE mutation was responsible for a low level of catalase activity 
in ST313 L1, ST313 L2, ST313 L2.1 and UK-isolated ST313 (Ashton et al., 2017; Singletary et 
al., 2016; Van Puyvelde et al., 2019), and here it was determined that ST313 L3 had a similarly 
low level of activity (determined experimentally by X. Zhu, University of Liverpool, UK) (Table 
S3.4). Catalase is required for multicellular growth as biofilms (Ma and Eaton, 1992), a 
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phenotype associated with survival outside the mammalian host, leading to the suggestion 
that pseudogenisation of katE in ST313 lineages reflects adaptation to a more restricted 
host-range.  
 
The RDAR-negative phenotype of ST313 L2 (MacKenzie et al., 2019) is caused by the 
pseudogenisation of bcsG (Singletary et al., 2016), a gene that encodes a cellulose 
biosynthetic enzyme required for biofilm formation. ST313 L3 has an intermediate RDAR 
phenotype, with an incomplete wrinkling pattern on the colony surface (experimentally 
determined by B. Perez Sepulveda, University of Liverpool, UK). As the bcsG gene is 
functional in ST313 L3, the genetic basis of the intermediate RDAR phenotype of ST313 L3 is 
unknown.  
 
Taken together, the loss of traits required for stress-resistance and biofilm formation by 
ST313 L2 and ST313 L3 is consistent with a reduced requirement for environmental survival 
by these lineages, and provides additional evidence that ST313 is spread by human-human 
transmission (Crump et al., 2020; Post et al., 2019). 
 
Adaptation to an invasive lifestyle by ST313 is associated with a decreased ability to colonise 
and survive within the gastrointestinal tract (Kingsley et al., 2009; Okoro et al., 2015). S. 
Typhimurium ST19 relies upon carbon metabolism to colonise the mammalian 
gastrointestinal tract (Nguyen et al., 2020) whereas genes required for utilisation of specific 
carbon sources, such as tartrate and melibiose, are not functional in ST313 lineages (Canals 
et al., 2019). ST313 L3 was unable to grow with tartrate or melibiose as a sole carbon source 
(shown experimentally by B. Perez-Sepulveda and H. Webster, University of Liverpool, UK), 
consistent with the pseudogenisation of the ttdA and melR genes in both ST313 L3 and ST313 
L2 (Kingsley et al., 2009),(Canals et al., 2019) (Figure 3.12).  
 
Further evidence of genome degradation, consistent with niche adaptation, is provided by 
the pseudogenisation of the genes ratB in all ST313 lineages, pipD in ST313 L2 and L3, and 
lpxO in ST313 L2. The PipD effector protein has been implicated in gastrointestinal 
pathogenesis of ST19, although a causal relationship has not been demonstrated (Lawley et 
al., 2006; Wood et al., 1998). The lpxO gene is pseudogenised by a stop codon in ST313 L2 
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(Kingsley et al., 2009). LpxO hydroxylates lipid A, a modification required for virulence of S. 
Typhimurium ST19 (Moreira et al., 2013). R. Canals (University of Liverpool, UK), J. 
Bengoechea and A. Dumigan (Queen’s University, Belfast) used mass spectrometry to show 
that the lack of functional LpxO caused structural modifications of Lipid A in ST313 L2 (Table 
S3.4). The lpxO gene is functional in ST313 L3, reflecting a different evolutionary path for this 
lineage. 
  
3.4.8 Invasiveness potential of novel ST313 L3 
As detailed above, genome degradation is a key feature in the evolution of bacterial 
pathogens that are adapted to systemic infection. Recently, the “invasiveness index” was 
defined as a value that represents the extent of genome degradation and diversifying-
selection that was specific to invasive serovars, and was based on a proven set of 
extraintestinal predictor genes (Wheeler et al., 2018). To determine the potential of ST313 
L3 to cause extraintestinal disease, the invasiveness index of each sample in this study was 
calculated and compared between different ST313 lineages using the Wilcoxon Mann 
Whitney test (Figure 3.13). Because the isolates used in this study originated from human 
bloodstream, I used the invasiveness index model that was pre-trained by Wheeler et al., 
because it incorporated a mixture of gastrointestinal and extraintestinal salmonellae 
(Wheeler et al., 2018). Consistent with previous studies, there was a significant increase in 
the invasiveness index of ST313 L2 compared with ST313 L1 (W=7636.5, p<0.001), and ST313 
L1 compared with ST19 (W=552.5, p<0.001) (Van Puyvelde et al., 2019; Wheeler et al., 2018). 
ST313 L3 had a particularly high invasiveness index (median=0.187, standard deviation 
(SD)=0.008), which was significantly greater than that of ST19 (median=0.110, SD=0.017), 
ST313 L1 (median=0.129, SD=0.008) or ST313 L2 (median=0.134, SD=0.006) (W=0, p<0.001) 
(Figure 3.13). ST313 L3 had a significantly greater invasiveness index than UK-isolated ST313 
(median=0.134, SD=0.018)(W=480, p-value<0.001).  
 
The invasiveness index is determined by assessing the level of degradation in 196 top 
predictor genes of Salmonella enterica, ranked in order of variable importance (Wheeler et 
al., 2018). In total, 17/196 genes had undergone additional degradation in ST313 L3 (isolate 
BKQZM9), compared with ST313 L2 (D23580), involving the presence of non-synonymous 
SNPs, indels or gene loss (Table S3.5). A number of the degraded genes in ST313 L3 are 
required for colonisation of the gastrointestinal tract by S. Typhimurium, including mrcB, 
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which was ranked highest in terms of importance. The mrcB gene, encodes penicillin binding 
protein 1b (PBP1b), a major target of b-lactam antibiotics and is important for survival in the 
presence of bile in Salmonella Typhi (Langridge et al., 2009b). In S. Typhimurium, a functional 
damX gene is required for resistance to bile (Lopez-Garrido et al., 2010), and was degraded 
in seven of the nine ST313 L3 isolates. The napA gene had extensive deletions in all but one 
ST313 L3 isolate, and encodes a periplasmic nitrate reductase required for gut colonisation 
(Canals et al., 2019; Lopez et al., 2015). Taken together, these findings suggest that ST313 L3 
is in the process of adapting from an intestinal to a systemic lifestyle. 
 
Figure 3.13 Invasiveness index of ST19 and ST313 lineages 
Box plot representing the distribution of invasiveness index values for all sequences included in this 
study summarised by lineage assignment. Groups were compared using the Wilcox Mann Whitney 
test and the resultant p-values are displayed above groups. Boxplot centre lines represent median 
values, boxplot limits represent upper and lower quartiles, boxplot whiskers represent the 1.5 































Together, my data provide an expanded and contemporary insight into the dynamics of S. 
Typhimurium responsible for systemic disease in Africa, elucidating the stepwise evolution 
of ST313. This study provides a snapshot of the large repertoire of genomic changes which 
have shaped the emergence of successful ST313 lineages. Host-adapted S. enterica serovars 
generally cause systemic disease, and often carry pseudogene mutations that prevent the 
production of certain effector proteins that are dispensable (or disadvantageous) for 
systemic infections (Klemm and Dougan, 2016). Therefore, genes which promote survival 
and growth in the gastrointestinal tract are often non-functional in host adapted, 
extraintestinal Salmonella (Klemm et al., 2016; McClelland et al., 2004; Nuccio and Bäumler, 
2014). The stepwise pseudogenisation of genes reported here is consistent with the host 
adaptation of S. Typhimurium ST313 lineages over evolutionary history and supports 
mounting evidence for a human ST313 reservoir (Post et al., 2019; Wheeler et al., 2018). My 
findings resemble the patterns of evolution as found in other Salmonella serovars that 
currently cause endemics of bloodstream infections globally. For example, S. Enteritidis 
represents a third of all iNTS disease cases in Africa and shows similar signs of genome 
degradation consistent with niche-adaptation (Reddy et al., 2010). 
 
I discovered that ST313 L3 emerged relatively recently as a cause of systemic disease in the 
Malawian population, and was first observed in 2016 with an MRCA of ~2007. It is possible 
that the phased removal of chloramphenicol from clinical practice following local policy 
changes in Malawi between 2002 and 2005 created a window of opportunity for the 
emergence of the fully-susceptible ST313 L3.  
 
Despite its contemporary nature, ST313 L3 is an evolutionary intermediate between ST313 
L1 and ST313 L2, forming a monophyletic cluster within a diverse group of ST313 originally 
identified in the UK. These UK-isolated ST313 could also be considered to be an intermediate 
phylogenetic group, albeit much more diverse that ST313 L3. A limitation of my analysis is 
that UK-isolated ST313 were not included in the Bayesian temporal phylogeny. Given the 
placement of ST313 L3 within the UK-isolated ST313 on the phylogeny (Figure 3.3), including 
the UK-isolated strains would facilitate more scrutiny of the evolutionary steps involved in 
the trajectory towards ST313 L3.  
 
 96 
After combining my phylogenetic and accessory genome analysis, I conclude that ST313 L3 
has been newly introduced into the Malawian population likely as a result of an international 
transmission event. Importantly, ST313 L3 had an elevated invasiveness index compared to 
ST313 L2, making it distinct from UK-isolated ST313 strains which had a lower invasiveness 
index than ST313 L2 (Ashton et al., 2017). The majority of ST313 L3-unique genes were 
plasmid or prophage-encoded, including the prophage RE-2010 (Wheeler et al., 2018) which 
is found in other extraintestinal Salmonella pathovariants (Hanna et al., 2012). Aside from 
accessory genome composition, the majority of ST313 L3-specific changes involve loss-of-
function SNPs in genes that are not required for systemic infection. These findings predict 
that ST313 L3 is better adapted to cause extraintestinal infection than other ST313 lineages 
from both the UK and in Malawi, a property that could have contributed the emergence of 
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NTS disease poses a significant burden to public health globally, causing approximately 153 
million cases and 57,000 deaths per annum (Kirk et al., 2015). Over the past decade, just six 
nontyphoidal Salmonella serovars have been responsible for ~70% of cases of human disease 
in Europe and the USA, namely Enteritidis, Typhimurium, monophasic Typhimurium 
1,4,[5],12:i:-, Infantis, Newport and Javiana (Centers for Disease Control and Prevention, 
2018; European Food Safety Authority and European Centre for Disease Prevention and 
Control (EFSA and ECDC), 2019). Of these, only S. Typhimurium and S. Enteritidis have been 
investigated intensively, however little research effort has focused on other NTS serovars 
that cause human disease globally, a disparity that needs to be addressed, particularly for 
those serovars which cause the most severe disease.  
 
As well as being responsible for gastroenteritis in humans, NTS can also invade normally 
sterile sites resulting in invasive infections such as bacteraemia and meningitis (Feasey et al., 
2012). This iNTS disease was responsible for 535,000 cases and 59,100 deaths globally in 
2017 (Stanaway et al., 2019a). In humans, the clinical presentation of NTS disease depends 
upon a combination of host immune factors and bacterial features that are specific to 
individual Salmonella pathovariants (de Jong et al., 2012; Gilchrist and MacLennan, 2019; 
Lokken et al., 2016). The high levels of iNTS disease caused by S. Typhimurium and S. 
Enteritidis in sub-Saharan Africa have generated a significant research focus (Ao et al., 2015; 
Stanaway et al., 2019a). However, as happened for NTS disease, other Salmonella serovars 
associated with iNTS infections have received little attention. One of these neglected 
serovars is S. Panama, which has been responsible for numerous geographically-localised 
outbreaks of NTS infections worldwide and causes more cases of iNTS than most serovars 
(Pulford et al., 2019). 
 
Whilst iNTS is most commonly seen in sub-Saharan Africa (Ao et al., 2015; Marchello et al., 
2019; Stanaway et al., 2019a), S. Panama has a very different geographical distribution. The 
first isolation of S. Panama occurred during an investigation of foodborne infection amongst 
American soldiers stationed in Panama in 1934 (Leeder, 1956). In French territories of 
America, such as Martinique, Guadeloupe and French Guiana, S. Panama is consistently 
reported as a leading cause of NTS disease (Gay et al., 2014; Guyomard-Rabenirina et al., 
2018; Olive et al., 1996; Papa, 1976) and is significantly associated with causing invasive 
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infections in children (Guyomard-Rabenirina et al., 2018). Although the proportion of NTS 
cases caused by S. Panama is high in these locations, AMR is reported to remain low 
(Guyomard-Rabenirina et al., 2018; Olive et al., 1996). In contrast, other regions have seen 
higher levels of AMR in S. Panama (Huang et al., 2013; Kempf and Pietzsch, 1977; Lee et al., 
2008; Matsushita et al., 2001; Stephan et al., 1977; van Leeuwen et al., 1982).  
 
In Europe, S. Panama caused public health concern after spreading through the pork industry 
and causing multiple hospital outbreaks in the 1970’s and 1980’s (Cherubin, 1981; Le Minor 
and Le Minor, 1981; Lee, 1974; Wilkins and Roberts, 1988). S. Panama maintained its ranking 
as one of the top 20 most frequently isolated serovars in the European Union until 2017 
(EFSA and ECDC, 2018) and is a frequent cause of invasive disease with 7% of cases causing 
extraintestinal infection in England (Wilkins and Roberts, 1988). Similarly, S. Panama has 
been an important cause of iNTS in Asia, as the 11th most frequently isolated serovar 
between 2001 and 2007 (Hendriksen et al., 2011). Asian isolates have been linked with high 
levels of antimicrobial resistance, with up to 83% of domestic and imported S. Panama 
isolates in Tokyo reported to be multidrug resistant by the early 2000s (Lee et al., 2008; 
Matsushita et al., 2001).  
 
WGS-based approaches have been used to characterise multiple NTS serovars that cause 
invasive disease such as S. Typhimurium and S. Enteritidis (Feasey et al., 2016; Kingsley et al., 
2009; Okoro et al., 2015, 2012; Van Puyvelde et al., 2019). These studies identified signature 
genomic features that discriminate between the gastrointestinal and extraintestinal 
lifestyles of Salmonella (Klemm and Dougan, 2016; Klemm et al., 2016). Specifically, 
functions required for escalating growth within the inflamed gut are often lost in a series of 
gene pseudogenisation events (Nuccio and Bäumler, 2014; Okoro et al., 2015).  
 
In addition to pseudogenisation, other genomic features have contributed to Salmonella 
invasiveness such as SNPs (Hammarlöf et al., 2018) or the presence of plasmids (Lawley et 
al., 2006), prophages (Brussow et al., 2004; Figueroa-Bossi et al., 2001; Ho and Slauch, 2001; 
Owen et al., 2017) and key virulence factors (den Bakker et al., 2011). To investigate 
associations between genotype and phenotype, GWAS have been valuable (Lees and 
Bentley, 2016). Although such techniques are in their infancy for bacterial pathogens, GWAS 
have successfully identified the genetic basis of increased virulence in Listeria 
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monocytogenes (Maury et al., 2016) and Staphylococcus aureus (Young et al., 2019), 
resistance-conferring variants in Mycobacterium tuberculosis (Desjardins et al., 2016) and 
host resistance in Salmonella Pullorum (Li et al., 2019).  
 
Although S. Panama is a globally disseminated serovar associated with iNTS, it has remained 
an enigma and has never been investigated in detail. In the current era of genomically 
informed pathogen surveillance, unravelling the molecular epidemiology and evolutionary 
history of S. Panama will provide a vital baseline of understanding for this important serovar 
going forward. Here, I used whole genome-based approaches to determine the genomic 
epidemiology of S. Panama collected during routine public health surveillance. I 
characterised six geographically associated S. Panama clades and revealed regional trends in 
AMR. My findings prompted a further phylodynamic investigation which revealed the 
migratory rates and spatial-temporal evolution of the serovar. Finally, I determined genetic 
markers of invasiveness between S. Panama clades, showing prophage presence and 




4.3.1 A dataset of 489 S. Panama strains from 27 countries collected over 26 years 
S. Panama samples were derived from three archived public health collections. Following 
sampling, whole-genome sequencing and quality control steps (described below), a total of 
489 samples were included in the study. A description of the isolates is summarised in Table 
4.1 and is available with all metadata and genome accession numbers in Table S4.1. 
 
Table 4.1 Description of 489 S. Panama isolates sourced from three collections. 
aBold font refers to sampling locations, non- bold font refers to inferred location based on travel data.  
bThe term extraintestinal includes isolates sourced from blood and cerebral spinal fluid 
  
The largest dataset was sourced from the Unité des Bactéries pathogènes entériques, Institut 
Pasteur, Paris, France which consists of 2,349 S. Panama collected from France and French 
overseas territories between 1993 and 2016. Due to budgetary constraints on the number 
of samples that could be sent for WGS, the total dataset was sub-sampled. To capture the 
maximum global context, all isolates associated with travel outside of France and French 
overseas territories were selected. The reason for focusing on French overseas was because 
S. Panama is reported to be the most common Salmonella serotype in these regions 
(Guyomard-Rabenirina et al., 2018). To encompass invasive S. Panama, all cerebral spinal 
fluid and bloodstream isolates from French overseas territories and a small number of 
isolates from Metropolitan France were included. To enable a contrast with non-invasive S. 
Panama, one stool isolate per year from each sampling location available was randomly 
selected using the excel random number generator (RAND function in Excel, Microsoft). The 
total number of sampled isolates was 439.  
 
To complement the Institute Pasteur dataset, S. Panama which had previously been whole 
genome sequenced during routine surveillance by the National Infection Service, Public 
Collection 















Martinique (n= 170), French Guiana (n=61), Guadeloupe (n=56), 
France (n=2), Thailand (n=9), Cambodia (n=5), Europe 
unspecified (n=2), Brazil, (n=1), Antilles (n=1), Chile (n=1), Laos 
(n=1), Martinique (n=1), Panama (n=1), Saint Lucia (n=1), Sri 
Lanka (n=1), Tunisia (n=1) 
315 25 98 217 - 
Public Health England 
UK (n=114), 
Thailand (n=13), Mexico (n=7), Barbados (n=3), Costa Rica (n=2), 
Asia Unspecified (n=1), Cameroon (n=1), Caribbean unspecified 
(n=1), Germany (n=1), Hong Kong (n=1), Malta (n=1), 
Mozambique (n=1), Spain (n=1), Sri Lanka (n=1), USA (n=1) 
149 35 117 16 16 
Doherty Institute 
Australia (n=25) 25 - - - 25 
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Health England, London, UK (PHE) and the Doherty Institute, Melbourne, Australia were also 
included. Specifically, the PHE dataset includes whole genome sequence data from 162 
routinely sequenced (Ashton et al., 2016) S. Panama collected between 2012 and 2019. The 
Doherty Institute dataset consists of whole genome sequence data from 25 S. Panama 
collected between 2005 and 2019. Doherty Institute isolates were sampled by Danielle Ingle 
(Doherty Institute, Australia).  
 
Metadata collected during surveillance questionnaires was used to assign an inferred 
geographical location to each sample. Where a patient reported a recent trip overseas, the 
travel destination was considered to be the inferred isolate location (Baker et al., 2018a; 
Ingle et al., 2019). Where travel was not reported, the sampling location was considered to 
be the location. Locations were grouped based on United Nations classifications. Specifically, 
locations belonged to one of four geographical regions; Africa, America (including the 
Caribbean), Asia/Oceania and Europe.  
 
4.3.2 Whole genome sequencing of S. Panama isolates from the Institute Pasteur 
Isolates from the Institut Pasteur collection have been stored as stab cultures. To resuscitate 
samples, a sterile loop was used to transfer culture into 10 ml of Tryptic Soy Broth (Neogen, 
NCM0004A, which was grown overnight at 37°C. To check for potential contaminants, each 
sample was also streaked onto Drigalski agar plates (BIO RAD, 63834), which were visually 
inspected following overnight growth at 37°C. If colonies appeared to be homogenous on 
Drigalski agar, 100 μL of culture was aliquoted into a FluidX 2D Sequencing Tube (FluidX Ltd, 
UK). Cultures were heat-killed in a 95°C water bath for 20 minutes to produce thermolysates 
before DNA extraction (MagAttract kit, Qiagen) and were whole-genome sequenced as part 
of the 10,000 Salmonella Genomes Project (Perez-Sepulveda et al., 2020). Illumina Nextera 
XT DNA Libraries were prepared (Illumina, FC-131-1096) and sequenced (Illumina HiSeq 
4000) in multiplex (768) as 150 bp paired-end reads.  
 
4.3.3 Assembly, quality control and annotation of short sequence reads  
To prepare genome sequence data for downstream analysis, reads were assembled, subject 
to quality control and annotated. Adapter content and raw read quality was assessed using 
FastQC v0.11.5 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and MultiQC 
v1.0 (http://multiqc.info). Adapter trimming was then performed using Trimmomatic (Bolger 
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et al., 2014) v0.36 and low-quality regions were trimmed using Seqtk v1.2-r94 
(https://github.com/lh3/seqtk) with the trimfq flag. Adapter and quality trimmed reads were 
re-assessed for quality using FastQC v0.11.5 and MultiQC v1.0. Quality metrics used to pass 
sequencing reads were as follows: passed basic quality statistics, per base sequence quality, 
per base N content and adapter content. GC content distributions were visually inspected to 
determine any isolates with unusual peaks. Only high-quality reads were used in 
downstream analysis. Unicycler (Wick et al., 2017) v0.3.0 was used to assemble genomes 
and QUAST (Gurevich et al., 2013) v4.6.3 was used to evaluate assembly quality to standards 
consistent with EnteroBase (Alikhan et al., 2018). Specifically, N50 > 20 kb, 600 or fewer 
contiguous sequences, total number of bases between 4Mbp and 5.8Mbp. Prokka (Seemann, 
2014) v1.12 was used to annotate the genomes. SISTR (Yoshida et al., 2016) v1.0.2 was used 
to confirm serovar designations.  
 
4.3.4 Phylogenetic analysis 
Trimmed sequencing data was mapped against the S. Panama reference genome (CP012346) 
using Snippy (https://github.com/tseemann/snippy) v4.4.0 with minimum coverage of 4 and 
base quality of 25. QualiMap (García-Alcalde et al., 2012) v2.0 was used to assess mapping 
quality and only samples with greater than 10x genome coverage were included in 
downstream analysis. The mean coverage depth across all isolates was 45.13x. Snippy-core 
v4.4.0 was used to build a reference-based pseudogenome for each isolate which was passed 
through snippy-clean v4.4.0 to replace non-ACTG characters with an N. Subsequently, 
Gubbins (Croucher et al., 2014) v2.2 was used to remove recombinant regions and invariant 
sites. The resultant multiple sequence alignment of reference based pseudogenomes 
(13,213 variant sites) was used to infer a maximum likelihood phylogeny using RAxML-ng 
(Stamatakis, 2014) v0.6.0 with 100 bootstrap replicates to assess support. To assign clusters, 
rhierBAPs (Tonkin-Hill et al., 2018) was used specifying two cluster levels, 20 initial clusters 
and infinite extra rounds. Cluster designations were visualised against the phylogenetic tree 
using iTOL (Letunic and Bork, 2016) v4.2. Pairwise SNP distances were calculated using snp-
dists v0.7.0 (https://github.com/tseemann/snp-dists). 
 
4.3.5 Determination of AMR determinants 
Genetic determinants for AMR were identified using staramr v0.5.1 
(https://github.com/phac-nml/staramr) against the ResFinder (Zankari et al., 2012) and 
PointFinder (Zankari et al., 2017) databases. Common resistance patterns were identified 
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and the respective contigs were extracted from the assembled genomes. To understand the 
genetic context of regions carrying AMR determinants, the contigs were manually inspected 
using Artemis (Carver et al., 2012) v10.2. The Prokka-based annotations were confirmed and 
updated using BLASTx (Altschul et al., 1990) v2.10.1 to compare all coding regions against 
the non-redundant protein sequence database. PlasmidFinder (Carattoli et al., 2014) was 
used to predict contigs containing plasmids, and the results were compared with contigs 
containing AMR determinants. Finally, BLASTn (Altschul et al., 1990) v2.10.1 was used to 
understand the wider context of relevant genetic regions. 
 
4.3.6 Temporal phylogenetic reconstruction 
To determine the evolutionary history of S. Panama and to model pathogen movement 
between regions, a chronogram was produced using Bayesian phylogenetic inference. Due 
to the complexity of the evolutionary model and the availability of computational resources, 
50/489 S. Panama were sub-sampled for the analysis. The 50 isolates were selected by 
stratifying the dataset into regions and selecting ~10% of isolates per region using the excel 
random number generator (RAND function in Excel, Microsoft). A reference-mapped 
multiple sequence alignment (3,178 variant sites) was created as described above.  
 
The multiple sequence alignment was loaded into BEAUti (Bouckaert et al., 2019) v2.6.1, 
using the MASCOT (Marginal Approximation of the Structured Coalescent) template (Müller 
et al., 2018) to implement a structured coalescent approximation to model migration. Dates 
and region classifications were extracted from the metadata file and used to specify tip dates 
and locations. The BEAST model test (Bouckaert and Drummond, 2017) was used to integrate 
over all possible site models. The clock model was specified as relaxed clock log normal in 
line with previously published Bayesian analysis for S. enterica (Ashton et al., 2017; Okoro et 
al., 2012; Van Puyvelde et al., 2019). TempEst (Rambaut et al., 2016) v1.5.1 was used to 
estimate the mean clock rate of 3.67e-4 substitutions per site per year. The estimated clock 
rate was set as a prior with a log normal distribution. To avoid very small integration steps 
(and an unfeasibly small probability of observing a phylogenetic tree), the prior distributions 
on migration rate and population size were adjusted. Specifically, the migration rate was set 
at 0.1 with an exponential distribution which will prohibit very large migration rates, whilst 
not discriminating between small and very small values. The prior distribution on the 
effective population size was set to log normal, to avoid very small values.  
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BEAST2 (Bouckaert et al., 2019) v2.6.1 was used execute three independent chains of length 
200,000,000 with 10% burn in, logging every 1,000 and accounting for invariant sites (Data 
S4.1). Tracer (Rambaut et al., 2018) v1.7.1 was used to assess convergence, with all 
parameter effective sampling sizes being > 200. LogCombiner (Bouckaert et al., 2019) v2.6.1 
was used to combine tree files and DensiTree (Bouckaert, 2010) v2.2.7 was used for initial 
visualisation. Finally, a maximum clade credibility tree was created using TreeAnnotator 
(Bouckaert et al., 2019) v2.6.0. The phylogeny was visualised using FigTree v1.4.3 
(http://tree.bio.ed.ac.uk/software/figtree/) and iTOL (Letunic and Bork, 2016) v4.2. 0 
 
4.3.7 Determination of invasiveness index 
The invasiveness index of each isolate was calculated using previously defined methods, 
using the 196 top predictor genes for measuring invasiveness of S. enterica (Wheeler et al., 
2018). The same pre-trained model was used to compare the mean invasiveness index for S. 
Panama with the invasiveness index of validation strains previously described (Wheeler et 
al., 2018). The distribution of invasiveness index values for each cluster were compared using 
the Wilcoxon Mann Whitney test implemented through R (R Core Team, 2017) v3.4.0. A 
custom-made database of the top 196 invasiveness predictor genes was then created from 
the multi-fasta file provided in Wheeler et al. (2018). SRST2 (Inouye et al., 2014) v0.2.0 was 
used to identify variations between the 196 genes in study isolates. 
 
4.3.8 Genome wide association study  
A GWAS was run to determine genomic features potentially associated with invasive disease 
presentation. First, a GWAS was used to investigate the association between invasiveness 
and accessory genes. Roary (Page et al., 2015) v3.11.0 was used to generate gene 
presence/absence data and a core gene alignment. SNP-sites (Page et al., 2016) v2.3.3 was 
used to extract SNPs and the resultant alignment (14,730 variant sites) was used to construct 
a maximum likelihood phylogeny using RAxML-ng (Stamatakis, 2014) v0.6.0 with 100 
bootstrap replicates to assess branch support. Visualisations were made using iTOL (Letunic 
and Bork, 2016) v4.2 to confirm tree topology. Scoary (Brynildsrud et al., 2016) v1.6.16 was 
then used to identify accessory genes associated with an invasive phenotype. A Benjamini 
Hochberg (BH) corrected p-value of 0.05 was used to filter significant results (Benjamini and 
Hochberg, 1995). To support the Scoary predictions, a Cluster of Orthologous Group (COG)-
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based analysis was run using the linear fixed effects model implemented through Pyseer 
(Lees et al., 2018) v1.3.5. To control for potential confounding, inferred locations were 
included as a covariate. The minimum allele frequency was set at 5 and the maximum 
number of dimensions was set at 8. Any result labelled as “bad chi sq” or “high bse” were 
filtered and used a standard significance cut off of 0.05 for p-value. Specifically, the likelihood 
ratio test (lrt) p-value was used which accounts for multiple comparisons. The results for the 
Scoary and Pyseer-COG analysis were compared to identify genes common to both analyses. 
The genetic context of this subset of genes was evaluated by manually investigating the 
contigs using Artemis (Carver et al., 2012) v16.0.0.  
 
A second GWAS was run to determine an association between SNPs and invasiveness. BWA 
mem (Li and Durbin, 2009) v0.7.10-r789 was used to map trimmed sequencing data against 
the S. Panama reference genome. Mapped reads were then cleaned and sorted using the 
SAMtools suite (H. Li et al., 2009) v1.7. Reads were realigned against the reference using 
GATK (McKenna et al., 2010) v3.7 by creating targets for realignment 
(RealignerTargetCreator) and performing realignment (IndelRealigner). Removal of optical 
duplicates was completed using Picard v2.10.1-SNAPSHOT 
(https://broadinstitute.github.io/picard/). Sequence variants were called using Bcftools 
v1.9-80 (http://samtools.github.io/bcftools). Vcfutils was used for variant filtering as part of 
the SAMtools suite (H. Li et al., 2009) v1.7. specifying 4 as the minimum depth of coverage.  
 
To run the SNP-based GWAS, the linear fixed effects model was used, implemented through 
Pyseer (Lees et al., 2018) v1.3.5. Inferred location was set as a covariate and a minimum and 
maximum allele frequency was set of 0.02 and 0.98 respectively. The lrt p-value, corrected 
for population structure, was used to assess significance. The significance threshold was 
adjusted for multiple comparisons by dividing the desired significance threshold (0.05) by 
the total number of variants (3,878) to achieve a suggestive p-value of 1.29e-5. A quantile-
quantile (qq) plot was created to look for evidence of p-value inflation. A Manhattan plot 
was created using R ggplot2 (Wickham, 2016). The top hits were manually investigated using 
Artemis (Carver et al., 2012) v16.0.0. 
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4.3.9 Prophage annotation and characterisation 
The online tool, PHASTER (Arndt et al., 2016) was used to characterise the prophage 
repertoire of the S. Panama reference genome (CP012346). The Fels-2-like prophage 
sequence was extracted and formatted as a custom-made database for analysis in SRST2. 
SRST2 (Inouye et al., 2014) v0.2.0 was then used to determine percentage coverage against 
the prophage region in the S. Panama reference. Results were manually mapped onto the 
phylogeny and chronogram using iTOL (Letunic and Bork, 2016) v4.2 which allowed inference 
of prophage presence and absence in clades. A representative strain from clade 4 and clade 
6 were selected and ran through PHASTER to identify the correct contiguous sequence with 
the prophage. Artemis (Carver et al., 2012) v16.0.0 was used to extract the prophage-
containing contig from the clade 4 and clade 6 representative strains. The prophage regions 
were annotated by cross-referencing results from BLASTx (Altschul et al., 1990), PHASTER 
(Arndt et al., 2016) and Prokka (Seemann, 2014). ACT (Carver et al., 2005) was used to 
perform a pairwise comparison of the clade 4 and  clade 6 prophages against the following: 
S. Panama reference strain prophage (CP012346, region 1108684-1155312bp), Fels-2 
(NC_010463.1), RE-2010 (HM770079) and SopEΦ (FQ312003.1 region 2855616 to 2901979). 
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4.4 Results and Discussion 
4.4.1 Establishing an informative collection of S. Panama isolates summary 
To create a relevant dataset, the whole genome sequence data of 489 S. Panama isolates 
was assembled from public health collections (Table 4.1, Table S4.1). The largest part of the 
dataset included 315 isolates sourced from the Unité des Bactéries pathogènes entériques, 
Institut Pasteur (IP), Paris, France. The isolates were sampled from the IP archives which hold 
2,349 S. Panama collected from France and French overseas territories between 1993 and 
2016. The strategy for sampling the IP collection was designed to capture both invasive and 
non-invasive isolates and put them into a global context. Specifically, 439 samples were 
selected which incorporated: all isolates associated with overseas travel; all blood and 
cerebral spinal fluid isolates from French overseas territories; a small set of isolates from 
metropolitan France; and one stool isolate per year from each sample location available. The 
majority (315/439) of sampled isolates could be resuscitated, sent for whole genome 
sequencing and passed sequence quality control.  
 
The IP dataset was complemented by 149 isolates collected in England and Wales, between 
2012 and 2019, by the National Infection Service, Public Health England (PHE), London, UK. 
PHE has routinely genome-sequenced every Salmonella isolate received by the Salmonella 
reference service since 2015 (Ashton et al., 2016) in addition to a small number of pre-2015 
isolates. The resulting genomic data are regularly deposited in publicly available repositories 
(Ashton et al., 2016). In total, the sequences of 162 S. Panama isolates were downloaded 
from the Sequence read archive, and 149 passed sequence quality control. Finally, 25 S. 
Panama isolates were analysed which were collected by the Doherty Institute (DI), 
Melbourne, Australia between 2005 and 2019. All 25 isolates passed QC and were included 
in the final dataset.  
 
4.4.2 Population structure of S. Panama isolates  
To define population structure of an understudied serovar, the phylogenetic relationship 
between 489 S. Panama genomes was explored (Figure 4.1). The sequences were mapped 
onto the high quality complete reference genome of S. Panama, strain ATCC7378 (Yao et al., 
2016) (GenBank Accession: CP012346), recombination was removed and SNPs were 
identified in the remaining sites. The resulting core genome SNP alignment, of length 13,213 
SNPs, was used to construct a maximum likelihood phylogenetic tree with 100 bootstraps to 
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assess support. Cluster designation using rhierBAPs (Tonkin-Hill et al., 2018) revealed seven 
clusters. Mapping of rhierBAPs designations onto the phylogenetic tree showed that six of 
the clusters were monophyletic, with greater than 95% bootstrap support. The six 
monophyletic clusters were defined as clade 1 to 6, specifically C1 (n = 56), C2 (n = 65), C3 (n 
= 44), C4 (n = 66), C5 (n = 95) and C6 (n = 68). Mean pairwise SNP distances were calculated 
both within and between clades (Table 4.2), which demonstrated a high level of genetic 
similarity between isolates belonging in C2 (mean pairwise distance =32 SNPs), followed by 
C1 (39 SNPs), C3 (64 SNPs), C5 (82 SNPs), C6 (88 SNPs) and C4 (122 SNPs).  
 
Table 4.2 Mean pairwise SNP distances between and within S. Panama clades 
 C1 C2 C3 C4 C5 C6 
C1 39 169 234 347 272 492 
C2 169 32 207 347 245 466 
C3 234 207 64 395 293 514 
C4 374 347 395 122 318 605 
C5 272 245 293 318 82 487 
C6 492 466 514 605 487 88 
NB: Mean pairwise SNP distances within clades are highlighted in light grey 
 
The remaining samples in this study belonged to a seventh, polyphyletic, cluster which was 
returned as a single cluster on rhierBAPs and included miscellaneous isolates that did not 
belong to any other clade. Inconsistencies between maximum likelihood phylogenetic clades 
and rHierBAPs clusters may arise due to intrinsic differences in the methodology of the two 
approaches. Specifically, rHierBAPs will cluster isolates based on SNP similarity by directly 
integrating over allele frequencies in each group (Tonkin-Hill et al., 2018), whereas maximum 
likelihood phylogenetics applies an evolutionary model to the sequencing data (Stamatakis, 
2014).  
 
To investigate the relationship between clades and geographic region, location data was 
mapped onto the phylogenetic tree (Figure 4.1). When patients reported a recent overseas 
journey, the travel destination was designated as the inferred location of the isolate (Baker 
et al., 2018a; Ingle et al., 2019). Locations were grouped into four regions based on 
geography and United Nations regional definitions, specifically America (including the 
Caribbean), Europe, Asia/Oceania, and Africa. Taken together, these findings revealed 
evidence of regional clustering throughout the phylogenetic tree which may be of relevance 
for the genome-based surveillance of future outbreaks.  
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Four clades were predominantly composed of American isolates (96.43% of C1, 96.92% of 
C2, 100% of C3, 100% of C5). Each of the four clades contained multiple isolates from the 
same country, suggesting localised clonal circulation (Figure 4.1). For example, 100% (44/44) 
of C3 isolates originated in French Guiana. In contrast, isolates from Martinique were largely 
spread across two clades, specifically making up 91.07% of C1 and 98.95% of C5. A small 
proportion of C2 isolates also originated in Martinique (12/65), however the majority were 
from Guadeloupe (49/65). Phylogenetically proximate isolates from Guadeloupe and 
Martinique were identified, suggesting that inter-island transmission of C2 may be occurring.  
 
The remaining two clades were mainly composed of European (C4) or Asia/Oceania (C6) 
isolates. In total, 96.97% of isolates in C4 originated in Europe. Whilst the majority of these 
isolates came from the UK (56/66), C4 also contained isolates from less-well sampled 
European countries including one from each of Germany, Malta and France. These findings 
are consistent with European-wide circulation, and so C4 was designated as the “European 
clade”. A proportion (22.06%) of the C6 isolates were also isolated in Europe, however most 
(76%) originated in Asia and Oceania, with specific locations including Thailand (22/68), 
Australia (22/68), Cambodia (5/68), Cameroon (1/68), Hong Kong (1/68) and Laos (1/69). To 
reflect the origin of the majority of the isolates, C6 was termed the “Asia/Oceania clade”.  
 
A key limitation of this analysis was the disparity in sampling depth between countries, 
reflected in the distribution of isolates which did not belong to any of the six clades. The 
miscellaneous isolates often originated from less well-sampled countries, suggesting that 




Figure 4.1 Population structure, AMR trends and geographical distribution of S. Panama 
(A) Maximum likelihood phylogeny (Section 4.3.4) demonstrating the population structure of 489 S. 
Panama from 27 countries, collected over 26 years (1993-2019) during routine public health 
surveillance (Section 4.3.1). Bootstrap values are displayed on key branches for C1 to C6. Colour strip 
immediately adjacent to the phylogeny shows cluster assignment (rHierBAPs), with grey representing 
a miscellaneous polyphyletic cluster. Bar graphs show the number of isolates in each clade from each 
inferred location. Locations are further grouped into regions, specifically America (blue), Europe 
(purple), Asia/Oceania (green) and Africa (orange). AMR colour strip indicates strains carrying >1 
antimicrobial resistance determinant (red), or strains which are predicted to be pan-susceptible (grey) 
(Section 4.3.5). (B) Horizontal bar charts show the percentage of isolates from each region carrying 
resistance determinants to each antimicrobial. Note that isolates from Africa were not shown, due to 
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4.4.3 Antimicrobial resistance trends 
To determine AMR trends in this collection of S. Panama isolates, the draft genome 
sequences of all 489 samples were examined for genes and mutations that confer reduced 
susceptibility to antimicrobials. Previous studies have demonstrated that genome-based 
AMR analysis accurately predicted phenotype for 97.82% of Salmonella isolates (Neuert et 
al., 2018). In total, 13.91% (68/491) of isolates were predicted to be resistant to at least one 
antimicrobial class, with the remaining 86.06% (421/489) predicted to be pan-susceptible, 
lacking any known antibiotic resistance genes or mutations. The majority of resistant isolates 
(66/68) fell within C4 or C6, and originated in Asia/Oceania (36/68) or Europe (29/68) (Figure 
4.1). These findings are supported by other phenotypic studies which reported an increase 
in S. Panama isolates from Asia that were resistant to multiple antibiotics, including 
cotrimoxazole, ampicillin, streptomycin, kanamycin and gentamicin (Lee et al., 2008).  
 
C4 is predominantly composed of European isolates, many of which have acquired MDR 
determinants. C4 may have arisen following an outbreak that involved the continental 
spread of S. Panama across Europe, associated with the food production industry in the 
1970’s and 1980’s (Cherubin, 1981; Le Minor and Le Minor, 1981; Lee, 1974; Wilkins and 
Roberts, 1988). It is generally believed that these European S. Panama has been exposed to 
a high antibiotic selective pressure in humans or food animals during their evolution and 
consequently became resistant to multiple antibiotic agents via acquisition of mobile genetic 
elements (Avril et al., 1977; Bouanchaud and Chabbert, 1969; Guinee, 1969, 1968; Guinee et 
al., 1967; Manten et al., 1971; van Leeuwen et al., 1982). 
 
The most common resistance profile, occurring in 51.47% (35/68) of resistant isolates 
included streptomycin (aadA1, aadA2), ampicillin (blaTEM-1B), chloramphenicol (cmlA1), 
trimethoprim (dfrA12), sulfisoxazole (sul3) and tetracycline (tetA). All 35 isolates belonged 
to C6 and a substantial proportion were sampled from patients who specifically reported 
travel to Asia (16/35). Detailed analysis of the draft genomes showed that most of the 
resistance genes (aadA1, aadA2, cmlA1, dfrA12 and tetA) were encoded by an MDR cassette 
located on a single contig (Figure 4.2). A BLAST search of the contig revealed 99.79% 
sequence identity to a 21.2kb region of an 83.2kb plasmid (CP044301.1), which had 
previously been identified in an E. coli isolate from Pork in Cambodia (unpublished).  
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Figure 4.2 Functional annotation of the most common S. Panama MDR cassette.  
Contiguous sequence containing MDR cassette extracted from 35 isolates of S. Panama with 
resistance against streptomycin (aadA1, aadA2), chloramphenicol (cmlA1), trimethoprim (dfrA12), 
and tetracycline (tetA). Resistance determinants are highlighted in red.  
 
The second most common AMR profile, occurring in 19.12% (13/68) of resistant isolates was 
against streptomycin (aph(3’)-Ib), kanamycin (aph(6)-Id), ampicillin (blaTEM-1B), 
trimethoprim (dfrA14), sulfisoxazole (sul2) and tetracycline (tetA). The 13 isolates were all 
part of C4 and were isolated from Europe. All genes were carried by an MDR cassette located 
on a single contig (Figure 4.3). The contig shared 99.98% sequence identity with a 28.3kb 
region of a 50.9kb S. enterica plasmid (CP028173.1), which has been identified in multiple 
strains including an S. Enteritidis isolate from a human in Ghana (Kudirkiene et al., 2018). 
Gene Name (Ordered) Functional Annotation
ebr Quaternary ammonium compound efflux SMR transporter
aadA1 Streptomycin resistance gene
cmlA1 Chloramphenicol resistance gene
aadA2 Streptomycin resistance gene
dfrA12 Trimethoprim resistance gene
intI1 Integron integrase
Unknown Tn3 family transposase
Unknown Hypothetical protein
tetR TetR family transcriptional regulator
tetA Tetracycline resistance gene
pecM EamA family transporter
Unknown Tn3 family transposase






Unknown DEAD/DEAH box helicase
Unknown IS5-like element ISKpn26 family transposase
Unknown IS5-like element ISKpn26 family transposase
Unknown Hypothetical protein
intI1 Integron integrase




Figure 4.3 Functional annotation of second most common S. Panama MDR cassette.  
Contiguous sequence containing MDR cassette extracted from 13 S. Panama isolates with resistance 
against streptomycin (aph(3’)-Ib), kanamycin (aph(6)-Id), ampicillin (blaTEM-1B), trimethoprim 



























































traD Type IV conjugative transfer system coupling protein
traI Conjugative transfer relaxase/helicase
Unknown Hypothetical protein
aph(6)-Id Kanamycin resistance gene
drfra14 Trimethoprim resistance gene
aph(3’)-Ib Streptomycin resistance gene
sul2 Sulfisoxazole resistance gene
Unknown Tn3 family transposase
pecM EamA family transporter
tetA Tetracycline resistance gene
tetR TetR family transcriptional regulator
blaTEM-1B Ampicillin resistance gene
Unknown Transposase
Unknown Tn3 family transposase
nuc Phospholipase D family protein
virB11 P-type DNA transfer ATPase
traI Conjugal transfer protein
traH Conjugal transfer protein
traG Conjugal transfer protein
Unknown Type IV secretion protein
Unknown Hypothetical protein
virB5 Type IV secretion system protein





hvrA Trans-acting regulatory protein
Unknown Hypothetical protein
Unknown IncN plasmid KikA protein
Unknown Hypothetical protein
Unknown Restriction endonuclease
insB Is1 family transposase
Unknown DNA cytosine methyltransferase
Unknown Restriction endonuclease
Unknown Recombinase family protein
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The remaining 7.00% of resistant isolates had a variety of susceptibility profiles including one 
XDR sample which was phylogenetically classified as C6. Epidemiological information showed 
that the sample was isolated in 2012 from the bloodstream of a 20-year-old male in France 
who had recently returned from Thailand. The isolate carried AMR determinants specific to 
eight different antimicrobial classes, including fluoroquinolones, polymyxins and ESBL-
mediated resistance to third-generation cephalosporins. In S. Typhi, XDR is defined as 
resistance to five antibiotic agents and includes resistance to fluoroquinolones and ESBL 
activity. The nomenclature used to describe the extensively drug resistant isolate, is 
consistent with previous definitions for XDR (Klemm et al., 2018). The resistance genes were 
distributed across five contigs (Figure 4.4). The first contig carried resistance genes against 
streptomycin (aadA1, aadA2), chloramphenicol (cmlA1), trimethoprim (dfrA12) and 
sulfisoxazole (sul3). A second contig contained resistance genes against ciprofloxacin (qnrS1), 
ampicillin and ceftriaxone (blaCTX-M-55). The remaining kanamycin (aph(3')-Ia), gentamicin 
(aac(3)-IId) and colistin (mcr-3.2) genes were each carried on separate contigs. 
 
These findings of clustered antibiotic resistance elements on the genome could be linked to 
the plasmid-mediated resistance in S. Panama that has previously been reported (Lee et al., 
2008). The plasmid complement of the S. Panama serovar has rarely been studied in the past, 
but it is clear that S. Panama does not commonly carry the large plasmids (Carneiro et al., 
2018), that have previously been associated with virulence in other Salmonella serovars 
(Silva et al., 2017). Rather, S. Panama has been reported to carry a heterogeneous population 
of plasmids (Table S4.1) (Stanley et al., 1995). The short read-based plasmid prediction 
analysis (Section 4.2.5) suggested that only 14.72% (72/489) of S. Panama isolates in this 
study carried plasmids. Overall, 76.47% (52/68) of resistant isolates and only 4.75% (20/421) 
of susceptible isolates were predicted to carry plasmids. The AMR determinants were almost 
always carried on a different contig to those predicted to be plasmids, which does not 
necessarily mean that AMR genes are not carried on a plasmid. Specifically, the methodology 
used to predict plasmid contigs, relies upon the identification of contigs containing replicons 
identified in the PlasmidFinder database (Carattoli et al., 2014). Due to limitations in short 
read sequencing data, many plasmid contigs with fragmented assemblies may be missed 
(Arredondo-Alonso et al., 2017). Long-read sequencing would be required to confirm 
plasmid presence/absence in individual S. Panama isolates.  
 117 
 
Figure 4.4 Functional annotation of contigs containing resistance determinants in XDR S. Panama isolate 
Contiguous sequences containing resistance genes extracted from XDR S. Panama. Description of annotations is available in the attached table.
Gene Name Functional Annotation (A)
Unknown Hypothetical protein
yusZ Multispecies KR domain containing protein
yqkA Hypothetical protein
Unknown Hypothetical protein
sul3 Sulfisoxazole resistance gene
insF IS256 family transposase
ebr Quaternary ammonium compound efflux SMR transporter
aadA1 Streptomycin resistance gene
cmlA1 Chloramphenicol resistance gene
aadA2 Streptomycin resistance gene
dfrA12 Trimethoprim resistance gene
IntI1 Integron integrase
Unknown DUF3330 domain-containing protein
Gene Name Functional annotation (B)
Unknown Hypothetical protein
repA Regulatory protein
Unknown Replication protein C
aph(3’)-Ia Kanamycin resistance gene
Unknown Hypothetical protein
mobC Mobilisation protein C
Unknown Hypothetical protein
mobB Mobilisation protein B
Gene Name Functional Annotation (C)
aac(3)-IId Gentamicin resistance gene
tmrB Putative tunicamycin resistance protein
Unknown Hypothetical protein
Unknown Hypothetical protein
Gene Name (Ordered) Functional Annotation (D)
qnrS1 Ciprofloxacin resistance gene
Unknown IS3 family transposase
Unknown IS3 family transposase
Unknown IS3 family transposase
Unknown Tn3 family transposase
Unknown Hypothetical protein
blaCTX-M-55 Ampicillin and ceftriaxone resistance gene
Unknown Hypothetical protein
tnpA IS1380 family transosase
Unknown Tn3 family transposase
Unknown Multispecies transposase
Gene Name (Ordered) Functional Annotation (E)
dgkA Diacyclglycerol kinase
mcr-3.2 Colistin resistance gene
Unknown NimC/NimA family protein
tnpA Tn3 family transposase
10,885 bp
yusZ yqkA sul3 insF ebr aadA1 cmlA1 aadA2 dfrA12 intI1














4.4.4 Phylodynamics and evolutionary timescales of S. Panama 
To infer the evolutionary dynamics and genetic history of the global S. Panama population, 
a Bayesian approach was used (MASCOT template (Müller et al., 2018) implemented through 
BEAST (Bouckaert et al., 2019) (Figure 4.5). Due to the complexity of the evolutionary model 
(Data S4.1) and the limited availability of computational resources, 50/489 S. Panama were 
sub-sampled for the analysis. Because such a small subset was selected to be included in the 
BEAST analysis, it will be important for future analysis to validate results by taking multiple 
random subsets of the data and comparing the results of these multiple runs. Alternatively, 
with increased computational resources, it may be possible to run the analysis on a larger 
dataset. Importantly, the spatial-temporal reconstruction of phylogeny yielded the same 
branching pattern as the maximum likelihood analysis, and major clades had greater than 
99% Bayesian posterior support (except C3 which contained only 1 isolate following sub-
sampling).  
 
The MRCA of all samples in this study date back to the year 1913 (95% HPD = 1815.61-
1986.10). This MRCA coincides with the opening of the Panama Canal in 1914 by the USA, 
raising the possibility of an epidemiological association. I speculate that S. Panama may have 
been circulating in an animal reservoir prior to this time, and the opening of the Panama 
Canal may have been a window of opportunity for global dissemination in humans. 
Predictions for MRCA were similar for all clades in this study, specifically 1987 for C1 (95% 
HPD = 1978.18-1992.75), 1988 for C2 (95% HPD = 1976.18-1996.52), 1988 for C4 (95% HPD 
= 1945.75-2011.92), 1990 for C5 (95% HPD = 1966.69-2003.99) and 1985 for C6 (95% HPD = 
1957.87-2000.99). A limitation of this analysis is that only a subset of randomly selected 
isolates was used to predict dates for lineage emergence. As previously demonstrated in 
Chapter 3, estimations for MRCA predictions can be improved by using older isolates. If 
access to historical isolates became available, then it would be beneficial to rerun this 





Figure 4.5 Phylogeographic and temporal evolution of S. Panama 
(A) Chronograph of 50 S. Panama strains isolated from America (n=29), Asia/Oceania (n=6) and Europe 
(n=13). The figure displays a maximum clade credibility tree. The colour of each branch indicates the 
most likely region of its daughter node. The pie charts indicate the probability of chosen nodes being 
in any of the possible regions. (B) The mean inferred migration rates for pathogen movement, as 
indicated by labels and the width and colour of the arrow. The larger the number, the more likely it is 
that a lineage in the destination location of the arrow originated from the source location of the arrow. 
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Analysing bacterial migration has proven useful in the past for establishing the movement of 
pathogens between different countries (Holt et al., 2012; Okoro et al., 2012). The 
implementation of a structured coalescent approximation in Bayesian statistics can be used 
to model the migration process (Barido-Sottani et al., 2017; Müller et al., 2018). To 
investigate spatial epidemiology, pathogen movement (migrations) was quantified between 
different geographical regions. The term “migration” is used here to describe the inferred 
movement of bacterial pathogens from one part of the world to another. 
 
Based on the current dataset, the most recent common ancestor for the S. Panama serovar 
most likely originated from Asia/Oceania (posterior probability Asia/Oceania=0.7376, 
Europe=0.0825, America=0.1772). This finding is however limited by geographical sampling 
locations and more specifically an absence of sampling from North America. North American 
isolates likely play a key role in the evolutionary history of S. Panama. Specifically, isolates 
from the United States (US) contribute 380 of the 912 S. Panama genomes available 
EnteroBase, but these were not included in my analysis. To determine how the US isolates 
compare with other variants of the S. Panama serovar, a phylogenetic tree was generated 
on EnteroBase. Figure 4.6 show several US-specific branches of the phylogeny. Future 
analyses involving the inclusion of samples from North America would be required in order 
to provide a more complete global picture. 
 
The average migration of S. Panama was lowest towards Asia/Oceania, specifically 3.00 
migrations per 100 years from Europe (95% HPD = 3.43e-5 to 9.75) and 2.11 migrations per 
100 years from America (95% HPD = 4.34e-7 to 7.05). The average rate of migration into 
America was slightly higher, specifically 2.74 migrations per 100 years from Europe (95% HPD 
= 1.33e-5 to 10.6) and 2.48 migrations per 100 years from Asia/Oceania (95% HPD = 3.95e-5 
to 8.95). Average migration was greatest into Europe, specifically 4.98 migrations per 100 
years from Asia/Oceania (95% HPD = 8.35e-4 to 12.8) and 3.57 migrations per 100 years from 
America (95% HPD = 5.11e-6 to 15.5). The high importation of bacterial strains from Asia into 
Europe relative to other average migration rates is of particular concern because the 
majority of Asian isolates carry MDR gene cassettes that confer resistance to multiple classes 






Figure 4.6 cgMLST phylogeny of S. Panama genomes available on EnteroBase 
A core genome MLST tree of 912 S. Panama (based in cgMLST HC400_369) showing additional United 
States branches that are not present in the current study. Colours indicate country metadata available 
on EnteroBase, with grey representing unknown country. The number of isolates available from each 
country is indicated in square brackets. 
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4.4.5 The invasiveness index of S. Panama 
Although S. Panama causes extraintestinal disease globally, the genetic basis of the ability of 
the serovar to cause systemic infection has never been assessed. This capacity, termed 
invasiveness, reflects the ability of the pathogen to cause systemic spread and extraintestinal 
infection in humans (Langridge et al., 2012). Invasive infections cause much higher levels of 
mortality than gastroenteritis; for example, the case-fatality rate of iNTS is 20% (Ao et al., 
2015), whereas the case-fatality ratio of S. Typhimurium-associated gastroenteritis is 0.6% 
(Jones et al., 2008). The invasiveness of some Salmonella serovars can be assessed 
experimentally with animal infection models (Tsolis et al., 2011), but no infection model has 
yet been developed for S. Panama. Consequently, a bioinformatics approach was used to 
determine the relative invasiveness of the various clades of this serovar. 
 
To quantify the extraintestinal potential of S. Panama, the invasiveness index was calculated 
for all 489 isolates in this study. The model previously trained by Wheeler et al. (2018) was 
used, which has already been employed to calculate the invasiveness index of other common 
Salmonella serovars (Van Puyvelde et al., 2019; Wheeler et al., 2018). The model relies upon 
nucleotide differences within genes identified as predictors for invasiveness (Wheeler et al., 
2018). The use of this validated model permitted comparison with the previously described 
invasiveness indices of other common Salmonella serovars (Figure 4.7) (Wheeler et al., 
2018).  
 
The median invasiveness index of S. Panama was determined to be 0.2216 (SD = 0.01952), 
slightly higher than that described for S. Enteritidis, S. Newport, S. Heidelberg, S. 
Typhimurium and S. Agona (Wheeler et al., 2018). In contrast, the invasiveness index of the 
host-restricted serovars Typhi, Paratyphi, Gallinarum, Pullorum, Dublin and Choleraesuis was 
significantly higher than S. Panama (Wheeler et al., 2018). SNPs and InDels were identified 
in each one of the 196 predictor genes for invasiveness, across all samples in this study (when 
compared to the reference list (Wheeler et al., 2018). Genome degradation is a hallmark 
feature of host-adapted serovars that cause systemic disease (Nuccio and Bäumler, 2014), 
raising the possibility that that the S. Panama serovar is in the process of evolving towards a 




Figure 4.7 Invasiveness index of S. Panama compared with common S. enterica serovars.  
Graph indicates the invasiveness index assigned to S. enterica serovars used for approach validation 
by Wheeler et al, (2018) compared with the median invasiveness index of S. Panama identified in this 
study (Section 4.3.7). 
 
To determine whether certain S. Panama clades had the potential to be more invasive than 
others, the invasiveness index values of the six S. Panama clades was compared, as shown in 
Figure 4.8. The median value of invasiveness index was greatest for C4 (median = 0.2356, SD 
= 0.01109), followed by C6 (median = 0.2356, SD = 0.01109), C3 (median = 0.2282, SD = 
0.01284), C2 (median = 0.2254, SD = 0.01870), C1 (median = 0.2193, SD = 0.01579), and C5 
(median = 0.2185, SD = 0.01254). Importantly, the two clades with the highest proportion of 
AMR isolates had significantly higher invasiveness indices than other clades, highlighting that 
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Figure SX: Invasiveness index of S. Panama compared with other common S. enterica serovars. Graph indicates the invasiveness index assigned to S.
enterica serovars used for approach validation in Wheeler et al, (2018) compared with the median invasiveness index of S. Panama identified in this study.
Serovar Invasiveness Index Accession Number Strain Name
Heidelberg 0.0923 CP016507 SH12_003
Agona 0.1129 CP006876 24249
Typhimurium 0.1358 FQ312003 SL1344
Newport 0.1826 CP007559.1 CDC2010K-1259
Enteritidis 0.2099 CP007507 Durban
Panama 0.2261 Not applicable Not applicable
Gallinarum bv. Pullorum 0.5551 CP003786 Not applicable
Dublin 0.7264 CM001151 SD3246
Choleraesuis 0.7963 CM001062 A50
Paratyphi 0.8007 FM200053 A AKU 12601
Typhi 0.8080 AL513382 CT18
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Figure 4.8 Invasiveness index of S. Panama clades 
Box plot representing the distribution of invasiveness index values for all 489 sequences included in 
this study summarised by clade assignment (Section 4.3.7). To determine whether there was a 
significant difference between the invasiveness indexes of groups, the Wilcox Mann Whitney test was 
used and the resultant p-values are displayed above groups. Boxplot centre lines represent median 
values for C1 to C6. Boxplot limits represent upper and lower quartiles, boxplot whiskers represent 

























4.4.6 Genome wide association study 
To understand the genetic basis of the invasiveness of S. Panama, a genome-wide association 
study was conducted. GWAS are increasingly being used to identify the genetic basis of 
bacterial phenotypic properties (Chen and Shapiro, 2015; Power et al., 2017), and can involve 
various technical approaches. Because of the advantages and limitations of each method 
(reviewed elsewhere (Lees, 2017)), a robust GWAS analysis requires the use of a combination 
of techniques (Lees, 2017; Lees et al., 2018; Lees and Bentley, 2016). Here, two accessory 
gene-based GWAS approaches were implemented (Brynildsrud et al., 2016; Lees et al., 2018) 
and one SNP-based GWAS approach (Lees et al., 2018). The results, from each analysis are 
available in Table S4.2. The first accessory gene analysis used a linear fixed effects model to 
identify 357 significant genes, five of which matched those listed in the top 196 
extraintestinal predictor genes used to calculate the invasiveness index, specifically; rna, 
lyxK, mglA, pduG, bcsA and oppA. The gene rna encodes ribonuclease I and had the lowest 
p-value of all genes in this analysis (lrt p-value = 5.09e-5). The second accessory gene analysis 
used a pan-GWAS approach to identify 225 significant genes. The hit with the lowest p-value 
corresponded to an unnamed gene predicted to be a lytic transglycosylase (Odds Ratio = 
5.74, BH p-value = 4.49E-16). Lytic transglycosylases are important in biofilm formation 
(Monteiro et al., 2011), cell wall metabolism and bacterial pathogenesis (Scheurwater et al., 
2008).  
 
To identify the candidate genes most likely to be associated with invasiveness, the findings 
from the two approaches were cross-referenced. In total, 14 genes were identified, 
identified by two different GWAS methods that I implemented, and represent good 
candidates for future invasiveness studies (Table 4.3). Four of the 14 genes were located 
within a prophage region, including a putative site-specific recombinase, a phage tail protein 
and two hypothetical proteins.  
 
Because individual mutations have previously been found to be responsible for systemic 
infection (Hammarlöf et al., 2018), the linear fixed effects model (Lees et al., 2018) was also 
used to search for SNPs associated with the invasive phenotype. No SNPs exceeded the 
suggestive significance threshold (p = 1.29e-5). However, a 46.6kb (1108684-1155312bp) 
region which represented the highest peak in the Manhattan plot was identified (Figure 4.9). 
The region corresponded the same prophage region that was implicated by the accessory 
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gene GWAS findings. The prophage was Fels-2-like and shared 72.22% similarity with the 
prophage RE-2010 (also known as ELPhiS, the Enteritidis lysogenic phage S) (Hanna et al., 
2012). RE-2010 is found in many other extraintestinal Salmonella serovars, including a global 
outlier cluster of Salmonella Enteritidis associated with foodborne disease (Feasey et al., 
2016; Mottawea et al., 2018).  
 
Table 4.3 Genes associated with invasiveness of S. Panama, identified by two independent GWAS 
approaches* 
Gene Annotation Odds Ratio BH p-value lrt p-value 
pin Putative site-specific recombinase on prophage region 0.032 1.38e-12 2.12e-3 
-a Hypothetical protein on prophage region 0.039 2.67e-10 5.04e-3 
-b ISNCY family transposase 13.33 1.77e-9 3.23e-2 
stf Phage tail protein on prophage region 0.15 2.73e-8 6.17e-4 
-c Hypothetical protein 3.83 4.65e-5 1.24e-2 
-d Rpn family recombination-promoting nuclease/putative 
transposase 
6.45 1.45e-4 1.06e-3 
-e 
Rpn family recombination-promoting nuclease/putative 
transposase 0.26 1.86e-4 1.77e-2 
-f Hypothetical protein 5.74 7.56e-4 2.88e-2 
-g Hypothetical protein on prophage region 4.12 1.65e-3 2.17e-3 
-h tRNA-Lys(ttt) 3.10 1.87e-3 1.44e-2 
siiD Periplasmic adapter subunit of HlyD-family type 1 secretion system  involved in adhesion to mammalian cells 0.43 1.00e-2 1.87e-2 
-i tRNA-Asp(gtc) 0.28 2.12e-2 4.22e-3 
rapA RNA polymerase 6.29 2.71e-2 1.86e-2 
yihQ alpha glucosidase 0.16 3.06e-2 2.70e-3 
* Genes were identified in both Scoary gene presence/absence analysis and Pyseer COG analysis 
(Section 4.2.8) 





Figure 4.9 GWAS indicating potential contribution of a Fels-2-like-prophage region. 

































Figure 4.9 GWAS indicating potential contribution of a Fels-2-like-prophage region. 
(A) Manhattan plot showing the –log10 lrt-adjusted p-values for SNPs identified in the GWAS (y-axis) 
plotted against their corresponding position on the reference genome (x-axis) (Section 4.3.8). (B) qq 
plot was created to determine p-value inflation and shows expected − log10-transformed p-values 
plotted against observed − log10-transformed p-values. (C) Annotation of Fels-2-like prophage region 
in S. Panama reference genome (CP012346), and a representative from C6 and C4. The results of a 
pairwise comparison between strains is shown as colour blocks, with red indicating presence and 
white indicating absence (Section 4.3.9). Annotation labels are available in Table S4.3. 
 
Although invasive-associated SNPs were distributed across the whole Fels-2-like region, the 
most significant SNPs (with the lowest p-values) were associated with two prophage-
associated predicted cargo genes. Specifically, SNPs were identified in genes encoding a 
predicted terminase endonuclease subunit and the RrrD lysozyme. The rrrD gene is located 
in the tail fibre region of the RE-2010 prophage, and over-expression of this gene leads to 
bacterial cell lysis (Srividhya and Krishnaswamy, 2007). Interestingly, the RrrD protein is 
required for curli-based biofilm formation (Toba et al., 2011), overlapping with the function 
of the lytic transglycosylase gene identified in the accessory gene-based GWAS above.  
 
Impaired biofilm formation has been linked to host adaptation and systemic disease in 
Salmonella (MacKenzie et al., 2019; Singletary et al., 2016), and further experimental work 
would be required to investigate the biofilm-forming properties of S. Panama. The most 
significant SNPs were most commonly found in C4 and C6, indicating lineage effects (Table 
S4.2). Consequently, the conservation of the Fels-2-like prophage region of the S. Panama 
reference strain ATCC 7378 was explored across phylogenetic clades (Figure 4.10). I found 
that the prophage region was more highly conserved in isolates belonging to C4 and C6 than 
in other clades.  
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Figure 4.10 Conservation of the Fels-2-like prophage across S. Panama clades 
Maximum likelihood phylogeny demonstrating the population structure of 489 S. Panama (details 
described in Figure 4.1). Left colour strip represents cluster assignment (rHierBAPs), with grey 
representing a miscellaneous polyphyletic cluster. To visualise the level of conservation of the Fels-2 
like prophage in individual isolates, a heat map was used. The right colour strip shows % coverage of 




4.4.7 Characterisation of prophages carried by S. Panama C4 and C6 
Prophages are important vehicles for horizontal gene transfer between different S. enterica 
serovars and often carry gene cassettes that contribute to the virulence of host cells 
(Brussow et al., 2004; Figueroa-Bossi et al., 2001; Ho and Slauch, 2001; Owen et al., 2017; 
Wagner and Waldor, 2002). To investigate the prophages implicated in invasiveness in S. 
Panama C4 and C6, the respective regions were extracted from a representative sample in 
each clade and pairwise comparisons were done with well annotated prophages (Figure 
4.11, Table S4.3).  
 
The novel C4 and C6 prophages were predicted to be intact and shared the same attachment 
site as Fels-2 and SopEΦ (Pelludat et al., 2003), located 3’ to the tmRNA-encoding ssrA gene. 
Both of the novel S. Panama prophages carried the majority of functional gene clusters 
required for integration/excision, lysis, and capsid and tail assembly. The C6 prophage was 
33.5kb in length, and resembled Fels-2 and RE-2010 in terms of gene content. Functional 
annotation showed that the C6 prophage also encoded a GNAT family N-acetyltransferase 
and a putative phage abortive infection system. The C4 prophage was larger (45.7kb) than 
the C6 prophage and resembled SopEΦ, carrying an additional 12 genes encoding repressor 
and integrase proteins. The C4 prophage also encoded a phosphoadenosine phosphosulfate 
reductase family protein and a multidrug ABC transporter.  
 
The discovery of two prophage regions that could be involved in mediating the iNTS 
phenotype of the two clades with the highest invasiveness index, and the greatest 
proportion of MDR isolates, clearly warrants further investigation. 
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Figure 4.11 Characterisation of Fels-2-like prophage in S. Panama C4 and C6  
Pairwise comparisons amongst well-characterised prophages and the Fels-2-like prophage in S. 
Panama C4 and C6 (Section 4.3.9). Red blocks indicate regions of similarity and white blocks indicate 
regions absent. Prophage annotations are shown for C4 and C6 (raw data available in Table S4.3). 
Specifically; (A) shows the pairwise comparison amongst C4, Fels-2 (NC_010463.1) and C6; (B) shows 
the pairwise comparison amongst C4, RE-2010 (HM770079) and C6; (C) shows the pairwise 


















This was the first large-scale phylogenetic analysis of the S. Panama serovar, and has 
revealed important information about population structure, AMR, global ecology and 
invasiveness potential. I have specifically identified six geographically associated S. Panama 
clades which share a most recent common ancestor in Asia/Oceania, and were predicted to 
have emerged in the early 1900s. By studying the phylogeographical history of S. Panama, I 
have calculated Bayesian migration rates and quantified global pathogen movement. A key 
finding was the relatively higher rate of immigration of S. Panama into Europe, compared 
with other regions. The importation of Asia/Oceania isolates into Europe could become a 
threat to public health in the future because the majority of Asian isolates carry MDR gene 
cassettes that confer resistance to multiple classes of antimicrobials. 
 
I found that the majority of MDR isolates belonged to two phylogenetic clades; C4 (the 
‘European clade’) and C6 (‘the Asia/Oceania clade’). Strikingly, C4 and C6 also exhibited the 
highest invasiveness indices of all clades in this study: the quantification of loss-of-function 
mutations involving genes which are not necessary in particular environmental conditions 
(Klemm et al., 2016; McClelland et al., 2004; Nuccio and Bäumler, 2014) suggested an 
increased extraintestinal potential. Coupled with the elevated invasiveness index, the C4 and 
C6 clades also carried novel Fels-2-like prophage regions which appeared to carry a signature 
of invasive disease in my SNP-based GWAS.  
 
It will be important to monitor the incidence of C4 and C6 in ongoing genome-based 
surveillance. It is possible that the evolutionary trajectory of S. Panama will parallel the 
Salmonella serovars Enteritidis and Typhimurium, which contain specific lineages and 
pathovariants with an increased invasiveness index that cause significant levels of human 








5.1 Brief introduction 
The question of how Salmonella evolved from simply being a gastrointestinal pathogen to develop the 
ability to cause systemic infections was first posed decades ago. In the genomic-era of pathogen 
surveillance and research, WGS-based technologies facilitate the investigation of nontyphoidal 
Salmonella in the context of bloodstream infections. Thus, my thesis aimed to determine the 
temporal, geographical and evolutionary trends in nontyphoidal Salmonella serovars, in order to 
understand the genomic signatures acquired on the trajectory towards extraintestinal adaptation. 
In this chapter, I will focus on the key conclusions from my research and relate my findings to the 
important literature. 
 
5.2 Population structure as a predictor for niche-adaptation 
In capturing Salmonella population-structure at multiple resolutions, I have revealed hitherto unseen 
insights into the evolution of niche-adaptation in a globally important pathogen. Initially, I found that 
reptiles were the ideal population of animals for the study of species-level evolution of S. enterica 
because they carry phylogenetically diverse isolates that belong to the majority of Salmonella 
subspecies. Thus, in Chapter 2 the population structure of S. enterica was determined using isolates 
collected from venomous snakes and non-venomous reptiles (Figure 2.2). The S. enterica subspecies 
clustered into two clades (A and B) (Section 2.4.2), reflecting findings from previous studies based on 
the alignment of 92 core loci (den Bakker et al., 2011; Falush et al., 2006). An integrated outlook on 
clade-specific serovar distributions and clinical surveillance data has demonstrated that clade A 
contains the majority of serovars responsible for salmonellosis in humans, whereas clade B contains 
several host-adapted serovars (Parsons et al., 2011). Consistent with this epidemiologically suggestive 
data, I have found clade-specific properties which show the reduced overall metabolic repertoire of 
clade B (Section 2.4.5, Figure 2.3), consistent with niche-adaptation that involves a decreased ability 
to occupy the mammalian gastrointestinal tract. In principle, categorising a serovar as clade B, could 
be used as a crude predictor for host-adaptation and the ability to cause systemic disease.  
 
S. Panama is an S. enterica clade B serovar which fits into this overarching classification, being 
responsible for extraintestinal infections globally (Pulford et al., 2019). In Chapter 4, I demonstrated 
that S. Panama has a slightly higher invasiveness index than several host-generalist serovars (Figure 
4.7, Figure 5.1), indicative of a narrowing host range. Global surveillance data suggests that S. Panama 
can survive in various organisms including reptiles, pigs, poultry, cows, goats and wild birds (Cordano 
and Virgilio, 1996; European Food Safety Authority and European Centre for Disease Prevention and 
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Control, 2012; Gay et al., 2014; Guyomard-Rabenirina et al., 2019; Matias et al., 2016). It is possible 
that S. Panama is better adapted to occupy these alternative hosts rather than humans, consistent 
with my finding of that genes involved in survival in the human gut carried loss-of-function mutations 
(Section 4.3.5). These pseudogenisation events are not limited to clade B Salmonella and have been 
seen in other serovars such as S. Choleraesuis which is typically associated with swine but causes a 
severe systemic infection in humans (Chiu et al., 2004). S. Choleraesuis is a clade within the Para C 
sub-lineage of S. enterica clade A which also includes S. Paratyphi C, Typhisuis and Lomita. Each of 
these serovars have evolved host-specificity within a specific niche, and are thought to have arisen 
over the past 4,000 years via a combination of pseudogenes and differential acquisition of two 
genomic islands (SPI-6 annd SPI-7) according to analysis involving ancient DNA (Zhou et al., 2018). To 
further elucidate niche-adaptation within S. Panama it will be important for future studies to adopt a 
one-health approach for selecting samples, incorporating samples from various animal reservoirs.  
 
Despite many host-restricted Salmonella falling into clade B, some of the most important human-
adapted serovars belong to clade A, including S. Typhi and S. Paratyphi C (den Bakker et al., 2011). 
Thus, classifying a serovar as clade A does not necessarily reflect host-range and disease outcome. It 
can also be the case that diversifying selection may occur within serovars that typically occupy a broad 
range of hosts, leading to independent lineages that have evolved to exploit a specific niche. For 
example, in Chapter 3 I have uncovered a series of events that have helped to shape the emergence 
of three invasive S. Typhimurium ST313 lineages in Africa, each at a different stage of niche adaptation. 
 
My data revealed the process of sequential genome decay and accessory genome acquisition, 
highlighting the evolutionary events that were crucial for the development of each lineage (Figure 
3.12). For example, the pseudogenisation of macB, sseI and lpxO appear to be critical to the 
emergence of ST313 L2 (Section 3.4.6). The stepwise pseudogenisation of genes reported here is 
consistent with the host adaptation of S. Typhimurium ST313 lineages over evolutionary history and 
supports mounting evidence for a human ST313 reservoir (Post et al., 2019). My findings in Chapter 3 
relied upon lineage-specific evolutionary insights and phylodynamic investigations, demonstrating 
that it is no longer enough to understand niche-adaptation based purely on serovar designations.  
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5.3 Using genome degradation to predict invasiveness 
I found a common theme of pseudogenisation in iNTS serovars throughout this thesis, supporting 
previous findings that genome degradation can be used as a marker for invasive disease (Langridge et 
al., 2015). The invasiveness index is a good tool for quantifying genome degradation and predicting 
extraintestinal potential (Wheeler et al., 2018). In Chapter 3, I used the invasiveness index to 
demonstrate that ST313 L3 has an elevated extraintestinal potential compared with that of ST19, 
ST313 L1, ST313 L2 and UK-ST313 (Section 3.4.6, Figure 3.13). Consistent with these findings, ST313 
L3 was also found to contain additional degradation in genes required for colonisation of the 
gastrointestinal tract by S. Typhimurium (Section 3.4.7).  
 
The invasiveness index was also used in Chapter 4, to characterise S. Panama. All of the S. Panama 
clades had a higher invasiveness index than the ST313 lineages, highlighting the increased 
extraintestinal potential of the S. Panama serovar compared with the S. Typhimurium serovar (Figure 
5.1). Amongst S. Panama, C4 and C6 had an elevated index (Section 4.3.5, Figure 4.8). It is possible 
that the evolutionary trajectory of S. Panama will parallel S. Typhimurium and S. Enteritidis, containing 
specific lineages and pathovariants with an increased invasiveness index and causing significant levels 
of human bloodstream infections (Stanaway et al., 2019a; Van Puyvelde et al., 2019; Wheeler et al., 
2018). Thus, it will be important to monitor the incidence of C4 and C6 in ongoing genome-based 
surveillance.  
 
Clearly, the use of genome-based genetic signatures does not prove with absolute certainty that 
particular iNTS pathovariants have adapted to an extraintestinal lifestyle. In the past, infection models 
have been important for understanding the virulence and systemic spread of Salmonella 
pathovariants that cause gastroenteritis (Tsolis et al., 2011). However, novel or uncharacterised 
Salmonella pathovariants generally lack animal models that accurately recapitulates human disease. 
Furthermore, the close relationship between systemic disease and host-adaptation has prompted 
concerns about the use of animals to assess the levels of invasiveness in terms of humans. A similar 
issue arose for the invasive pathogen Salmonella Typhi, leading researchers to develop a human 
infection model that proved that the typhoid toxin is not required for clinical infection (Gibani et al., 
2019).  
 
No human challenge model has yet been developed for S. Panama or S. Typhimurium ST313, and 
previous studies have demonstrated that cellular and animal infection models fail to discriminate 
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between levels of invasiveness of ST313 L1 and ST313 L2 (Okoro et al., 2015). This problem was 
exemplified in a recent study which defined a new ST313 sub-lineage identified in the DRC. The study 
by Van Puyvelde and colleagues (Van Puyvelde et al., 2019) showed that the murine whole-animal 
infection model and the human macrophage cellular infection model did not find robust differences 
in terms of invasive disease between the different ST313 lineages and sub-lineages. Extensive animal 
experiments in chickens, chicken embryos and Galleria larvae (Lacharme-Lora et al., 2019) have 
revealed the limitations of discriminating between ST19 and ST313 in all three systems. 
 
Although the invasiveness index cannot be experimentally validated at the moment, it is clear that the 
Salmonella isolates that vary in terms of invasiveness index do produce distinct clinical symptoms in a 
human population (Langridge et al., 2009a; Tack et al., 2020). The routine monitoring of genome 
degradation could be beneficial in a public health setting, to identify host-adapted Salmonella variants 
likely to be responsible for future outbreaks of invasive disease at an early stage. This technique would 
prove particularly useful for emerging pathovariants, for which no animal model yet exists, such as 
ST313 (Chapter 3) and S. Panama (Chapter 4). A limitation of this approach would be the potential for 
false negatives, which may mean that invasive serovars which do not exhibit genome degradation are 
underestimated in terms of clinical disease severity. For example, an internationally distributed 
monophasic S. Typhimurium ST34 variant (S. I:4,[5],12:i:−) has recently reacquired a secondary 
flagellin gene and become associated with invasive disease in HIV-infected individuals. Unlike ST313 
in sub-Saharan Africa, this Vietnamese ST34 variant does not exhibit extensive genome degradation 
(Mather et al., 2018). The development and validation of experimental approaches for the robust 





Figure 5.1 Invasiveness index of S. Typhimurium and S. Panama compared with common S. enterica serovars.  
Graph indicates the invasiveness index assigned to S. enterica serovars used for approach validation by Wheeler 
et al. (2018) (smaller circles) compared with the median invasiveness index of S. Typhimurium lineages (Section 
3.3.9) and S. Panama clades (Section 4.3.7) identified in this study (larger circles). Colours are used to distinguish 



















































































































































5.4 AMR status likely reflects the selection pressures acting upon Salmonella 
pathovariants 
The evolution of virulence to Salmonella lineages involves more than just genome degradation. 
Another factor that has a profound impact upon the emergence of successful iNTS lineages is AMR, a 
property that can be horizontally transferred between bacteria. Plasmid-mediated conjugation of 
AMR genes has recently been demonstrated experimentally following exposure of S. Typhimurium to 
antibiotics in the mammalian gut (Bakkeren et al., 2019).   
 
Differing AMR profiles provide an indication of alternative origins of bacteria and/or variation in 
selective evolutionary pressures within and between bacterial niches (Liao et al., 2020; Mellor et al., 
2019). Throughout this thesis, I have presented evidence of AMR reflecting environmental selection 
pressures. For example, I found very low levels of antibiotic resistance in the Salmonella isolated from 
venomous snakes housed in the LSTM venom unit (Section 2.4.3, Table 2.4), consistent with a lack of 
selection pressure associated with the limited use of antibiotics in reptiles.  
 
I developed this theme by using a genomic approach to confirm that clades of S. Panama from French 
territories of America such as Guadeloupe do not usually carry AMR genes (Section 4.3.3, Figure 4.1). 
Wild reptiles have previously been described as a key reservoir for S. Panama infections in these 
regions of America (Guyomard-Rabenirina et al., 2019) and as I observed in venomous snakes, the 
pan-susceptibility to antibiotics likely reflects a low selection pressure in the wild reptilian reservoirs 
in the French Caribbean. 
 
In contrast, the majority of MDR S. Panama in this study originated in Asia/Oceania or Europe (Section 
4.3.3, Figure 4.1). Microorganisms associated with Asia tend to have higher rates of resistance 
(Nguyen et al., 2013; Nhung et al., 2016). Heavy use of antimicrobials has driven the circulation of 
numerous MDR Salmonella lineages in Asia, including a new variant of MDR S. Typhimurium ST34 
which has been associated with iNTS in Vietnamese HIV-infected patients (Mather et al., 2018) and an 
XDR S. Typhi clone encoding resistance to fluoroquinolones and third-generation cephalosporins 
(Klemm et al., 2018). Thus, S. Panama represents yet another example of the widespread AMR crisis 
in Asia.  
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In Section 4.3.4, the inter-regional migration patterns demonstrated pathogen movement from 
Asia/Oceania into Europe, which may have contributed to AMR in the European S. Panama clade (C4) 
(Figure 4.5). However, this European clade (C4) may also have arisen following an outbreak that 
involved the continental spread of S. Panama across Europe, associated with the food production 
industry in the 1970’s and 1980’s (Cherubin, 1981; Le Minor and Le Minor, 1981; Lee, 1974; Wilkins 
and Roberts, 1988). It likely that the European lineage of S. Panama (C4) has been exposed to a high 
antibiotic selective pressure in humans or food animals and consequently became resistant to multiple 
antibiotic agents via acquisition of multiple mobile genetic elements.  
 
Because AMR Salmonella infections are associated with a higher probability of hospitalisation and 
treatment failure (Krueger et al., 2014), there has been a general bias towards sequencing MDR 
isolates in human surveillance programmes. However, such a bias may obscure the evolutionary 
drivers of AMR that can only be revealed by studying the full range of resistance profiles, including 
susceptible isolates. In Chapter 3, sub-sampling of a comprehensive archive of pathogens allowed an 
extensive range of AMR profiles in S. Typhimurium ST313 responsible for bloodstream infections to 
be captured (Section 3.3.4, Figure 3.7). Across the sampling period changes in antimicrobial usage 
policies occurred at the local level (Queen Elizabeth Central Hospital) in Malawi, including the phased 
removal of chloramphenicol from clinical practice. From approximately 2002 onwards, 
chloramphenicol was replaced by the oral fluoroquinolone, ciprofloxacin for treatment of culture-
confirmed iNTS disease. Additionally, beginning in 2005, the Department of Medicine Malawi began 
to use the third-generation cephalosporin, ceftriaxone for the empirical management of suspected 
sepsis (Feasey et al., 2015). More recently, chloramphenicol has largely been removed from hospital 
and private pharmacies in Malawi suggesting that it is infrequently used to treat any infection (M. 
Gordon, personal communication). Across the study sampling period a reduction in the proportion of 
chloramphenicol-resistant isolates of ST313 L2 was observed (Figure 3.7), raising the possibility that a 
change in policy on empirical chloramphenicol use played a role in shaping the epidemiology of ST313 
S. Typhimurium in Malawi.  
 
Combining the available details on antimicrobial usage with fluctuating AMR profiles allows 
speculation on trends in circulating Salmonella lineages, particularly the switch from MDR ST313 L2 to 
the pan-susceptible ST313 L3 in (Section 3.4.2). Interestingly, UK-isolated ST313 also tend to be 
susceptible to antimicrobial agents (Ashton et al., 2017), raising the possibility that ST313 L3 was 
introduced to Malawi from the UK via an international transmission event. Furthermore, I hypothesise 
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that the phased removal of chloramphenicol from clinical practice following Malawian policy changes 
has reduced selection pressure and opened a window of opportunity for the emergence of fully 
susceptible ST313 L3 in Blantyre. A comprehensive epidemiological study on antimicrobial usage 
would be required to properly investigate this hypothesis. 
 
Combining details of resistance determinants with population structure demonstrates the significant 
advantages of using WGS to study AMR. Previously, such studies have permitted the identification of 
distinct S. Typhimurium (Definitive Type) DT104 populations found in co-located animals and humans 
in an industrialised country (Mather et al., 2013) and discriminated between S. Enteritidis lineages 
associated with gastrointestinal disease in high income settings compared with invasive disease in 
low-income settings (Feasey et al., 2016). Studies in other bacterial pathogens have demonstrated 
how horizontal transfer of an AMR plasmid amongst Shigella enhanced existing epidemics and 
facilitated new outbreaks in the UK (Baker et al., 2018b). Taken together, my findings on AMR have 
captured a snapshot of population-level epidemiological consequences of AMR in the Salmonella 




5.5 Parallel prophage repertoires of invasive pathovariants  
As important vehicles for horizontal gene transfer, prophages also play a diverse and complex role in 
the evolution of bacterial pathogens in response to external selection pressures and often carry gene 
cassettes that contribute to the virulence of host bacterial cells (Brussow et al., 2004; Fang et al., 2017; 
Figueroa-Bossi et al., 2001; Ho and Slauch, 2001; Owen et al., 2017; Wagner and Waldor, 2002). For 
example, ST313 L1 and L2 carry a unique prophage repertoire that includes BTP1 and BTP5. In Chapter 
3, I have demonstrated that both of these prophages were absent from ST313 L3 and UK-isolated 
ST313 (Section 3.4.3, Figure 3.4), suggesting that the two prophages were independently acquired by 
L1 and L2, an important example of convergent evolution. 
  
BTP1  has recently been found to carry the BstA family of prophage defence proteins which defend 
bacterial cells against exogenous attack by a variety of lytic phage, without sacrificing lytic autonomy, 
thus conferring a beneficial trait (Owen et al., 2020). ST313 L3 does not carry BTP1, but instead carries 
a similar P22-like prophage which differs in the phage immunity region, carrying the sieB 
superinfection exclusion phage immunity protein (Section 3.4.3) (Susskind et al., 1974). It is possible 
that the carriage of a gene that mediates abortive phage infection confers a selective advantage to 
ST313 L3, just as BstA improves the fitness of ST313 L2 during phage attack (Owen et al., 2020).  
 
An unexpected finding from my study was the identification of Fels-2-like prophages, in S. Panama C4 
and C6 and S. Typhimurium ST313 L3 which were genetically similar to RE-2010 (Section 3.4.3, Section 
4.3.7, Figure 4.11). The RE-2010 prophage has also been identified in S. Enteritidis causing iNTS disease 
globally (Feasey et al., 2016). Previously, functional insights into Fels-2-like prophages have revealed 
important virulence genes. For example the sopE gene found in the tail fibre region of the prophage 
sopEΦ encodes a protein involved in modulating host cell signalling and causes dramatic increases of 
bacterial cell invasion into host cells (Pelludat et al., 2003). Although the sopE gene was not present 
in any of the Fel-2-like prophages in this study, other genes were highlighted as potentially associated 
with invasiveness by my GWAS (Section 4.3.6, Figure 4.9). The discovery of closely related prophages 
in the three lineages/clades predicted to have the highest invasiveness potentials throughout this 
thesis clearly warrants further investigations at the functional level, particularly focussing on genes 
highlighted in my GWAS.  
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5.6 Towards an integrated approach for pathogen surveillance 
My thesis has demonstrated the benefit of using genomic epidemiology to understand nontyphoidal 
Salmonella serovars and their association with invasive disease, showcasing the revolutionary impact 
of WGS-based approaches. Many of the samples involved in this study were sourced from low-middle 
income settings, which have modest accessibility to routine WGS for pathogen surveillance. Thus, my 
study has been important in improving our understanding of the genomic epidemiology of iNTS in 
these regions. For the future, it is important to strive to improve the accessibility of genomic research 
for lower income settings by continuing studies such as this and boosting capacity.     
 
As genomics becomes a cornerstone of contemporary pathogen surveillance and prevention, it will be 
important to maintain awareness of the limitations of computational approaches. I look forward to an 
integrated approach to public health and scientific research that will enhance our understanding of 
bacterial pathogens in the future. Harnessing the combined power of genome-level discrimination, 
with epidemiological rigour and clinical observation with experimental biology will, ultimately, benefit 
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Data S3.4 Salmonella Typhimurium pseudogenes including description, genotype and phenotype 
Gene 
Name 








Secreted outer membrane 
protein associated with 
gut persistence in murine 
models. 
ST313 L1: Q657*, Q1067H, T885I 
ST313 L2: Q657*, Q1067H, R66C 
ST313 L3: Q657*, Q1067H, R66C, G820S 
Abundance of SNPs occur sporadically 
throughout the phylogeny. 
Although a causal relationship is unproven, inactivation of ratB 
suggested to have reduced the enteric potential of ST313, 
resulting in more systemic infections (Okoro et al., 2015).  
    
katE 
(STM1318) 
Stationary phase catalase 
involved in protecting high 
density bacterial 
communities in the 
environment from 
oxidative stress. 
ST313 L1: E117G 
ST313 L2: E117G 
ST313 L3: E117G 
Synonymous SNPs are additionally present in 
ST313 L1 (AàG at base 1452) and ST313 L3 
(AàG at base 1908). 
Reduction in catalase activity across all ST313 (Ashton et al., 2017; 
Singletary et al., 2016). ST313 L3 had lower catalase activity than 
ST19 (this study). 
 
*bubbles represent catalase activity 




involved in tartaric acid 
utilisation. 
ST313 L1: Q68* 
ST313 L2: Q68* 
ST313 L3: Q68* 
Additional mutations sporadically present 
across the phylogeny. 
L-tartaric acid and dihydroxyacetone cannot be used as sole 
carbon sources by ST313. Results were originally generated with 
Biolog phenotype microarrays (Okoro et al., 2015). ST313 L3 was 





















involved in melibiose 
utilisation. 
ST313 L2: F311L 
ST313 L3: F311L 
An additional synonymous SNP was also 
identified at base position 462 in ST313 L3. 
 
ST313 L2 cannot grow on melibiose as a sole carbon source (Yang 
et al., 2015). Assessment of the alpha-galactosidase activity of 
ST19 and ST313 wild-types and mutant strains showed that melR 
controlled the melibiose utilisation system (Canals et al., 2019). 



















The A166T SNP caused reduced motility in ST313 L2, 
demonstrated by comparing D23580 flhA474 mutant to wild type 
(Canals et al., 2019).  




encoded protein D. 
ST313 L2: 283bp deletion 
ST313 L3: 283 bp deletion plus additional 109 
bp deletion. 
Although a causal relationship is unproven, the pipD gene 
contributes to macrophage persistence in murine models (Lawley 
et al., 2006; Okoro et al., 2015). Of further interest, the 
Salmonella pathogenicity island SPI-5 gene sopB encodes a SPI-1 
effector and has an associated chaperone pipC. In ST19 strains, 
these genes are upregulated in the gastrointestinal tract, which 
facilitates invasion into epithelial cells. However, in ST313 strains 
sopB and pipC are also upregulated in SPI-2 media and 
macrophages (Canals et al., 2019). It is possible that this 
regulatory change is due to the loss of orfX, STM1093 and the 3’ 
end of pipD.  





enzyme involved in biofilm 
formation. 
ST313 L2: W247* The RDAR phenotype of ST313 L2 is negative due to a mutation in 
bcsG (Singletary et al., 2016). The RDAR phenotype of ST313 L3 
has an intermediate RDAR phenotype, however the genetic basis 
is unknown (this study).  
 
*RDAR colony morphology at 25°C 





ST313 L2: E198* 
An additional, synonymous SNP was also 
present across all ST313 lineages (GàT at 
base 411).   
In D23580, lpxO is a pseudogene due to the presence of one SNP 
introducing an early STOP codon (Kingsley et al., 2009). By mass 
spectrometry, it was confirmed that the lipid A of D23580 was not 
modified by LpxO during growth in InSPI2 medium, while the lipid 
A of 4/74 contained this modification when grown in this medium. 
To confirm that LpxO-mediated modification of lipid A, it was 
established that the mass spectrum of the lipid A from a 4/74 
ΔlpxO::aph (KmR) mutant grown in InSPI2 was similar to the 


















Type III secretion system 
effector protein (SPI-2) 
involved in host cell 
dissemination.   
 
In ST313 L2, the sseI gene contains an IS26 
transposase insertion. Generally, ST19, ST313 
L1 and ST313 L3 strains carry a functional sseI 
gene. However, there are several ST313 L1 
genomes which contain the IS26 transposase. 
sseI mutations are abundant and sporadic 
throughout all ST313 lineages. Specific non-
synonymous mutations commonly occur in at 
least 10 amino acid positions; V13N, T47A, 
V69I, V70N, D81A, N86S, L91Q, D114Y, V115A 
and R266G. 
Studies in mice have demonstrated that an accumulation of SNPs 
within sseI in ST313 L2 leads to an increased ability of ST313 L2 
bacteria to disseminate rapidly from the gut to the draining lymph 
nodes in a murine model (Carden et al., 2017). 
    
macB 
(STM0942) 
Putative ABC superfamily 
transport protein required 
to resist peroxide 
mediated killing 
ST313 L1: W262* 
ST313 L2 sub-lineage: Deletion of A and C at 
nucleotide position 444 and 445. 
MacAB is involved in oxidative stress resistance (Bogomolnaya et 
al., 2013) and mediates resistance to macrolide antibiotics 
(Nishino et al., 2006). Recently, ST313 L2-associated variants of 
the MacAB-TolC tripartite efflux pump have been shown to affect 
replication in macrophages, and influence fitness during 
colonisation of the murine gastrointestinal tract (Honeycutt et al., 
2020). 
    
Note: Phenotypic testing was conducted to determine the relevance of functional gene loss by B. Perez-Sepulveda, R. Canals, N. Wenner, X. Zhu, H. Webster 
(University of Liverpool, UK), J. Bengoechea and A. Dumigan (Queens University Belfast, UK). 
* Note that predicted functionality (see methods) is depicted as a colour strip for each gene and is based on whole genome-based predictions of SNPs likely to 
play a functional role. Specifically, blue indicates functional and pink indicates non-functional. 
** Mutations refer to position in individual genes taken from D23580, non-synonymous mutations are listed as amino acid changes including amino acid positions 
and synonymous changes are listed as nucleotide changes with nucleotide positions. 
